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Abbreviations
[Ca2+]i intracellular Ca2+ concentration
ADP adenosine 5’ -diphosphate
APC antigen presenting cell
BAL broncho-alveolar lavage
BHR broncho hyperresponsiveness
CR3 complement receptor 3
DAG diacylglycerol
EAR early asthmatic response
ECM extracellular matrix
ECP eosinophil cationic protein 
EDN eosinophil-derived neurotoxin 
EGF epidermal growth factor 
EPO eosinophil peroxidase
Erk extracellular regulated kinase
ESL-1 endothelial selectin ligand-1
FACS fluorescence activated cell scan
FEV1 forced expired volume in one second
fMLP N formylmethionine leucyl phenylalanine
FN fibronectin
FucT fucosyl transferase
GAP GTP-ase activating proteins
GDI guanine nucleotide dissociation inhibitors
GDP guanosine diphosphate
GEF guanine nucleotide exchange factors
GlyCAM-1 glycosylation-dependent cell adhesion molecule-1
GM-CSF granulocyte/macrophage colony stimulating factor
G-protein guanosine phosphate binding protein 
GRO- a growth related oncogene- a
GTP guanosine triphosphate
HIV human immunodeficiency virus
HSA human serum albumin
HUVEC human umbilical vein endothelial cells
ICAM-1 intercellular adhesion molecule-1
IL-.. interleukin-..
IP3 inositol 1,4,5-trisphosphate
LAD leukocyte adhesion deficiency
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LAR late asthmatic response
LPA lysophophatidic acid 
LPS lipopoly saccharide
MadCAM-1 mucosal addressin cell adhesion molecule-1
MBP major basic protein
MCP monocyte chemoattractant protein
MLC myosin light chain
MoAb monoclonal antibody
PAF platelet activating factor
PAK p21-activated kinase
PECAM-1 platelet endothelial cellular adhesion molecule-1
PIP2 phosphatidylinositol (4,5) bisphosphate
PKA protein kinase A
PKB protein kinase B
PKC protein kinase C
PLC phospholipase C
PMA phorbol myristate acetate
PMN polymorphonuclear cells
PNAd peripheral node addressin
PSGL-1 P-selectin glycoprotein ligand-1
PTX pertussis toxin
RACK receptor for activated C-kinase 
RANTES regulated on activation normal T-cell expressed and secreted
ROCK Rho-associated coiled-coil forming protein kinase
SCR short consensus repeat
SLC secondary lymphoid-tissue chemokine
TNF tumor necrosis factor
VCAM-1 vascular cell adhesion molecule-1
VLA-4 very late antigen-4
Zap70 zeta chain-associated protein 70
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GENERAL INTRODUCTION
Multistep paradigm of 
leukocyte extravasation
For a leukocyte to leave the blood stream and to enter an organ a general model
has been described, often referred to as the multistep model (figure 1) (1;3). The first
step involves tethering and rolling of leukocytes along the endothelial cell layer. 
The second step is the exposure of chemoattractants in soluble form and/or presented
by endothelial cells to the leukocytes. The third step is the activation of the leukocytes
resulting in firm adhesion and spreading. And the fourth step implies the migration of the
leukocytes through the endothelial layer to the inflammatory site. These four steps are
described in detail in the following paragraphs.
Figure 1. Multi step model for leukocyte extravasation. Cells roll on the activated endothelial
cells. Leukocyte activation by encountered chemoattractants results in firm adhesive interactions
to the endothelium. Finally, the cells migrate through the endothelial lining to the site of 
inflammation.
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Tethering and Rolling 
Leukocyte migration to inflammatory sites occurs mainly in the postcapillary 
venules. The blood flow at these sites roughly varies between 3-6 cm/sec. Cells flowing
with these velocities can tether (=a short transient interaction) on the endothelium that
lines the vessel walls. Subsequently, they roll with a speed that is around a thousand
times lower than the speed of free flowing leukocytes in the venule. The moment a cell
is rolling it endures a force of the blood stream called “shear stress”. A certain minimal
shear stress is required for rolling interactions to occur (4;5). As the first interaction
between leukocytes and endothelial cells preceding the rolling phase is called “primary
tethering”, additional recruitment of cells to the surface involves the tethering of fast 
flowing leukocyte to an already bound leukocyte. These homotypic interactions or
“secondary tethering” facilitate the subsequent formation of clusters (6) or strings (7) 
of cells on the vessel wall. The molecules involved in tether and rolling interactions are
the selectins and their ligands (figure 2), which are mucin-like carbohydrate structures
that are sialylated, fucosylated and/or sulfated. 
Selectins
The selectins consist of an N-terminal Ca2+ dependent lectin-like domain (8), 
a single epidermal growth factor (EGF)-like domain, from two to nine short consensus
repeats (SCR), a single membrane-spanning region and a cytoplasmic tail. Three types
of selectins are known, L(eukocyte)-, E(ndothelium)- and P(latelet)- selectin. L-selectin
(CD62L) is present on almost all leukocytes and is located on the tips of the microvilli (9).
This extended cellular distribution is ideal for capturing and rolling of cells on the 
endothelium (10;11). Upon leukocyte activation L-selectin is shed from the surface (12).
Although healthy individuals have already soluble L-selectin in their blood, increases in
plasma levels of soluble L-selectin is associated with disease status and might be used
for monitoring diseases (13-15). E-selectin (CD62E) is expressed on activated endothelial
cells. Inflammatory mediators such as TNF a , IL-1 and bacterial lipopolysaccharide
(LPS), control the expression at the level of transcription. Typically, E-selectin is expres-
sed 2-3 hours after stimulation, peaks around 4-6 hours and returns to basal levels after
10 to 12 hours on human umbilical endothelial cells (HUVEC), that are commonly used
as an in vitro model for endothelial cell monolayers. Besides its upregulation in inflam-
mation it is known that E-selectin is constitutively expressed on skin venules mediating
rolling of leukocytes, thereby increasing the immune-surveillance (16). P-selectin
(CD62P) is pre-stored in Weibel-Palade bodies and a -granules present in endothelial
cells and platelets, respectively. Upon activation by inflammatory mediators such as
14
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histamine, thrombin or complement factors (17) the granules fuse with the plasma
membrane ensuring a fast expression of P-selectin on the cell surface. Besides this direct
expression, P-selectin can also be induced at the transcriptional level by inflammatory
mediators. E- and P-selectin have overlapping functions in vivo. Knock-out models have
shown that E-selectin and P-selectin double knock-out mice are susceptible for sponta-
neous cutaneous infections whereas their single deficient counterparts are not (18). 
Selectin ligands
The counter ligands of the selectins form a diverse group of carbohydrate 
structures attached to a core of specific glycoproteins (figure 2). Fucose-, sialic acid- and
sulfate residues on the carbohydrates largely determine the functionality of the ligand
(19). This is illustrated by the fact that removal of sialic acid from leukocytes or cell lines
by neuraminidase treatment results in reduced binding to selectins (20;21). Furthermore,
sulfotransferases have been shown to add a sulfate to a glycan chain, leading to specific
Figure 2. Selectins and selectin ligands are presented by eosinophils and endothelial cells.
PSGL-1 binds to P-selectin but can also bind to E- and L-selectin. ESL-1 is a specific ligand for 
E-selectin. L-selectin has many specific ligands: CD34, MadCAM, GlyCAM and PNAD. 
Further ligands for E-,P- and L-selectin are discussed in the text.
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structures (22). Also, much research has been done on the enzymes that decorate 
glycoproteins with fucose, of which fucosyltransferases (FucT) IV and VII are the most
important in leukocytes (23;24). A study on skin venules in FucT-VII and -IV knock-out
mice has established that FucT-VII is most important for decoration of P-selectin ligands
and subsequent tethering to the endothelium, whereas both FucT- VII and -IV are 
needed for efficient E-selectin ligands and subsequent slow rolling (16). The need for
fucose residues is further illustrated by the rare genetic human disease leukocyte 
adhesion deficiency type II (LADII) (25). The deficient fucose metabolism in these
patients results in afunctional selectin epitopes, leading to decreased leukocyte 
adhesion to the endothelium and therefore recurrent episodes of bacterial infection.
Thus far, oral fucose therapy has been shown to be a succesful therapy in one patient
because it induced the expression of fucosylated selectin ligands and as a consequence
the infections disappeared (26). 
All three selectins can recognize the sialyl Lewisx and sialyl Lewisa tetrasaccharides
(27;28) and their sulfated equivalents, as suggested from adhesion studies. However,
Slex has a very low affinity for selectins ranging from micro- to milli-molars (29;30).
Therefore, the recognition of these structures in vitro does not automatically imply that
these interactions occur in vivo. The context in which the residues are presented seems
more important for the functionality of the ligand. In this respect high affinity ligands have
been described for each selectin. L-selectin has four specific high affinity ligands, PNAd
(Peripheral Node Addressin) (31), GlyCAM-1 (Glycosylation-Dependent Cell Adhesion
Molecule-1) (32), CD34 (33) and MadCAM-1 (Mucosal Addressin Cell Adhesion 
Molecule-1) (34). E-selectin binds with high affinity to ESL-1 (E-selectin ligand-1) (35).
PSGL-1 was originally described as a specific ligand for P-selectin (36) but it can also
bind E-selectin (37) and L-selectin (38). The presence of Slex moieties in P-selectin 
glycoprotein ligand-1 (PSGL-1) is not enough for the high affinity binding to selectins.
Binding of PSGL-1 to P-selectin requires a 1,3 fucosylation by FucT-IV and/or -VII and a 2,3
sialylation. Also, the location of Slex on O-branched glycans and sulfation of tyrosine 
residues within the N-terminal of the polypeptide makes PSGL-1 a specific ligand for the
selectins (39). A recent paper demonstrated an additional complexity; the presence of
the O-linked branching enzyme core 2 b 1,6-N-glucosaminyltransferase (C2GlcNacT-1)
adds an additional O-linked glycan chain on an existing one and creates an epitope for
high affinity binding to P-selectin, which is not required for binding to E-selectin (40). 
It is thought that what a selectin actually recognizes is a clustered saccharide patch
(reviewed in (27)). Treatment of cells with the enzyme O-sialoglycoprotease (41) that
recognizes and cleaves large numbers of closely spaced O-linked oligosaccharides 
abrogates the binding to selectins (42). Overall, the presence of specific enzymes in a
cell determines the decoration of the selectin ligands, thereby controlling the 
interactions with the different selectins. 
Chemoattractants and their receptors
Binding of chemoattractant to receptors on the rolling leukocyte induces firm
adhesion of the cell to the endothelial lining and subsequent migration. It is thought 
that an important part of the chemoattractants are presented by glycoproteins on the
endothelium and this has been shown for IL-8 (43). Chemoattractants can be divided in
classical chemoattractants that have been described decades ago and chemokines that
have been described more recently. Both groups bind to GTP-binding protein 
(G-protein)-coupled seven spanning transmembrane receptors (or serpentine 
receptors). These receptors are characterized by the presence of a G-protein that 
consists of an a and a bg subunit. Upon receptor activation the G-protein exchanges GDP
for GTP resulting in dissociation of the a from the bg subunit. This process leads to 
activation of phospholipase C (PLC) and this enzyme hydrolyses its substrate 
phosphatidylinositol (4,5)- bisphosphate (PIP2) into inositol (1,4,5) trisphosphate (IP3)
and diacylglycerol (DAG). IP3 binds to its receptor on intracellular Ca2+ storage 
organelles with subsequent release of Ca2+ in the cytosol, whereas DAG activates 
protein kinase C (PKC) (44). Ca2+, PKC and other intracellular messengers that are 
activated control a broad array of cellular processes such as chemotaxis, differentiation,
proliferation and survival (45). 
Classical chemoattractants 
The classical chemoattractants activate most leukocyte subsets. These chemo-
attractants can be divided in at least 3 different groups; bacterial peptides such as fMLP,
serum factors such as C5a and C3a, and bioactive lipids such as LTB4 and PAF. 
Chemokines
The chemokine family can be divided in four groups, the CCL, CXCL, CX3CL and
CL chemokines that bind to their receptors CCR, CXCR, CX3CR and CR, respectively (46).
All chemokines share structural elements including conserved cysteine residues that
form disulfide bonds in the tertiary structure. The CCL, CXCL and CX3CL have four 
cysteines that form disulfide bonds with no, one or three amininoacids (X) in between
the cysteines, respectively. The C group only has one disulfide bond. Of each of the 
subgroups CL and CXC3L only one member is known today, lymphotactin (47) and 
fractalkine/neurotactin (48), respectively. The number of chemokines in the CCL (28
members) and CXCL (16 members) groups has grown extensively in the last decade,
16
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and they have overlapping functions, although some specificity is present (49). Besides
the structural classification of chemokines a classification according to function can also
be made. Part of the chemokines are continuously expressed in the body for direct
homing of leukocytes, thereby securing immuno-surveillance. An example is the stromal
cell derived factor (SDF-1, CXC chemokine), which plays a major role in homing of stem
cells to the bone marrow (50). Furthermore, secondary lymphoid-tissue chemokine
(SLC) is expressed by lymph nodes and spleen and attracts lymphocytes to these sites
(51). Other chemokines are expressed upon an inflammatory reaction, and might 
therefore be called inflammatory chemokines. Generally, it is thought that CCL 
chemoattractants are more chemotactic for monocytes, eosinophils, lymphocytes and
basophils whereas the CXCL chemoattractants are probably more specific for 
neutrophils and to a lesser extent for basophils and T-cells (52). One reason why 
chemokines have overlapping functions is that different chemoattractants can bind to
the same receptor and that one chemokine can bind to distinct chemokine receptors. 
In this respect RANTES, eotaxin and MCP2 and MCP3 can all bind to CCR3 (53;54) and
RANTES binds to CCR1, CCR3 and CCR5 (55).
Firm adhesion and spreading
Activation of the rolling cell by chemoattractants induces firm adhesion and 
subsequent spreading of the cell. Firm adhesion is mediated by integrins on the 
leukocytes that bind to their counter ligands on the endothelium belonging to 
the immunoglobulin superfamily (figure 3).
Figure 3. Integrins are expressed by leukocytes and their ligands of the IgS are expressed 
on endothelial cells. For eosinophils the integrins VLA-4 and MAC-1 are important for firm 
adhesion to VCAM-1 and ICAM-1, respectively. LFA-1 is less abundant on eosinophils. 
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Integrins
Integrins are heterodimeric proteins that consist of an a subunit that is 
non-covalently bound to a b subunit. At least 8 different b subunits ( b 1-8) and 18 different
a subunits ( a L,M,X,D, a 1-11, a E, a IIb, a v) have been described on human cells that 
combine to form 24 known adhesion receptors (56) (Hemler Keystone 2001) (Table 1).
The integrins that are important for leukocyte adhesion to endothelium are all four 
members of the b 2 integrin family; a Lb 2 (CD11a/CD18, LFA-1), a Mb 2 (CD11b/CD18, 
Mac-1, CR3), a Xb 2 (CD11c/CD18, p150,95) and a D b 2(CD11d/CD18) and two members of
the b 1 and b 7 integrin family, a 4b 1 (VLA-4) and a 4 b 7, respectively. a Lb 2 is expressed on all
leukocytes although the highest expression is found on lymphocytes. a Mb 2 and a Xb 2 are 
predominantly expressed on granulocytes, monocytes and macrophages. a D b 2 was
characterized as an integrin present on foam cells (57) but also appears to be present on
a subset of leukocyte populations (58). a Lb 2 binds to ICAM-1,-2 and -3, whereas a Mb 2
binds to ICAM-1 (59), C3bi (60), fibrinogen (61), heparin (62), LPS (63), factor X (64) and
an unknown molecule (65). a D b 2 and a 4 b 1 integrins both bind to VCAM-1 (66;67). 
The importance of functional b 2 integrins in host defense mechanisms is illustrated by
the rare genetic disease LAD I (Leukocyte adhesion deficiency I) (68;69). These patients
have no expression of b 2 integrins on their leukocytes and suffer from recurrent bacterial
infections. The only permanent therapy for this disorder is allogeneic bone marrow
transplantation of which graft verus host disease is the major drawback (70). 
On non-activated, resting cells integrins maintain a conformationally inactive state. 
An exception of this characteristic accounts for the a 4b 1 integrin that is present on 
resting cells and is able to bind to its ligand VCAM-1 (71-73). Upon stimulation by 
chemoattractants or other stimuli integrins change their conformation leading to 
increased affinity and/or avidity. This process is called “inside-out” signaling (74-76). 
The binding, however, of integrins to their ligands in itself may lead to activation of 
intracellular signaling pathways; this process is called “outside-in” signaling. 
19
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Table I The integrin receptor family. Table is a modified form of Hynes (56) with additives from
(77, 78, 74).
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Adhesion counter-receptors belonging to 
the Ig superfamily members
Immunoglobulins are plasma proteins including all antibody molecules and 
are characterized by an immunoglobulin domain. Members of the immunoglobulin
superfamily share structural and genetic features with immunoglobulin molecules and
contain at least one immunoglobulin domain. The vascular endothelium expresses
molecules of the immunoglobulin superfamily, which act as counter-receptors for 
leukocyte integrins. Three immunoglobulin type ligands are present on the endothelium,
of which ICAM-2 is constitutively present and ICAM-1 and VCAM-1 are induced by 
cytokine stimulation. ICAM-1 is also expressed on activated epithelial cells, mediating
eosinophil adhesion and activation in patients with allergic asthma (79;80). VCAM-1 is
constitutively expressed on bone marrow endothelium and is thought to play a role in
homing to this site (81). 
Migration
Chemoattractant-induced activation of leukocytes leads to firm adhesion and 
spreading on the endothelium. Subsequently, cells crawl to the site where endothelial
cells connect to each other and migrate in between them to the inflammatory site. It was
shown that outside-in signaling by adhesion of neutrophils to endothelial receptors 
increased the endothelial permeability by disorganizing endothelial cell-to-cell adherent
junctions and thus facilitating migration (82). Another mechanism for passing the 
endothelial layer is the observation that neutrophils do not crawl in between endothelial
cells but migrate through an endothelial cell (83). When cells have passed the 
endothelium they interact with the extracellular matrix (ECM) (84). For neutrophils 
b 1- and b 3- but to a lesser extent b 2-integrins are essential for adhesion to ECM proteins
such as fibronectin, collagen I and IV, laminin, vitronectin and tenascin (85). Finally, cells
enter the site of inflammation.
The process of migration
The spread cell has a typical tear-drop resembling shape (figure 4). The broad and
flat edge is the leading front of the cell also called the lamellipodium, while the narrow
end at the rear of the cell is called uropod (86). Signals both from chemoattractants and
from integrin crosslinking lead to extension of the lamellipodium membrane, a process
called protrusion. Filopodia are other protrusions and resemble thin cylindrical 
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needle-like projections. Protrusion is associated with an increased polarization of 
filamentous actin (F-actin), and in fibroblasts it has been shown that in the protruding
lamellipodium focal adhesion formation takes place. Focal adhesions are structures of
clustered integrins associated intracellularly with structural and signaling molecules
(87). In fibroblasts, focal adhesions were shown to increase in size as the cell moves over
them, and when they reach the rear of the cell, they are left behind (88;89) and/or are 
recycled (90). In leukocytes smaller structures than focal adhesions are present that 
are called focal complexes or adhesisomes, and these appear to have the same 
characteristics (91). In neutrophils, a 5 b 1 integrins are translocated from the uropod to the
leading edge via endosomes (92). This might be a Ca2+ dependent process since 
buffering of Ca2+ transients was shown to inhibit the recycling of integrins. Moreover,
eosinophils showed low Ca2+ concentration in the leading edge and a high Ca2+
concentration in the uropod (93). However, in neutrophils this could not be shown (94).
Such Ca2+ distribution might enable release of cell-substratum attachments in the 
uropod without also contracting the leading edge, since the myosin based contraction is
a Ca2+ dependent process.
Role of Rho GTP-ases in migrating cells
The most important molecules regulating cell migration are the members of 
the Rho GTP-ase family including Rac, Cdc42 and RhoA (95). Rho GTP-ases are low
molecular weight molecules that switch between an inactive GDP bound state and an
active GTP bound state (96). Rac1 is implicated in lamellipodium formation (97), Cdc42
mediates filopodia formation (98) and RhoA controls actomyosin mediated contraction
and focal adhesion formation (99). In general, the adhesion sites in fibroblasts induced
by Rac activation are smaller than those induced by RhoA and are called focal 
Figure 4. Specific characteristics of a
migrating eosinophil. Clearly visible 
are the bilobed nucleus (1) and the 
granules (2). The leading lamellipodium
(3) protrudes on the albumin coated 
surface in the direction of migration (4).
The rear of the cell is called the uropod (5)
and release of this part allows movement
of the cell.
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complexes. Adhesion sites induced by RhoA are large arrow-shaped complexes and are
called the focal adhesions. The latter are connected to the RhoA-induced stress fibers in
the cell which in this way can generate traction force in the cell leading to migration. 
As discussed before, focal adhesions and stress fibers are not present in leukocytes;
however, RhoA is implicated in generating traction force and therefore could be 
important for retraction of the uropod.
The role of the multistep model in chronic 
inflammatory diseases
The multistep paradigm is a valid model for leukocyte homing to different organs.
For immunological homeostasis it is important that leukocytes travel back and forth
between the blood, the lymphoid tissue and the peripheral tissues. The adhesion 
molecules and cytokines needed for this leukocyte extravasation are continuously 
present. This is in clear contrast to inflammatory situations in the tissues. Pathogens 
present at a specific site of the body should be eliminated. At that site an inflammatory
response is evoked and characterized by de novo cytokine production and adhesion
molecule upregulation. This leads to the extravasation of leukocytes that clear the 
pathogens from the body. However, when the immune system cannot control this
response properly, a chronic inflammatory response may be evoked. A typical example
of this situation is the disease allergic asthma that is characterized by a sustained 
leukocyte infiltration and inflammation in the bronchial tissue. However, one important
difference with a pathogen-driven inflammatory reaction is that in asthma the response
is directed to non-hazardous allergens (see below). 
Facts and clinical aspects of asthma 
Over the last decades the prevalence of asthma has dramatically increased 
(100-102). The incidence of asthma is up to 30% of certain populations in the Western
civilization (103, 104). The clinical symptoms of this disease, like wheezing, dyspnoea
and cough, are due to reversible airway obstruction and hyperresponsiveness of the 
airways (105). Airway obstruction is caused by contraction of smooth muscle cells,
secretion of mucus, oedema due to enhanced vascular permeability and cellular 
infiltration of the airway wall. Hyperresponsiveness is an exaggerated bronchoconstric-
tive response to a variety of non-specific stimuli, which under healthy conditions do not
evoke an airway obstruction. Pharmacological agents like histamine and methacholine
can also induce this hyperresponsiveness and are used in the clinic to determine the
23
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severity of the disease. An asthmatic reaction can be divided in an early and a late 
asthmatic response (EAR and LAR respectively) (106). In general, the onset of the EAR is
immediately after allergen challenge; it peaks around 15 minutes and resolves within 
1 to 3 hours. In approximately 50% of the patients the EAR is followed by a LAR that starts
around 4-6 hours after allergen challenge and can last for 12 hours or even longer. 
Both EAR and LAR are associated with decreased but reversible changes in lung 
function, as expressed by forced expired volume in one second (FEV1), but the 
underlying mechanisms causing the shortness of breath are different. The main event
evoking the early asthmatic response is the IgE-dependent release of histamine and
other mediators from the mast cell. Histamine is a potent bronchoconstrictor and 
can also induce mucus secretion and microvascular leakage. Besides mast cells,
macrophages and epithelial cells are also activated and release acute-phase and 
chemotactic factors like leukotrienes, thromboxanes and platelet activating factor (PAF)
and cytokines. The development of the LAR is characterized by a mobilization of 
inflammatory cells. Several leukocyte subtypes, of which eosinophils are the most 
dominant, migrate into the mucosa of the bronchi upon locally produced chemoattrac-
tants (107). The number of eosinophils present in bronchial biopsies and broncho-
alveolar lavage (BAL) fluid are associated with the severity of the disease (108). 
Immunological processes in asthma
It is well accepted that the clinical features of allergic asthma are caused by a 
chronic inflammation of the airways (109-110) (figure 5). However, the exact mechanism
of the onset of the disease is not known. Genetic and environmental factors are thought
to play a role in creating the conditions in which the immune system is triggered to react
on non-hazardous antigens (allergens). Allergens can be divided in two catagories:
indoor allergens (like house-dust mite, cat and cockroach) and outdoor allergens (like
birch pollen and hay). Indoor allergens are believed to account for the increase in 
asthmatic patients seen in the last decades (112). Antigen-presenting cells (APC) take up
allergens from the environment on a daily basis in any individual. The immune system of
part of the population sees these allergens as hazardous. In these people the induction
of atopy starts. Atopic individuals have allergen-specific IgE in their serum and show 
positive reactions to extracts of common allergens on skin prick tests. However, the 
presence of atopy does not necessarily mean that a person develops an allergic disease
like asthma. Also, the moment of production of allergen-specific IgE and the moment of
an asthmatic response can be years apart. The allergens are presented by APCs in a MHC
class II restricted way to CD4+ T-cells that become activated and subsequently start
secreting cytokines like IL-4, IL-13, IL-5, GM-CSF and IL-3 (113). IL-4 induces isotype 
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switching of B cells that start to produce allergen-specific IgE (114). This IgE binds to
high-affinity IgE receptors on mast cells. 
An early asthmatic response can be initiated when an allergen crosslinks the IgE 
molecules on a mast cell. This induces a direct release of histamine, cytokines and other
mediators from pre-stored granules. Subsequently, these compounds mediate the
recruitment and survival of leukocytes and induce a shift of T cells to a Th2 like subtype
(113;115). At this point the late response leads to chronic inflammation. Additionally, 
on top of the chronically inflamed bronchial tissue in allergic asthmatics, an additional
allergen challenge can induce an early and a late response and an exacerbation of the
disease. 
Eosinophils are one of the main leukocyte subtypes present in allergic asthmatic airway
tissue. They are thought to contribute to the severity of the disease. Therefore, this 
thesis focuses on eosinophils and how they extravasate to bronchial tissue.
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Figure 5. The onset of an immune response against allergens involves the uptake of the 
allergen by the antigen presenting cell (APC). Environmental and genetic factors are thought to
contribute to the decision of the immune system to respond to “non-hazardous” allergens. 
The allergen is processed by the APC and presented in a MHC class II restricted way to a T-cell
in a draining lymph node (LN). The Th2 cell produces IL-4 and IL-13 and activates a B-cell, and
the latter starts producing allergen-specific IgE. At this stage atopy is induced. This stage can be
maintained for years without developing allergic symptoms. The IgE present in the blood and 
tissues can bind to IgE receptors on mast cells. The early reaction starts when an allergen
crosslinks IgE bound to the mast cell, which leads to activation and degranulation of the mast
cell. Secretion of histamine, PAF and other cytokines leads to several effects: bronchoconstriction
(BC), vasodilatation (VD), nerve stimulation (NS), mucus secretion (MS). The late response starts
when inflammatory cells, such as eosinophils, enter the lung. The cascade triggered by mast cells
eventually leads to activation of endothelial cells and subsequently, T cells and eosinophils (eos)
enter the lung. IL-5, secreted by Th2-cells, is a potent priming agent for eosinophils. The grey
rectangle depicts the working field of this thesis.
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Eosinophils
Eosinophil structure and function
Eosinophils were already recognized in 1880 (116;117). They contain a bilobed
nucleus and many granules. These granules, that could be stained by the acidic dye
eosin, gave eosinophils their name. The granules contain many cationic proteins, of
which eosinophil peroxidase (EPO), eosinophil-derived neurotoxin (EDN), eosinophil
cationic protein (ECP) and major basic protein (MBP) are most abundant (118). These
basic proteins are thought to play an important role in eosinophil associated diseases
such as parasitic infections and allergic asthma. In parasitic infections, eosinophils are
thought to play a positive role. Indeed, it has been shown that the basic proteins can kill
helminths (119). In allergic asthma eosinophils are thought to play a negative role. 
The basic proteins secreted by eosinophils might be responsible for remodeling the
bronchial epithelial layer, resulting in an increase in bronchial hyperreactivity (120).
Eosinophils of asthmatic patients have been found in close contact with the epithelium
and filled the holes of desquamated epithelial cells (109). Also, bronchoalveolar lavage
fluid of hyperreactive compared to normoreactive mild atopic asthma patients has been
shown to contain more eosinophils, MBP and epithelial cells (121). In addition, IL-5 
activated eosinophils have been shown to degranulate and secrete eosinophil cationic
protein when bound to activated epithelial cells in a b 2 integrin-dependent way (122).
Thus, eosinophils that appear in the lung during the late asthmatic response contribute
to the damage of functional structures, leading to impairment of the disease.
Priming of eosinophils
A characteristic of allergic asthma is not only the elevated number of eosinophils
in the bronchial mucosa, but also in the peripheral blood. Normally 1-3% of the white
blood cell population are eosinophils, whereas in allergic asthmatics this is generally
between 3-6% and it can even be higher. Many data suggest that the presence of the 
eosinophilotrophic factor IL-5 causes elevated levels of eosinophils. A correlation
between elevated eosinophil counts in peripheral blood and tissues and an increase in
IL-5 was found in asthmatic patients (123;124) but also in other diseases such as a 
parasite infection (125) and some forms of hypereosinophilia (126). In accordance, it is
well established that IL-5 is important for the differentiation of a pluripotent stem cell
towards the eosinophilic lineage (127;128) and the survival (129) of mature eosinophils. 
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Since eosinophils are thought to be the major effector cells in chronic asthma, many 
studies have addressed the role of IL-5 in the development of this disease. It has been
shown that IL-5 inhalation by asthmatics induces an increase in eosinophils in the 
peripheral blood and an increase in BHR (130;131). Also, many animal models of 
asthma show correlations between IL-5, pulmonary eosinophilia and airway 
hyperresponsiveness (132-135). Furthermore, anti-IL-5 treatment abolished pulmonary
eosinophilia and bronchohyperresponsiveness in animal models (132;133). Together,
these studies suggest that antagonism of IL-5 might be an attractive anti-asthma therapy.
Leckie et al. (136) studied the effect of a humanized anti-IL-5 antibody in allergic 
asthmatics and showed a reduction in blood eosinophils, but not a change in airway
hyperresponsiveness and LAR. These first results seem to be disappointing but some 
critical points can be raised regarding this study: 1) the investigated group was very small
and 2) the mild asthmatics did not have a clear induction of BHR upon allergen 
provocation at the start of the study, making it difficult to see an effect of therapy (137).
Although the role of IL-5 in allergic asthma has not crystalized yet, the role of IL-5 on 
eosinophil function is much more clear. 
An important effect of IL-5 and also of the related cytokines IL-3 and GM-CSF on the 
eosinophil is preactivation or priming of the cell (138). Priming by itself does not induce
effector responses of leukocytes but instead elevates the (pre)activation status of the
cell. Upon addition of a second stimulus the cellular responses are much stronger than
those induced by the stimulus alone. For example, eosinophils of healthy subjects when 
primed with IL-5, IL-3 or GM-CSF have an enhanced respiratory burst in response to 
opsonized particles (139) and migration in response to PAF (140) compared to the 
addition of these activators alone. Eosinophils from allergic asthmatic patients show
similar responses in the absence of a priming cytokine, indicating that a primed 
phenotype is already induced in vivo in these patients (140;141). Priming of the cells is a
potent mechanism that is likely to contribute to the severity of the disease. Especially
adhesion processes of eosinophils are increased by priming of the cells (140;142-149).
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Eosinophil rolling, adhesion and migration 
to allergic inflammatory sites
The observation that eosinophils are specifically recruited to the bronchial 
mucosa in allergic asthmatic patients suggests the existence of specific adhesion 
pathways. However, common pathways are used by different cells and probably only the
combination of molecules used in each step might give a specificity in recruitment
(146;150). Eosinophils roll on activated endothelial cells, using all three selectins, E-, 
P- and L-selectin. L-selectin has been shown to mediate eosinophil adhesion to 
activated endothelium in a rotation assay (151) and also in vivo (152). The observation
that a specific antibody against L-selectin (LAM1-11) can block eosinophil-, but not 
neutrophil-dependent L-selectin interactions with the endothelium suggests that the
recognition site on L-selectin differs between neutrophils and eosinophils (151). This
might contribute to specificity. Many studies suggest that P-selectin/PSGL-1 interaction
contributes to specific eosinophil recruitment. A role for P-selectin was found in binding
of eosinophils to nasal polyp endothelium (153), under flow conditions (154-156) and in
animal models for allergy (157-159). Eosinophils bind with greater affinity to P-selectin
than neutrophils. However, it is not known whether this is due to the increased 
expression of PSGL-1 on eosinophils compared to neutrophils (153), a difference in
structure of PSGL-1, or the presence of other P-selectin ligands on eosinophils. Although
P-selectin seems important in eosinophil recruitment to allergic inflammatory sites, 
E-selectin is likely to play a role too. E-selectin, ICAM-1 and VCAM-1 expressions are
increased on venules in bronchial mucosa of allergic asthmatics compared to controls
(160-163), whereas no immunohistochemical studies have reported the presence of 
P-selectin. Although eosinophils cannot roll as efficiently as neutrophils on E-selectin
(164;165), eosinophil recruitment in a murine model of allergic skin was dependent both
on P-selectin as well as on E-selectin (166). Also, in P-selectin-deficient mice the 
eosinophil recruitment to the lung after ovalbumin challenge was only reduced by 50%
compared to wild-type mice, suggesting that additional pathways such as E-selectin 
and VCAM-1/VLA-4 can occur (159). The versatile a 4 b 1 integrin behaves not only as an
integrin but can also mediate tethering and rolling (167;168). Eosinophils, like 
lymphocytes, use a 4 integrins for initial attachment to VCAM-1-expressing endothelial
cells, and subsequently it is used for firm adhesion (154). Although VLA-4 has been
shown to be present on neutrophils (169;170), many studies have shown that 
eosinophils but not neutrophils adhere to VCAM-1-expressing endothelium in an a 4 b 1
integrin dependent way (71-73;171). Many in vivo (172-176) studies suggest that the 
a 4 integrin/VCAM-1 interaction is important for eosinophil recruitment to allergic 
inflammatory sites. Of the b 2 integrin members the a Mb 2 (Mac-1) integrin is most highly
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expressed on granulocytes whereas a Lb 2 integrin is most prominent on lymphocytes.
Upon stimulation, the a Mb 2 integrin on eosinophils is activated (177) and binds to its
diverse ligands, including ICAM-1. This interaction is a prerequisite for firm adhesion and
migration of eosinophils, as determined by in vitro (178;179) and in vivo data (180-183).
Another level of controlling specific recruitment is the presence of cytokines and 
chemoattractants. The cytokines IL-13 and IL-4 specifically upregulate VCAM-1 and 
P-selectin on endothelial cells (184), whereas IL-1 b and TNF a induce E-selectin, 
VCAM-1 and ICAM-1. Adhesion and migration studies have shown that C5a (185), 
PAF (186;187), RANTES (188) and eotaxin-1, -2 and -3 (181;189;190) are potent 
chemoattractants for eosinophils, of which the eotaxins are most specific. However, 
the eotaxins also induce migration of basophils (191) and under specific conditions 
of T-cells (192), since the eotaxin receptor (CCR3) is present on these cells. The 
mechanism by which eosinophils pass the endothelial layer is not known. PECAM-1 has
been shown to be involved in migration for different leukocyte subtypes (193-195) 
however not for eosinophils (196;197). Finally, eosinophils enter the bronchial tissue by
directed migration through the ECM proteins. Since asthma is characterized by airway
remodeling (198), the composition of the ECM in asthmatic patients (199) might finally
also give specificity to the migration of the eosinophils. 
Aim of the study
This study focuses on the different mechanisms by which eosinophils interact with
the vasculature. A prerequisite for studying these interactions is that experiments are
performed under flow conditions. Only under flow conditions the different steps 
described in the multistep model (tethering, secondary tethering, rolling and firm 
adhesion) can be studied. Figure 6 depicts the model system used to answer 
the research questions 1-3, as described below. Migration processes have been studied
with a time-lapse microscopy technique on 2D substrates, and this was used to answer
the fourth research question. 
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Figure 6. In vitro flow chamber model. Coverslips with a layer of confluent TNF a -activated
endothelial cells are placed in the in vitro flow chamber (1). Eosinophils are put in a reservoir (2)
and a pump (3) pulls the eosinophils through the flow chamber over the endothelial cells. 
On the microscope (4) a video camera (5) is mounted and with the video recorder (6) video
sequences of rolling and adhering cells (7) are recorded. Experiments are performed at 37°C. 
A heater (8) regulates the temperature in the incubation box (9).
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Research questions:
1) Which adhesion molecules mediate the recruitment of eosinophils on activated 
endothelium?
In chapter 2, the adhesion molecules involved in the rolling and adhesion events of
eosinophils to TNFa -activated HUVEC are characterized under flow conditions. 
2) Do eosinophils of allergic asthmatic patients differ from eosinophils of healthy
controls in adhesive behaviour on activated endothelial cells under flow 
conditions?
In chapter 3, the adhesive behaviour of eosinophils of healthy individuals and 
allergic asthmatic patients on activated HUVEC is compared.
3) Which effects do different chemoattractants have on the transition of rolling to 
firm adhesion of eosinophils and how is this regulated?
In chapter 4 and 5, the effects of IL-8, eotaxin and C5a are examined on the 
transition from a rolling to a (firm) adhesive state. Furthermore, the effects of IL-8,
eotaxin and C5a on integrin-mediated inside-out control are investigated.
4) Which mechanisms are used by granulocytes to migrate in response to 
chemoattractants?
In chapter 6, the role of the GTP-ase RhoA in the detachment process of 
granulocytes on 2D surfaces is investigated.
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Abstract
The multistep model of leukocyte adhesion reveals that selectins mediate rolling
interactions and integrins mediate firm adhesion processes. In this study the interaction
between eosinophils and TNF a -activated HUVEC (second or third passage) was studied
under flow conditions (0.8 and 3.2 dyn/cm2). Especially the role of a 4 integrins on 
eosinophils and E-selectin on HUVEC was studied. Inhibition of the integrin a 4 chain 
on eosinophils reduced the number of firmly adhered resting eosinophils to 
TNF a -stimulated endothelium by 43 %, whereas the percentage of rolling cells increased
2.2-fold compared to untreated control eosinophils. Blocking of E-selectin on the 
endothelium reduced the number of adherent eosinophils only by 23 % and 16 %. In this
situation however, hardly any rolling adhesion was observed, and the few rolling cells
showed a low rolling velocity. Blocking both a 4 integrin on eosinophils and E-selectin 
on HUVEC reduced the number of adhered eosinophils by 95 %. P-selectin did not 
significantly participate in eosinophil adhesion to TNFa -activated HUVEC. Inhibition of
both a 4 integrins and b 2 integrins on eosinophils resulted in a reduction of adhered cells
by 65 % and a 3-fold increase in percentage of rolling cells. Taken together, these results 
clearly show that resting eosinophils preferentially use constitutively active a 4 integrins
(a 4 b 1, a 4 b 7) for the first attachment to TNF a -activated HUVEC. In addition, a 4 integrins
and E-selectin work synergistically in eosinophil adherence to TNF a -activated HUVEC.
While E-selectin is important for eosinophil rolling under these conditions, P-selectin
plays only a minor role.
Introduction
Eosinophils play an important role in allergic inflammatory diseases such as 
allergic asthma. Infiltrates of these cells are present in the interstitium and the lumen of
the bronchi of asthmatic patients (1). Eosinophils must pass the endothelium to enter
this site of inflammation. A widely accepted paradigm for leukocyte extravasation is 
the multistep model. In this model selectins mediate rolling interactions between 
leukocytes and endothelium and subsequently, activated integrins facilitate firm 
adhesion and extravasation of the cells (2). For eosinophils these specific interactions
with the endothelium have not been fully elucidated and are subject of this study. 
In marked contrast to neutrophils, eosinophils constitutively express the b 1 integrin a 4 b 1
(very late antigen 4, VLA-4, CD49dCD29) (3-6). VLA-4 is also present on monocytes,
lymphocytes and basophils, while its counter structure VCAM-1 is present on activated
endothelium (7;8). Although selectins primarily mediate rolling interactions, it has 
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been suggested that VLA-4 on lymphocytes (9;10) and cell lines (11) can play a role in
this process as well. For eosinophils, discrepancies exist on the role of a 4 integrin in
mediating initial attachment to the endothelium. A study in postcapillary venules of 
IL-1 b -activated rabbit mesentery showed that eosinophils utilize VLA-4 and L-selectin for
rolling interactions. However, still 50 % of the rolling interactions persisted even though
VLA-4 and L-selectin were blocked (12). Very recently, Patel et al. (13) showed that 
eosinophils use a 4 integrins in tethering to IL-4-stimulated endothelial cells under 
flow conditions. In contrast, Kitayama et al. showed in a flow chamber model that a 4
integrins did not mediate initial attachment nor constitutive rolling interactions of 
eosinophils on TNF a -activated HUVEC but only mediated immediate arrest after 
P-selectin-dependent initial attachment (14). 
In contrast to a 4 integrins, E-, P- and L-selectin are generally agreed upon as very 
important molecules in initial tethering and rolling adhesion of leukocytes to 
endothelium, including eosinophils. Under static conditions eosinophils can adhere both
to P- and E-selectin (4;15). Under flow conditions eosinophils have been reported to
accumulate more avidly on P-selectin compared to neutrophils (16). On the other hand,
neutrophils adhere more efficiently to E-selectin-coated surfaces under flow conditions
(17). In concordance with these findings, Kitayama et al. showed a role for P-selectin in
the first attachment of eosinophils to TNFa -stimulated first passage HUVEC and did not
see an effect on primary tethering when E-selectin was blocked (14). Taken together,
eosinophils seem to be less E-selectin-dependent for rolling interactions with activated
endothelium when compared to neutrophils. The role of L-selectin in rolling of 
eosinophils is thought to be of less importance than E- and P-selectin. However, 
L-selectin has been shown to mediate adhesion of eosinophils to HUVEC under 
conditions of shear, although experiments were performed at 4°C and no controlled
shear stress was used (18).
Increased expression of VCAM-1, E-selectin and ICAM-1 is associated with pulmonary
allergic inflammation (19-22). Therefore, these molecules and their ligands might be
adhesion receptors for eosinophils to adhere to postcapillary venules present in the
bronchial mucosa. However, many animal models do not lead to a consensus regarding
this issue. An interesting primate model for asthma showed that anti-ICAM-1 therapy
reduces lung eosinophilia and hyperreactivity (23). In addition, the latter study showed
that after single antigen exposure anti-E-selectin treatment reduces lung neutrophilia in
primates. In rats, anti-VLA-4 treatment did not have an effect on neutrophilia (24) nor on
eosinophilia (25). In contrast, the combination treatment of anti- a 4 integrins and anti-
VCAM-1 showed a reduction in eosinophil and lymphocyte infiltration in the lung of mice
(26). in vivo studies in mice showed that recruitment of eosinophils (27;28) and other
48
CHARACTERIZATION OF EOSINOPHIL ADHESION TO TNF a -ACTIVATED
ENDOTHELIUM UNDER FLOW CONDITIONS: a 4 INTEGRINS MEDIATE
INITIAL ATTACHMENT AND E-SELECTIN MEDIATES ROLLING
leukocytes (29) at inflammatory sites is mainly mediated by P-selectin. However, these
studies also suggest a role for E-selectin in this process (28;29). 
In the current study the interactions between eosinophils and TNFa -activated HUVEC
were investigated in an in vitro flow chamber model. Special emphasis was given to a 4
integrins on the eosinophils and E-selectin on the endothelium. 
Materials and Methods
Reagents 
Percoll was obtained from Pharmacia (Uppsala, Sweden). N-formyl-methionyl-
leucyl-phenylalanine (fMLP) was purchased from Sigma Chemicals (St. Louis, MO).
Human serum albumin (HSA) was purchased from the Central Laboratory of 
The Netherlands Red Cross Blood Transfusion Service (Amsterdam, The Netherlands).
Recombinant human TNF a was purchased from Boehringer Mannheim (Germany).
HEPES incubation buffer contained 20 mM HEPES, 132 mM NaCl, 6 mM KCl, 1 mM
MgSO4, 1.2 mM KH2PO4, supplemented with 5 mM glucose, 1.0 mM CaCl2, and 0.5 %
(w/v) HSA. All other materials were reagent grade.
Antibodies 
The MoAb HP2/1 (anti VLA-4, CD49d) was purchased from Immunotech (Marseille,
France). Two blocking anti E-selectin (CD62e) MoAbs were used; ENA2 was kindly 
provided by Dr. W.A. Buurman (University Hospital, Maastricht) (30) and BBIG-E4 (5D11)
was purchased from R&D systems ( Abingdon, UK). MoAb IB4 and MoAb DREG56 were
isolated from the supernatant of a hybridoma obtained from the American Type Culture
Collection (Rockville, MD, USA). The MoAb WASP12.2 (anti P-selectin, CD62p) (31) was
purchased from Endogen (Boston, MA, USA). The MoAb PL-1 (anti PSGL-1, anti CD 162)
was purchased from Immunotech (Marseille, France). All MoAbs mentioned above are
functionally blocking antibodies. Control antibody W6/32 (anti HLA-A,B,C) was isolated
from the supernatant of a hybridoma obtained from the American Type Culture
Collection (Rockville, MD, USA). MoAbs were incubated with eosinophils (4x106
cells/ml) or with confluent HUVEC layers on cover slips at 10 m g/ml during 15 minutes
before the experiments. The cell suspensions were diluted once with incubation buffer 
(final concentration of 5 m g/ml MoAb at 2x106 cells/ml in HEPES incubation buffer), 
and the coverslips were placed directly in the system.
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Isolation of eosinophils
Blood was obtained from healthy volunteers from the Red Cross Blood Bank,
Utrecht, The Netherlands. Mixed granulocytes were isolated from the buffy-coat of 
500 ml blood anti-coagulated with 0.4 % (w/v) trisodium citrate (pH 7.4) as previously
described (32). Mononuclear cells were removed by centrifugation over isotonic Ficoll
(1.077 g/ml). After lysis of the erythrocytes with an isotonic ice-cold NH4Cl solution, the
granulocytes were washed and resuspended in RPMI 1640 (Gibco, Paisley, UK) with 
0.5 % (w/v) human serum albumin (HSA). 
Granulocytes were incubated for 30 min at 37°C to restore the initial density of the cells.
Thereafter, the cells were washed and resuspended in phosphate-buffered saline (PBS)
supplemented with 0.5 % HSA and 13 mM trisodium citrate, and incubated with fMLP 
(10 nM) for 10 min at 37°C, to decrease the specific gravity of the neutrophils, but not that
of the eosinophils. Subsequently, eosinophils were obtained by centrifugation (20 min,
1000 g) over isotonic Percoll (density 1.082 g/ml, layered on Percoll with a density of 
1.1 g/ml), washed and resuspended in HEPES incubation buffer. Purity of eosinophils
was >95 %, (and recovery was usually 80-90 %). This procedure leads to the isolation of 
relatively unprimed eosinophils compared to conventionally used isolation procedures
with immunomagnetic beads (33). 
Endothelial cells
Human umbilical vein endothelial cells (HUVEC) were isolated from human 
umbilical cord veins according to Jaffe et al. (34), with some minor modifications (35).
The cells were cultured in RPMI 1640 containing 20 % (vol./vol.) heat-inactivated human
serum, 200 m g/ml penicilin/streptomycin (GIBCO, Life Technologies, Breda, 
The Netherlands) and fungizone (GIBCO, Life Technologies, Breda, The Netherlands).
Cell monolayers were grown to confluence in 5-7 days. Endothelial cells of the second
passage or third passage were used in perfusion assays. HUVEC was activated by TNF a
(100 U/ml, 7 hours, 37°C) prior to the perfusion experiments.
Perfusion chamber
Perfusions under steady flow were performed in a modified form of transparent
parallel plate perfusion chamber (36) as previously described by Van Zanten et al. (35). 
This micro-chamber has a slit height of 0.2 mm and width of 2 mm. The chamber 
contains a circular plug on which a coverslip (18 mm x 18 mm) with confluent HUVEC
was mounted. 
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Eosinophil perfusion and evaluation
Eosinophils in suspension (2x106 cells/ml in HEPES incubation buffer) were 
aspirated from a reservoir through plastic tubing and the perfusion chamber with a
Harvard syringe pump (Harvard Apparatus, South Natic, MA). In this way, the flow 
rate through the chamber could be precisely controlled. The wall shear stress (t) 
was calculated according to the Navier Stokes equation: t = (6Q • h )/(w • h2). In this
equation Q is the volumetric flow rate, h is the suspending medium coefficient of 
viscosity (assumed to be equal to water at 0.01 poise), w the slit width and h is the slit
height. The shear stress is proportional to the rate of flow of the cells and can be 
calculated as dyn/cm2.
Eosinophil perfusions were performed as individual runs under specific shear conditions
all in a 37°C temperature box. During the perfusion, the flow chamber was mounted on
a microscope stage (DM RXE, Leica, Weitzlar, Germany) which was equipped with a
B/W CCD-video-camera (Sanyo, Osaka, Japan), coupled to a VHS video recorder.
Perfusion experiments were recorded on video tape. Video images were evaluated for
the number of adhered cells, the rolling velocity per cell and the cluster index, using 
dedicated routines made in the image-analysis software Optimas 6.1 (Media Cybernetics
systems, Silverspring, MD, USA). The eosinophils which were in contact with the surface,
appeared as bright white-centered cells after proper adjustment of the microscope
during recording. The adhering cells on the HUVEC were detected by the image-
analyzer. The number of surface-adhered eosinophils was measured after 5 minutes 
perfusion at a minimum of 25 randomized high power fields (total surface of at least 
1 mm2). Then buffer was perfused and shear rates were increased from 0.8 to 2, 3.2 
and 6.4 dyn/cm2 each for 1 minute during which high power fields were recorded to
determine rolling velocities at these shear rates. To automatically determine the velocity
of rolling cells custom-made software was developed in Optimas 6.1. A sequence of 
50 frames representing an adjustable time interval (d t, with a minimal interval of 80 
milliseconds) was digitally captured. At each frame, the position of every cell was 
detected and for all subsequent frames the distance travelled by each cell and the num-
ber of images in which a cell appears in focus was measured. The velocity of a cell (v)
in micrometers per sec was calculated from the equation: v = L/ d t(x-1) in which L is the
covered distance (m m), d t is the time interval between images (seconds), and x the 
number of images in which a cell appears. The cut-off value to distinguish between 
rolling and static adherent cells was set at 1 m m/sec. Rolling velocity classes were 
depicted which is defined as the fraction of the total number of rolling cells in each group
exhibiting a rolling velocity corresponding to the velocity classes as indicated (figure 3).
With this method, static adherent, rolling and freely flowing cells (which were not 
in focus) could be clearly distinguished. Cluster index was measured as previously
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described (37). The number of surface adhered eosinophils per mm2 was measured
after 5 minutes of perfusion at a minimum of 20 randomized fields. For each adherent
cell the number of cells in the surrounding area of approximately 1750 m m2 was 
measured. In the case of a random distribution, the expected number of cells inside this
area was calculated based upon the mean number of surface-adherent cells per mm2. 
The cluster index was set to be the difference between the measured and the expected
number of cells inside an arbitrary area around the cell. In equation: Cluster index per
cell = |m-(X*a/A-1)|, in which m is the measured number of cells in the rectangle area, 
X is the total number of cells in the image, A is the size of the total image and a is the
size of a rectangular cell-surrounding area. For each experiment the mean cluster index
of a minimum of 500 cells was calculated. 
Statistical Analysis. Results are expressed as mean ± standard error of the mean (SEM).
Statistical analysis of the data was performed using a one-way ANOVA against fixed value
with Bonferroni correction, one-way ANOVA with Bonferroni correction or paired
Student T test as indicated in the figures. P values < 0.05 were considered to be 
significant.
Results
E-selectin and aa 4 integrins are important adhesion molecules in initial 
attachment to TNF aa -stimulated HUVEC
The role of different adhesion molecules in eosinophil-endothelium interactions
was examined using blocking antibodies. Figure 1 shows the number of adherent cells
per mm2 (= total number of firmly adhered and rolling cells) to activated HUVEC 
(TNFa , 100 U/ml, 7h) under flow conditions (0.8 dyn/cm2) as a percentage of control
(untreated) eosinophils. Panel A focuses on the adhesion molecules mediating rolling
and panel B focuses on those mediating adhesion interactions. Treatment of eosinophils
with the anti-PSGL-1 antibody PL-1 or treatment of HUVEC with anti-P-selectin WASP12.2
did not significantly decrease the number of adherent cells, showing the minor 
importance of these adhesion molecules under these conditions. HUVEC incubated with
anti-E-selectin antibodies (ENA-2 or 5D11) showed a slight decrease in adherent cells.
However, this did not reach significance. When eosinophils were incubated with the
anti-integrin a 4 chain antibody HP2/1, only 58 ± 7 % of the eosinophils were able to
adhere. Interestingly, a combination of anti-a 4 MoAb with anti-E-selectin MoAbs ENA-2 or
BBA2 almost completely abolished adhesion. The percentage of binding eosinophils was
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only 4.3 ± 1.6 % and 5.9 ± 1.7 %, respectively. This additive effect was not observed for
anti-P-selectin treatment in combination with HP2/1 (46 ± 16 % adhesion, figure 1A). 
In panel 1B the treatment of eosinophils with the anti-integrin a 4 chain antibody HP2/1
is shown again. Furthermore, the combination of blocking a 4 integrins and b 2 integrins
resulted in an additive effect whereby 35 ± 9 % of the cells remained adherent. 
This effect was significant (paired Student T test; p=0.002). The combination of blocking
E-selectin and a 4 integrins is significantly different from blocking a 4 integrins alone
(ANOVA with Bonferroni correction: p<0.005). Treatment of b 2 integrins by MoAb IB4
resulted in 89 ± 7 % of adherent eosinophils compared to control. Also, blocking both 
b 2 integrins on the eosinophils and E-selectin on the endothelium did not result in 
a change in percentage adherent cells (89 ± 12 %). Treatment of eosinophils with the
antibody W6/32 (anti HLA-A,B,C) compared to control eosinophils (no MoAb) showed
no difference in adhesion, 1169 ± 233 and 1292 ± 134, respectively (p=0.362 paired 
Student T test).
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Figure 1. Effect of inhibition of selectins and integrins (int.) with blocking antibodies on the 
interaction of eosinophils to TNF a -activated endothelium. Panel A shows the effect of blocking
rolling receptors and panel B shows the effect of blocking firm adhesion receptors (except the
combination in which E-selectin is blocked). Cells (2x106/ml) preincubated in the presence or
absence of blocking monoclonal antibodies (10 m g/ml, 15 minutes, 37°C) were perfused at a
shear stress of 0.8 dyn/cm2 during 5 minutes, and images were recorded on video. At least 
30 images were counted off line by image analysis (see Materials and Methods section). Number
of adherent eosinophils (rolling and firm adherent cells) was determined as a percentage of 
control values (resting, non treated eosinophils on 7h TNF a -stimulated HUVEC). The absolute
number of adherent cells in the control situation was 1142 ± 167 eosinophils/mm2. Percentages
are shown ± SEM of 3 to 5 different experiments. The statistically significant effects of the 
blocking antibodies were determined by ANOVA against fixed value with Bonferroni correction
for non-paired data (* p<0.001) or by paired Student T test for paired data (** p=0.002).
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E-selectin, aa 4 integrins and bb 2 integrins function differently in the rolling 
behaviour of eosinophils
The role of different adhesion molecules in rolling processes of eosinophils on 
activated endothelium was examined using blocking antibodies. Percentage of rolling
cells was determined by image analysis of video images (see Materials and Methods 
section, figure 2). Panel 2a focuses on adhesion molecules mediating rolling interactions. 
On activated HUVEC (TNFa , 7h, 37°C), 21 ± 4.4 % of the surface-interacting eosinophils
were rolling. Blocking PSGL-1 or P-selectin did not affect percentage rolling compared to
the control situation. By blocking E-selectin the percentage rolling cells decreased by
more then 50 % compared to control (ENA-2: 4.2 ± 1.8 %, BBA2: 8.0 ± 2.0). A significant
increase in the percentage rolling cells was observed when a 4 integrins were blocked
(44 ± 5.9 %). However, blocking both a 4 integrins and P-selectin did not significantly
differ from blocking a 4 integrins alone (54 ± 7.5 %). Panel 2b focuses on adhesion 
molecules mediating firm adhesion. The control situation and treatment of eosinophils
by anti a 4 integrins are depicted as in figure 1a. Blocking b 2 integrins did not have 
a significant effect on percentage of rolling cells. By blocking both b 2 and a 4, again a 
significant increase in the percentage of rolling cells was observed (61 ± 8.1 %). Blocking
a 4 integrins and E-selectin simultaneously resulted in an amount of cells too low to 
evaluate percentage of rolling cells.
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Figure 2. Effect of inhibition of selectins and integrins (int.) with blocking antibodies on the 
percentage of rolling eosinophils on TNFa -activated endothelium. A) shows the effect of blocking
rolling receptors and B) shows the effect of blocking firm adhesion receptors. Cells (2x106/ml)
preincubated in the presence or absence of blocking monoclonal antibodies (10 m g/ml, 
15 minutes, 37°C) were perfused at shear stress 0.8 dyn/cm2 and during the second and third
minute of perfusion at least three areas were recorded on video for a period of at least 
5 seconds. At least 100 cells were studied per perfusion and data were analyzed off line by
image analysis (see Materials and Methods section). Percentage of rolling cells (>1 m m/sec) 
of the total amount of adhering cells was calculated. Means are plotted for 3 to 4 experiments
± SEM. The statistically significant effects of the blocking antibodies against control situation 
or between different treatments (as indicated in figure) were determined by paired Student T-test
(*: p<0.05) or One Way ANOVA with Bonferroni correction (**: p< 0.005, ***: p<0.001).
Rolling velocities are shown in figure 3. The percentage cells in each velocity class is 
plotted against the different velocity classes. Rolling velocity classes are defined as the
fraction of the total number of rolling cells in each group exhibiting a rolling velocity 
corresponding to the velocity classes as indicated. The median and mean rolling 
velocities are shown in table I. The mean rolling velocity of control eosinophils to 
activated endothelium was 4.8 m m/sec (median; 2.6 m m/sec). Eosinophils treated with
anti PSGL-1 (PL-1, median; 2.8 m m/sec), anti b 2 (IB4, median; 3.1 m m/sec) and HUVEC
treated with WASP12.2 (anti-P-selectin, median; 3.6 m m/sec) showed the same profile in
frequency distribution as control cells (data not shown). However, when E-selectin was
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blocked, the mean rolling velocity decreased to 4.3 m m/sec and the median rolling 
velocity was shifted to 1.7 m m/sec, although this was not significantly different from the
control situation. By blocking a 4 integrins it was shown that besides the significant 
increase in percentage of rolling cells, the mean rolling velocity of the cells increased to
12.2 m m/sec (median; 9.4 m m/sec). Blocking both a 4 integrins and P-selectin or both a 4
integrins and b 2 integrins resulted in similar velocity profiles compared to blocking of a 4
integrins alone (data not shown, medians; 12.2 m m/sec and 10.0 m m/sec, respectively). 
Figure 3. Effect of inhibition of selectins and integrins with blocking antibodies on the rolling
velocity of eosinophils on TNF a -activated endothelium. Frequency distribution of rolling cells at
shear stress 0.8 dyn/cm2. Percentage of rolling cells of the total number of cells (= rolling and
firmly adhering to the endothelium) in each velocity class is plotted. The sum of the percentages
per group equals the percentages shown in figure 2. First point represents velocity class of 
1 to 2 microns/sec, following points represent velocity class of 2 to 4, 4 to 6 microns/sec etc.
Cells rolling faster than 1 m m/sec were considered as rolling cells. Data represent mean 
percentages ± SEM of indicated number of experiments.
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Table I. Effect of inhibition of selectins and integrins with blocking antibodies on the median 
rolling velocity of eosinophils on TNFa -activated endothelium.
Eosinophils were incubated with indicated MoAbs (10 m g/ml) for 15 minutes and flow 
experiments on 7h TNFa -activated HUVEC at 0.8 dyn/cm2 were performed. The rolling 
velocities of at least 100 cells per experiment out of at least 3 experiments were determined 
(see Materials and Methods) and the median and mean rolling velocities (m m/sec) were 
calculated. The statistically significant effects (p) of the blocking antibodies against control 
situation were determined by one-way ANOVA with Bonferroni correction.
Effect of different shear rates on rolling velocities and 
behaviour of eosinophils
The effects of different shear rates on median rolling velocities of resting untreated
eosinophils and HP2/1-treated eosinophils were examined. Eosinophils were allowed to
interact with the endothelial surface for 5 minutes (0.8 dyn/cm2). Then buffer was 
perfused with increasing shear stresses of 2, 3.2 and 6.4 dyn/cm2 each for 1 minute.
Rolling velocities of at least 100 cells were measured at these time intervals and the
median rolling velocity of the total amount of rolling cells is shown in table II. Increasing
shear forces of 0.8, 2, 3.2 and 6.4 dyn/cm2 had a slight increasing effect on median 
rolling velocity of resting eosinophils on TNFa -activated HUVEC. The mean rolling 
velocity of control eosinophils at a shear rate of 3.2 and 6.4 dyn/cm2 was significantly 
different (p<0.05) from the rolling velocity at shear rate 0.8 dyn/cm2. The median rolling
velocity of eosinophils treated with HP2/1 increased from 8.6 m m/sec at 0.8 dyn/cm2
to 19.5 m m/sec at 6.4 dyn/cm2. These cells increased their mean rolling velocity with
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increasing shear stresses of 2, 3.2 and 6.4 dyn/cm2 significantly (p<0.001) compared 
to a shear stress of 0.8 dyn/cm2. The mean rolling velocity of control eosinophils versus 
HP2/1-treated eosinophils was significantly lower at all four different shear rates
(p<0.001, table II).
Table II. Median rolling velocities and mean rolling velocities (± SEM) of total amount of 
rolling cells at different shear rates for resting control eosinophils and anti-a 4 integrin-treated
eosinophils on 7h TNF a -stimulated HUVEC.
Effect of different shear stresses on the rolling velocity of eosinophils on TNF a -activated HUVEC
in the presence or absence of an anti-a 4 integrin MoAb (HP2/1). After 5 minutes of perfusion 
at a shear stress of 0.8 dyn/cm2 the shear was increased to 2.0, 3.2 and 6.4 dyn/cm2 during 
1 minute, respectively. Median and mean rolling velocities (m m/sec) ± SEM were calculated from
at least 100 cells (see Materials and Methods section) out of three experiments (except #: n=2).
The statistically significant effects (p) of anti- a 4 integrin treatment (HP2/1) versus control situation
were determined for each velocity class by one way ANOVA. The asterisk (*) indicates the 
significant effects (p<0.05) of the mean rolling velocity in the shear class 2, 3.2 and 6.4 dyn/cm2
versus the 0.8 dyn/cm2 value in each group (control- and HP2/1-treatment) determined by 
one-way ANOVA.
Effect of high shear stress on adhesion and rolling of eosinophils
When resting, untreated eosinophils were perfused at a shear stress of 3.2 dyn/cm2
during 5 minutes, the total number of adherent cells was 1089 ± 167, which was not 
significantly different from experiments performed at a shear stress of 0.8 dyn/cm2
(p=0.72 paired Student T test). At a shear stress of 3.2 dyn/cm2, strings (cell clusters in
the direction of the flow) were visible. This suggests a role for L-selectin (19;38). 
To address the role of L-selectin in this situation, blocking studies were performed. 
In the control situation strings were observed (figure 4a) and the cluster index was 
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1.5 ± 0.2. Inhibition of L-selectin by blocking MoAb DREG-56 (10 m g/ml) resulted in a
cluster index of 0.85 ± 0.2 (p=0.05 Paired Student T-test) and less strings were observed
compared to the control situation as shown in figure 4b. Incubation of eosinophils with
control antibody W6/32 (anti HLA-A,B,C) did not affect percentage of adherent cells 
(103 ± 14 %). Also, blocking E-selectin did not significantly influence the number of
adherent cells (102 ± 14 %) while blocking a 4-integrins did (39 ± 8 %). When both 
L-selectin and E-selectin were blocked still 30 ± 8 % of the eosinophils remained 
adherent (table III). No cells were attached to the surface when both E-selectin and 
a 4 integrins were blocked, which is similar to the situation at a shear stress of 
0.8 dyn/cm2 (n=1). The percentage rolling cells at a shear stress of 3.2 dyn/cm2
increased 1.5-fold compared to 0.8 dyn/cm2. When a 4 integrins were blocked at a shear
stress of 3.2 dyn/cm2, 67.5 ± 14 % of the cells were rolling. In contrast, when E-selectin
was blocked only 13.6 ± 6 % of the cells showed a rolling interaction, which did not
decrease further when L-selectin was blocked in addition to E-selectin. The mean rolling
velocity in the control situation was 7 ± 0.5 m m/sec, which is 1.5 times higher than at 
a shear stress of 0.8 dyn/cm2. Inhibition of a 4-integrin increased the rolling velocity to 
18 ± 0.6 m m/sec which is 1.6 times as high as at a shear stress of 0.8 dyn/cm2 (table II).
However, blocking E-selectin did not significantly reduce the rolling velocity compared
to the control situation. Also, inhibition of both L-selectin and E-selectin did not 
significantly differ from the control situation. 
Figure 4. Effect of inhibition of L selectin with blocking antibody DREG56 (10 m g/ml) on the 
distribution pattern of eosinophils on TNF a -activated endothelium. Cells were perfused in 
the presence or absence of anti-L-selectin over 7h TNFa -activated HUVEC at a shear stress of
3.2 dyn/cm2. Images were recorded on video during 5 minutes, and cluster indexes were 
determined subsequently (see Materials and Methods): A;1.8 and B;1.1. The images depicted
above were taken after 30 seconds of cell perfusion in a time frame as indicated. 
The experiment shown is representative of 2 experiments.
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Eosinophils were incubated in the presence or absence of indicated MoAbs (10 m g/ml) 
for 15 minutes, and flow experiments on 7h TNF a -activated HUVEC at 3.2 dyn/cm2 were 
performed. Images were recorded on video. Data are plotted for 3 to 7 experiments ± SEM. 
At least 30 images were counted off line by image analysis and number of adherent 
eosinophils (rolling and firm adherent cells) was determined as a percentage of control values
(resting, non treated eosinophils on 7h TNFa -stimulated HUVEC). The statistically significant
effects of the blocking antibodies were determined by ANOVA against fixed value with
Bonferroni correction (*: p<0.005). Percentage rolling cells (>1 m m/sec) of the total amount of
adherent cells was calculated. The statistically significant effects of antibody-treated eosinophils
in contrast to control cells on percentage rolling cells were determined by a paired Student T-test
(**: p<0.05). The rolling velocities of at least 40 cells per experiment were determined 
(see Materials and Methods). The statistically significant effects of antibody treated eosinophils
in contrast to control cells on mean rolling velocity were determined by one-way ANOVA with
Bonferroni correction (***: p<0.001).
Table III. Effect of inhibition adhesion molecules with blocking antibodies on adhesion, 
percentage rolling cells and the mean rolling velocity of eosinophils on TNFa -activated 
endothelium at a shear rate of 3.2 dyn/cm2.
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Discussion
In this study, the interactions between resting human eosinophils and 
TNF a -stimulated HUVEC were evaluated using a flow chamber model. TNF a -stimulated
HUVEC (7 hours) was used to induce increased VCAM-1, E-selectin and ICAM-1 
expression, simulating the vasculature in allergic inflammation. The influence of 
inhibition of different adhesion molecules with blocking monoclonal antibodies was
evaluated with real-time video-assisted image analysis. By determination of the number
of adherent cells, percentage rolling cells and rolling velocity distributions, we showed
that eosinophils preferentially use constitutively active a 4 integrins for mediating the first
attachment to activated HUVEC. Also, E-selectin on the activated endothelium is used 
for initial attachment, and it mediates rolling interactions even at high shear stress. 
Most strikingly, blocking a 4 integrins and E-selectin together totally abolished adhesion,
indicating the strong cooperation of these two molecules in eosinophil adhesion, 
to activated HUVEC and the minor importance of b 2 integrins under these conditions. 
The well-established multistep paradigm for leukocyte-endothelium interactions 
describes rolling adhesion mediated by selectins and firm adhesion mediated by 
integrins. These processes are divided in time and place. However, the situation is more
complex, since several recent studies described a situation in which both tethering and
firm adhesion are mediated by the same adhesion receptors. A clear example for this
overlapping behaviour are the a 4 integrins (a 4 b 1, a 4 b 7), which have been described as
rolling receptors (9-12) besides their role in firm adhesion (5;14;39). The a 4 integrins are
present on lymphocytes, monocytes, basophils and eosinophils but are not expressed on
neutrophils. Berlin et al. (9) were the first to show a 4-dependent rolling of mouse lymph
node cells on VCAM-1- and MADCAM-1-coated surfaces. Later studies also showed 
initial tethering and rolling interactions by a 4 integrins of human T lymphocytes (11) and 
B lymphocytes (40) in a VCAM-1-dependent way. For monocytes some studies showed
that a 4 integrins play a role in stabilizing initial tethering on activated endothelium
(39;41) and another study showed that monocytes can tether on VCAM-1 (42). For 
eosinophils little is known about the role of a 4 integrins in attachment to inflamed 
endothelium. Alpha 4 integrins on resting, non activated eosinophils are functionally 
active for adherence to VCAM-1-coated substrates or activated HUVEC under static 
conditions (3;4;5;6;43). We confirmed this by performing experiments in which resting
eosinophils bound to VCAM-1-coated magnetic beads or VCAM-1-coated 96-well plates.
This interaction could be specifically blocked by MoAb HP2/1 (data not shown).
However, the question remained if a 4 integrins on human eosinophils are functionally
active in mediating initial attachment to activated HUVEC under flow conditions. 
Thus far, a few groups have investigated this in an in vitro flow system (13;14). We used
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an in vitro flow chamber assay to study the interactions of the a 4 integrins on 
eosinophils with activated endothelium under different shear forces. Also, the 
importance of the rolling receptor E- and P-selectin were studied, under the same 
conditions.
We found that inhibition of a 4 integrins (CD49d) by blocking anti- a 4 chain MoAb HP2/1
resulted in more than 40 % decrease in the total number of adherent eosinophils to
TNF a -activated HUVEC (7h, 100 U/ml), while blocking E-selectin or P-selectin did not
have a significant effect on adhesion. Remarkably, the percentage adherent eosinophils
decreased by more than 95 % by blocking both a 4 integrin and E-selectin (figure 1). 
This was found for each of the two anti-E-selectin antibodies (ENA-2, 5D11) that were 
tested. In contrast, no synergistic effect was observed when a 4 integrin and P-selectin
were both blocked. We conclude that in our system a 4 integrin and E-selectin are both
important for the first attachment to activated HUVEC at a shear stress of 0.8 dyn/cm2. 
In contrast with another report (14), P-selectin did not play a role under these 
conditions (see below). Thus, a 4 integrins and E-selectin together are responsible for 
initial attachment and work synergistically in our model. 
These results are in disagreement with the study of Kitayama et al. (14). These authors
concluded that a 4 integrins play a minor role in initial attachment, while we did find 
a major role for a 4 in this process. They also showed that P-selectin and not E-selectin is
important in eosinophil rolling on TNF a -stimulated HUVEC (6h, 100 U/ml). These 
differences are difficult to explain. However, two considerations must be taken in
account. (I) The (pre)activation status of eosinophils is of major importance in this type
of studies. Eosinophils from mild eosinophilic donors (44) or cells isolated via different
isolation procedures (33;44) might have been preactivated and have upregulated their 
b 2 integrins and thereby have altered adhesion characteristics to endothelial cells 
(see below). (II) We used second passage HUVEC, which did not express an 
appreciable amount of P-selectin (data not shown), whereas Kitayama et al. used first
passage HUVEC possibly expressing sufficient amounts of P-selectin (39;42;45). 
P-selectin can be expressed significantly on HUVEC in response to stimulation with 
histamine (46) or thrombin (31;47). However, another important source for P-selectin are
platelets. In this respect it was shown that activated and P-selectin-expressing platelets
can bind leukocytes, thereby facilitating P-selectin-dependent secondary tethering to the
surface (48). Interestingly, platelets have been shown to adhere to eosinophils of allergic
donors and might contribute to P-selectin-mediated interactions between eosinophils
and endothelial cells (49). In our studies, eosinophils were carefully studied and no 
attached platelets were present on the cell surface. 
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Blocking the b 2 integrins did not result in a significant decrease in adhesion, whereas the
combination of anti- a 4 integrin antibodies and anti- b 2 integrin antibodies resulted in a
percentage adherent cells of 35 ± 9 % compared to the control situation (figure 1). 
This 65 % reduction was significantly different from anti- a 4 treatment alone, suggesting
that b 2 integrins only play a minor role for resting eosinophil adherence to activated
HUVEC. In contrast, Kitayama et al. (14) and Patel (13) showed that the combination of
anti- b 2 integrins and anti a 4 integrins totally abolished accumulation of eosinophils on 
6h TNFa -activated HUVEC and 24 h IL-4-activated HUVEC, respectively. This suggests 
differences in activating state of the b 2 integrins of eosinophils isolated by different
methods (see above). The combination of blocking b 2 integrins and E-selectin did not
have a significant effect on adhesion compared to control. This further suggests that 
a 4 integrins are perfectly capable in mediating initial attachment to the endothelium
under these conditions.
Although eosinophils express less sialylated Lewisx (Slex) than neutrophils, causing
these cells to bind E-selectin less avidly (50), neutrophils as well as eosinophils are able
to roll on E-selectin (51). Figure 2 shows that eosinophils roll on E-selectin, because 
inhibition of E-selectin resulted in an immediate arrest of more than 90 % of 
surface-interacting cells. This a 4 integrin-dependent immediate arrest of eosinophils
was also shown by others (13;14) and it has also been shown for monoblastoid and
lymphoblastoid cells (52). When a 4 integrins were blocked however, eosinophils rolled
on the surface using E-selectin. The anti a 4-treated cells rolled faster compared to 
untreated control eosinophils. This suggests that the a 4 integrin/VCAM-1 interaction
decreases cell rolling velocity. Simultaneous inhibition of a 4 and b 2 integrins did not
result in higher rolling velocities (figure 3, table I), thereby confirming the unprimed 
phenotype of eosinophils (53;54). Blocking E-selectin reduced the rolling velocity of the
eosinophils, whereas blocking PSGL-1 did not. This indicates that PSGL-1 is not the
ligand for E-selectin on eosinophils. Alternatively, one (or more) of the known E-selectin
ligands (cutaneous lymphocyte antigen (CLA) (55), E-selectin ligand 1 (ESL-1) (56)
and/or L-selectin (57)) might be involved.
Next, we wanted to test the resistance of the rolling interactions of eosinophils on 
activated HUVEC. Therefore, the shear stress was increased at the end of 5 minutes cell
perfusion from 0.8 to 2, 3.2 and 6.4 dyn/cm2 each for 1 minute (table II). Rolling 
velocities of resting eosinophils increased with increasing shear stresses: 0.8 to 2, 3.2 and
6.4 dyn/cm2 and a significant difference between mean rolling velocities was found
between 0.8 and 6.4 dyn/cm2. When these shear forces were applied to anti- a 4 integrin
treated eosinophils, cells rolled with velocities which were at least two times higher 
64
CHARACTERIZATION OF EOSINOPHIL ADHESION TO TNF a -ACTIVATED
ENDOTHELIUM UNDER FLOW CONDITIONS: a 4 INTEGRINS MEDIATE
INITIAL ATTACHMENT AND E-SELECTIN MEDIATES ROLLING
at all four different shear stresses. These results again show that a 4 integrins are also 
active in reducing the rolling velocity at high shear stress. 
At a shear stress of 0.8 dyn/cm2, L-selectin played a minor role in eosinophil recruitment
to the activated endothelium (data not shown). It is known that L-selectin is 
functionally important above a certain shear rate threshold (39;42). To address the
importance of L-selectin on eosinophils, which had been shown to mediate adhesion to
activated endothelium under shear (18), we applied 3.2 dyn/cm2 to the system during 
5 minutes (figure 4). L-selectin-dependent tethering with formation of cell clusters 
became important in the eosinophil recruitment to TNFa -activated HUVEC at this shear
stress. Inhibition of both a 4 integrin and E-selectin totally abolished adhesion of 
eosinophils as was also observed at a shear stress of 0.8 dyn/cm2, suggesting that 
L-selectin only mediates secondary tethering processes at high shear stresses.
Remarkably, inhibition of both L-selectin and E-selectin resulted in a residual binding of
30 ± 8 % of the eosinophils compared to the control situation (table III). Thus, even at
high shear stress a 4 integrins are functional in mediating initial attachment to activated
endothelium. 
In conclusion, we showed that resting eosinophils use constitutively active a 4 integrins
and to a lesser extent E-selectin on TNFa -activated HUVEC for initial attachment under
flow conditions. Also, E-selectin can mediate stable rolling interactions even at 
high shear stresses. These data provide new insights in the way eosinophils can get
recruited to inflamed endothelium, and emphasize the importance of E-selectin as 
rolling receptor for eosinophils on TNFa -activated endothelium. The importance of 
identification of the mechanisms involved in eosinophil extravasation is that it might lead
to development of specific antagonists of this process, which might be used as targets
for specific anti-allergic treatment.
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Abstract 
During the late-phase asthmatic response eosinophils migrate to the bronchial 
tissue and cause severe damage. In this study we compared in vivo primed eosinophils
from allergic asthmatics with eosinophils from healthy controls in their adhesion 
behaviour to TNF- a -activated endothelium under flow conditions (0.8 dyn/cm2). 
More eosinophils from asthmatic patients compared to cells from healthy controls 
adhered to activated endothelium (1240 ± 130 vs. 890 ± 90 cells/cm2 respectively). 
In the presence of blocking antibodies directed against VLA-4 and E-selectin the 
residual binding of the cells of allergic asthmatic individuals was significantly higher 
than that of the healthy controls (28 ± 4 vs. 12 ± 3 %, p<0.02, of control situation, 
respectively). In addition, secondary tethering of the eosinophils of allergic asthmatic
patients was significantly increased compared to the healthy controls (cluster indices 1.8
± 0.3 vs.0.8 ± 0.2, respectively, p<0.05). Since patient cells showed an enhanced 
interaction with platelets during the perfusions, the role of P-selectin on platelets was
investigated. Blocking antibodies directed against P-selectin reduced the enhanced 
binding and clustering of eosinophils of allergic asthmatic patients. We conclude that 
P-selectin-bearing platelets contribute to secondary tethering processes of eosinophils 
to activated endothelium. Therefore, platelets might play an important role in chronic 
inflammatory processes. 
Introduction
Eosinophil accumulation is a hallmark of allergic inflammation, as found in the 
airway mucosa of asthmatic patients. Adhesion of eosinophils to endothelial cells of 
the blood vessel is one of the initial and crucial steps in the accumulation of eosinophils
to these allergic inflammatory sites. As all leukocytes, eosinophils use adhesion 
molecules in a multistep mechanism to adhere to endothelial cells and migrate to the
inflammatory site (reviewed in (1;2)). First, specific carbohydrate structures interact with
selectins expressed by activated endothelium and allow them to slow down from the 
circulation in a rolling interaction with the substrate. In vitro flow chamber studies have
addressed the relative importance for all three selectins, E-, P- and L-selectin (3-6) in 
the rolling process of eosinophils to TNFa -activated endothelium. For eosinophils and
monocytes also the a 4 b 1 integrin (VLA-4) / VCAM-1 interaction plays a role in the initial
adhesion (3;7). Firm adhesion is subsequently mediated by chemokine-induced 
activation of b 1 and b 2-integrins (8) that bind to their Ig-superfamily member counter
structures, VCAM-1 and ICAM-1, respectively, on the endothelium. Finally, the cells 
spread and migrate to the site of inflammation. 
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Studies with animal models have addressed the importance of different adhesion 
molecules used by eosinophil to migrate to allergic inflammatory sites (reviewed in 9).
A role for P-selectin was found by using P-selectin knock-out mice in a ragweed 
allergen-induced peritonitis. The percentage of rolling eosinophils decreased drastically
compared to control mice in the mesentery as determined by intravital microscopy (10).
In this study, eosinophil migration in the peritoneum was not only dependent on 
P-selectin but also on ICAM-1 and VCAM-1. Remarkably, in a delayed-onset allergic 
reaction in skin, both E-selectin and P-selectin were needed for eosinophils recruitment
(11). Furthermore, a 4 and b 2 integrins were found to play a role in eosinophil migration
(12;13). Also, a role for ICAM-1 was found: I) using ICAM-1 knockout mice in mice
models of allergen challenge (14;15) and II) using blocking antibodies in a monkey
model of asthma (16). Overall, the in vivo animal studies address the importance of the
selectins (E- and P-selectin), the integrins ( a 4 and b 2 integrins), and the Ig superfamily
members (VCAM-1 and ICAM-1) in homing of eosinophils to allergic inflammatory sites. 
Studies showing that endothelial cells in biopsies of allergic asthmatic patients after 
allergen challenge have increased expression of E-selectin, ICAM-1 (17) and VCAM-1
(18;19) confirm the importance of these molecules in eosinophils adhesion and 
migration in humans. Static adhesion experiments showed that eosinophil from allergic
asthmatic patients have increased adhesion to and transmigration through IL-1- 
stimulated HUVEC (20). Another study showed that eosinophils from asthma patients
had an increased adhesion to VCAM-1 and ICAM-1 compared to eosinophils from 
healthy controls (21). Enhanced physiological functions of eosinophils of asthmatic
patients compared to healthy controls are known to be a result of priming of the cells 
in vivo (22). Eosinophil priming in vivo can be mimicked in vitro by adding the cytokines
IL-3, GM-CSF and particularly IL-5 to eosinophils of healthy controls. In an in vitro Boyden
chamber assay it was shown that eosinophils from allergic asthmatic patients had an
enhanced migration towards a PAF gradient compared to healthy controls.
Subsequently, priming of eosinophils from healthy controls with IL-3, IL-5 or GM-CSF
induced comparable enhanced migration as was observed for the eosinophils from the
patients (23). 
Although it is well established how eosinophils interact with inflamed endothelium
under static conditions, only few studies address the role of eosinophils from allergic 
asthmatic patients under flow conditions. Sriramarao et al. (6) showed that eosinophils 
of mild allergic asthmatic patients use L-selectin and VLA-4 for rolling interactions with
inflamed endothelium in a rabbit model. However, eosinophils from a non-asthmatic
control group were not included in the study. 
Thus far, it is unclear whether the primed phenotype of eosinophils in the peripheral
blood from allergic asthmatic patients will influence adhesion to endothelial cells under
physiological flow conditions. Therefore, we investigated whether eosinophils from 
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allergic asthmatic patients differ in rolling and adhesive behaviour on TNFa -activated
endothelial cells in comparison with eosinophils from healthy individuals in an in vitro
flow chamber model. We found an unexpected role for platelets contributing to the
adhesion of eosinophils of allergic asthmatics to inflamed endothelium. 
Materials and Methods 
Reagents
CD16, CD14 and CD3 beads and isolation tools were purchased from Miltenyi, 
Biotec (Germany). Human serum albumin (HSA) was obtained from the Central
Laboratory of The Netherlands Red Cross Blood Transfusion Service (Amsterdam, 
The Netherlands). Recombinant human TNF a was purchased from Boehringer
Mannheim (Germany). Incubation buffer contained 20 mM HEPES, 132 mM NaCl, 
6 mM KCl, 1 mM MgSO4, 1.2 mM KH2PO4, supplemented with 5 mM glucose, 
1.0 mM CaCl2, and 0.5 % (w/v) HSA. All other materials were reagent grade. 
Antibodies 
The MoAb HP2/1 (anti VLA-4, CD49d) was purchased from Immunotech (Marseille,
France). MoAb BBIG-E4 (5D11, anti E-selectin, anti CD62e) was purchased from R&D 
systems ( Abingdon, UK). MoAb IB4 was isolated from the supernatant of a hybridoma
obtained from the American Type Culture Collection (Rockville, MD, USA). The MoAbs as
mentioned above are functionally blocking antibodies. Control antibody W6/32 
(anti HLA-A,B,C) was isolated from the supernatant of a hybridoma obtained from the
American Type Culture Collection (Rockville, MD, USA). MoAbs were incubated with
eosinophils (4x106 cells/ml) at 10 m g/ml during 15 minutes before the experiments. 
The cell suspensions were diluted once with incubation buffer (final concentration of 
5 m g/ml MoAb at 2x106 cells/ml in incubation buffer), and the coverslips were placed
directly in the system. 
Patients had documented allergy as shown by positive skin-test reactions to several 
allergens (including inhalation allergens such as house dust mite, pollen and cat 
allergens), correlated with raised levels of specific IgE antibodies (Rast>2). Patients had
respiratory complaints and were examined for asthmatic symptoms. For this study,
patients were included according to the criteria of the American Thoracic Society 
(ATS, 1986). Briefly, patients were included who showed increased bronchial 
hyperresponsiveness to histamine. These patients used inhaled bronchodilators when
needed (and some were receiving daily therapy with inhaled corticosteroids). The study
was approved by the hospital ethics committee, and all patients gave informed consent
before entering the study.
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Isolation of eosinophils
Blood was obtained from healthy volunteers from the Red Cross Blood Bank
(Utrecht, The Netherlands) anti-coagulated with 0.4 % (w/v) trisodium citrate (pH 7.4) or
by sodium heparine and from allergic asthmatic patients anti-coagulated by sodium
heparine. Mixed granulocytes were isolated as described previously (24). Mononuclear
cells were removed by centrifugation over isotonic Ficoll (1.077 g/ml). After lysis of the
erythrocytes with an isotonic ice-cold NH4Cl solution, the granulocytes were washed and
resuspended in isolation buffer. Eosinophils were purified from granulocytes by negative
immunomagnetic selection using anti-CD16-conjugated microbeads (MACS; 
Miltenyi Biotec) (25). To avoid mononuclear cell contamination also anti-CD3 and anti-
CD14- conjugated microbeads were added to the granulocyte suspension. Purity of 
eosinophils was always >95 %. 
Endothelial cells
Human umbilical vein endothelial cells (HUVEC) were isolated from human 
umbilical cord veins according to Jaffe et al. (26), with some minor modifications (27).
The cells were cultured in RPMI 1640 containing 20 % (vol./vol.) heat-inactivated human
serum, 200 m g/ml penicilin/streptomycin (GIBCO, Life Technologies, Breda, 
The Netherlands) and fungizone (GIBCO, Life Technologies, Breda, The Netherlands).
Cell monolayers were grown to confluence in 5-7 days. Endothelial cells of the second
passage or third passage were used in perfusion assays. HUVEC was activated by TNF a
(100 U/ml, 5-7 hours, 37°C) prior to the perfusion experiments.
Perfusion chamber
Perfusions under steady flow were performed in a modified form of transparent
parallel plate perfusion chamber as described previously by Van Zanten et al. (28). 
This micro-chamber has a slit height of 0.2 mm and a width of 2 mm. The chamber 
contains a circular plug on which a coverslip (18 mm x 18 mm) with confluent HUVEC
was mounted. 
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Eosinophil perfusion and evaluation
Eosinophil adhesion under flow conditions was performed as described before
(3;8). In short, eosinophils were aspirated from a reservoir through the perfusion 
chamber. Eosinophil perfusions were performed as individual runs under shear 
conditions at 37°C. During the perfusion, the flow chamber was mounted on a 
microscope stage (DM RXE, Leica, Weitzlar, Germany) which was equipped with a B/W
CCD-video-camera (Sanyo, Osaka, Japan), coupled to a VHS video recorder. Perfusion
experiments were recorded on video tape. Video images were evaluated for the number
of adherent cells, cluster index and velocity of rolling cells using dedicated routines
made in the image-analysis software Optimas 6.1 (Media Cybernetics systems,
Silverspring, MD, USA). The eosinophils which were in contact with the surface appeared
as bright white-centered cells after proper adjustment of the microscope during 
recording. The adherent cells on the HUVEC were detected by the 
image-analyzer. The eosinophil suspension was perfused during 5 minutes at a shear
stress of 0.8 dyn/cm2. The number of surface-adherent eosinophils and the cluster index
(29) was measured after 5 minutes perfusion at a minimum of 25 randomized high-
power fields (total surface of at least 1 mm2). 
Statistical Analysis. Results are expressed as dot plots with mean values. Statistical 
analysis of the data was performed using the Student’s T test and p values < 0.05 were
considered to be significant.
Results
Increased adhesion of eosinophils of allergic asthma patients compared 
to healthy controls
To investigate whether eosinophils from allergic asthma patients showed 
increased adhesion to activated HUVEC compared to cells from healthy individuals, 
cells were perfused over activated HUVEC at a shear stress of 1 dyn/cm2 for 5 minutes in
an in vitro flow chamber.
Figure 1a shows that 1240 ± 130 patient cells adhered to the surface compared to 
890 ± 90 control cells, which did not reach significance (p=0.059). The adhesion 
molecules responsible for capturing eosinophils from healthy individuals from the 
flow stream are a 4-integrins on the eosinophils and E-selectin on TNF- a -activated 
endothelium, as determined by a study using blocking MoAbs (3). To investigate whether
these adhesion molecules mediated the increased adhesion of patient cells, blocking
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MoAbs against a 4 integrins and E-selectin were used, and 28 ± 4 % of the control W6/32 
treated patient cells remained adhered. Blocking both a 4 integrins on the healthy control
cells and E-selectin on the endothelium 12 ± 3 % of the control W6/32 MoAb treated
healthy control cells remained adhered (p<0.02), which is comparable to previous data
(3). These results show that in addition to a 4 integrins and E-selectin, additional 
adhesive interactions mediate the increased adhesion of eosinophils of allergic 
asthmatic patients to activated endothelial cells. 
Figure 1. Adhesion of eosinophils of control donors vs. allergic asthmatic patients on 
TNF a -activated HUVEC under flow conditions. Cells were perfused during 5 minutes at a shear
rate of 0.8 dyn/cm2 and then the amount of cells and the cluster index were determined. 
A) The amount of adherent cells of controls (887 ± 94) vs. patients (1237 ± 126). B) Eosinophils
incubated with anti-a 4 integrin MoAb and HUVEC was incubated with anti-E-selectin MoAb and
% adhesion of control situation (control W6/32 MoAb-treated cells) is depicted. 
Asterisk (*) indicates p<0.05.
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Figure 2. Cluster index of eosinophils of control
donors vs. allergic asthmatic patients on 
TNF a -activated HUVEC under flow conditions.
When the adhesion molecules a 4 integrins on
eosinophils and E-selectin on the endothelium
were blocked, cells of patients but not of healthy
controls clustered on the endothelium. In A) a
non random, clustered, distribution of 
eosinophils of allergic asthmatic patients is
depicted, and in B) a random distribution of
eosinophils of control subjects. C) quantified
cluster index of control vs. asthmatic subjects.
Unpaired Students T-test, asterisk (*) indicates
p<0.05.
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Platelet-derived P-selectin and activated bb 2 integrins mediate residual 
binding of eosinophils from allergic asthmatics
Remarkably, the residual adhesion of patient cells in the presence of blocking
MoAbs against a 4 integrins and E-selectin was characterized by clusters, in marked 
contrast to healthy control cells (figure 2a and b respectively). Indeed, when this 
clustering was expressed as an index for non-random adhesion (as described in (29)),
patient cells showed a significant increase in cluster index as compared to controls 
(1.8 ± 0.3 vs. 0.8 ± 0.2 resp, p<0.05, figure 2c). Furthermore, it was clear that patient
cells interacted with platelets, forming clear eosinophil/platelet rosettes (figure 3a). 
The eosinophil/platelet interactions participated in the formation of flow-orientated
strings of clustered cells, also known as secondary tethering. This was not observed with
control cells (figure 3b). 
Figure 3. A) Eosinophils of allergic asthmatic patients and B) eosinophils of healthy controls
were perfused on activated HUVEC cells. Platelets are present on the eosinophils of patients but
not of healthy controls. Platelets are indicated by arrows.
Platelets, when activated, express P-selectin. This adhesion molecule has been shown
to mediate initial tethering of leukocytes to platelets that are present and activated at
injured vessel wall models (30;31). Moreover, binding of platelets to monocytes in the 
circulation has been shown to mediate rolling on activated HUVEC (32). The influence
of platelet-decorated leukocytes (in this case eosinophils) on adhesion in the context of
clustering behaviour has not been studied before. This secondary tethering process
results in cells that cluster on the endothelial surface. To investigate if increased 
adhesion of eosinophils from patients is due to P-selectin that is expressed by adherent
platelets, cells were isolated and perfused in the presence of a blocking anti-P-selectin
monoclonal antibody (WASP12.2). Figure 4a depicts the total amount of adherent 
eosinophils from patients and control individuals treated with anti-P-selectin MoAbs.
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Where the anti-P-selectin treatment did not significantly effect eosinophil adhesion from
healthy controls (in the absence or presence of anti-P-selectin treatment the total 
adhesion was 887 ± 94 and 665 ± 121, respectively), the treatment did inhibit the 
adhesion of patient eosinophils by 50 % from 1237 ± 126 to 627 ± 166 ;the latter value
being comparable to adhesion of control eosinophils. Additionally, when combining anti-
P-selectin MoAbs, anti- a 4 integrin MoAbs and anti-E-selectin MoAbs, also the percentage
of residual adhesion became comparable between controls and patients (15 ± 3 % 
and 15 ± 4 % respectively, figure 4b). The combination of anti- a 4 integrin MoAb, anti- 
P-selectin MoAb and anti-E-selectin MoAb (figure 4c) in perfusions with patient 
cells resulted in a cluster index of 0.24 ± 0.07, which was significantly different from 1.8
± 0.3 when no anti-P-selectin was added (figure 2c). However, the additional presence
of anti-P-selectin MoAb, besides blocking a 4-integrins and E-selectin, in healthy 
individuals did not result in a significant change in the cluster index (0.58 ± 0.25 to 0.78
± 0.2). These results show that P-selectin-expressing platelets on eosinophils of patients
are responsible for this phenomenon. Secondly, when the function of platelets is 
inhibited by blocking anti-P-selectin antibodies, the phenotype of increased adhesion
and cluster index is abrogated.
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Figure 4. Adhesion behaviour of eosinophils
of control vs. allergic asthmatic subjects 
when E-selectin on the endothelium and a 4
integrins and P-selectin was blocked in the 
eosinophil suspension. A) shows the amount
of adherent eosinophils when all three 
adhesion molecules were blocked. B) shows
the % adhesion of control situation (control
MoAb-treated cells) and C) shows the 
cluster index. No significant differences were
found between control vs. allergic asthmatic
subjects.
In the presence of blocking antibodies against a 4 integrins, E-selectin and P-selectin, 
still 15 ± 3 % of the cells from healthy controls and 15 ± 4 % of the cells from patients
adhered to activated HUVEC (figure 4b). When in addition b 2 integrins were inhibited,
adhesion was abrogated both for cells of patients and of healthy controls to an average
of less than 5 % of the control situation (=control antibody W6/32-treated cells, figure 5).
When P-selectin was not inhibited but a 4 integrins and E-selectin were inhibited, 
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Figure 5. Adhesion behaviour of eosinophils of control vs. allergic asthmatic subjects when 
E-selectin on the endothelium and a 4- and b 2-integrins were blocked in the eosinophil 
suspension in the presence or absence of anti P-selectin MoAbs. Percentage adhesion of control
situation (control MoAb-treated cells) is depicted.
we showed that 28 % of the cells of patients and 15 % of the cells of healthy controls
remained adhered (figure 1b). The question whether this residual binding was mediated
by b 2 integrins was addressed. Figure 5 shows that in the presence of blocking MoAbs
against b 2 integrins in addition to blocking MoAbs against a 4 integrins and E-selectin the
residual binding of healthy controls and patients both decreased to less than 5 %. Thus,
to reduce virtual all adhesion in patient cells, we need blocking of at least E-selectin, 
a 4 and b 2 integrins. When b 2 integrins on patient cells are not blocked but a 4 and 
E-selectin are blocked (figure 1b), then anti-P-selectin is needed to reduce the adhesion
values to healthy control values (figure 4b). Most likely, P-selectin mediates tethering 
processes of eosinophil/platelet conjugates of patients to the endothelium and b 2
integrins mediate firm adhesion.
Discussion
In this study we show that eosinophils of allergic asthmatic patients have an 
augmented adhesion to TNF a -activated HUVEC under flow conditions compared to 
eosinophils from healthy controls. Three observations suggest that platelets bound 
to eosinophils of asthmatic patients are causing the increased adhesion compared to
eosinophils of healthy controls: I) eosinophils of patients but not of healthy individuals
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bear platelets on their surface II) increased adhesion of patient eosinophils to activated
HUVEC is prevented by treatment with anti P-selectin MoAbs III) cluster index of patient
eosinophils on activated HUVEC is blocked by anti-P-selectin treatment. Figure 3 
(chapter 7) illustrates the consequences of the presence of platelets on eosinophils of
allergic asthmatics but not of healthy controls. It is known that eosinophils can bind 
P-selectin very well, especially under flow conditions (33). Recently, Woltmann et al.
showed that eosinophils, but not neutrophils, rolled on P-selectin expressing HUVEC
cells (34). In that study the asthma-related Th2 cytokines IL-13 and IL-4 induced the 
P-selectin on the endothelium. We stimulated endothelial cells with TNF a , which is also
a cytokine made by inflammatory cells in allergic sites (35). TNF a -activated HUVEC 
(passage 3) did not express P-selectin (data not shown, (34)). Therefore, we think that
in our study the effect of anti-P-selectin is caused by platelet-derived P-selectin and not
endothelial-derived P-selectin. Furthermore, only when the anti-P-selectin MoAbs were
incubated during isolation and preparation of eosinophils of patients it had its inhibiting
effect, suggesting that during isolation platelets already bound to eosinophils.
For leukocytes other than eosinophils an important role for platelets has already 
been established. Neutrophils and monocytes are known to bind platelets on damaged
vessel wall models in a P-selectin-dependent manner. Moreover, circulating complexes
of leukocytes with platelets on their membrane play an important role in the 
pathogenesis of atherosclerosis (30;31;36 and reviewed in 37). However, also in allergic
asthmatic diseases platelets may play an important role (reviewed in 38). Wardlaw et al.
showed that eosinophils of allergic asthmatic patients were positive for b 3 integrins.
However, these were not b 3 integrins expressed on the eosinophils itself but on platelets
that bound very tightly to the eosinophils. Electron microscopy studies demonstrated this
tight interaction (39). Also, platelets have been shown to be in contact with the 
vasculature of the bronchi of asthmatic patients but not of healthy controls (40). Another
study showed that inhalation of PAF-acether in a baboon model of asthma increased the
amount of platelets in the pulmonary circulation in contrast to the periphery. This 
increase in platelets was followed by an increase in eosinophils (41). Furthermore, in a
rabbit model of allergen-induced late asthmatic airway obstruction, Coyle et al. showed
that platelet depletion by injecting anti-platelet serum reduced the eosinophil infiltration
in the BAL 24 hours after allergen challenge and the bronchial hyperresponsiveness (42).
Also, the release of platelet derived factors in allergic asthmatics has been reported (43).
Although not consistently, platelet factor 4 (PF4) has been detected in the plasma of 
allergic asthmatic patients but not in healthy control subjects (44). For secreting PF4, 
platelets must be activated by stimuli like collagen, thrombin or ADP (adenosine 
diphosphate). Thus, a correlation between activated platelets and eosinophil infiltration
exists. We suggest that P-selectin bearing platelets associated with eosinophils could be
a mechanism for an increased recruitment of these cells. 
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Under physiological flow conditions anti-P-selectin MoAbs reduced the cluster index and
the total adhesion of eosinophils to activated endothelial cells. Cluster formation occurs
in several situations: I) already adhering eosinophil/platelet complexes serve as 
secondary tethering platforms recruiting fast-flowing cells II) free flowing eosinophil/
platelet complexes get recruited to eosinophils already adhering to the endothelial 
surface III) free flowing platelets adhere transiently to eosinophils, thereby recruiting
them to the surface. The mechanism by which platelets and eosinophils bind to each
other is partially clear. Since anti-P-selectin MoAbs blocked the enhanced adhesion 
and clustering, we conclude that P-selectin mediates the interaction of eosinophils and
platelets. Indeed, it has been shown by FACS analyses that activated platelets bind to
eosinophils in a P-selectin-dependent way (45). It is very likely that PSGL-1 is the ligand
for P-selectin since it is expressed on eosinophils and has been shown to mediate 
interactions with P-selectin (33). However, we can not exclude that the interaction
between eosinophils and platelets is mediated by other adhesion molecules as well. 
It is known that platelet-bound fibrinogen can serve as a ligand for b 2 integrins on 
leukocytes (29). Furthermore, the platelet adhesion molecule GP1b a has been identified
as a counter receptor for Mac-1 ( a M b 2 integrin, 46). Thus it seems possible that 
b 2 integrins on the eosinophils are able to bind to ligands on platelets. 
It seems that the b 2 integrins in the patient group was slightly activated because the 
additional inhibition of b 2 integrins besides the inhibition of E-selectin and a 4 integrins
reduced the adhesion to <5 % of the control situation (anti HLA MoAb), irrespectively of
the presence or absence of anti-P-selectin MoAbs (figure 5). These findings thus 
suggest that the b 2 integrins are slightly activated on eosinophils of allergic asthmatic
patients under resting, non-activating conditions. Studies (21) performed under static
conditions showed that eosinophils from patients that were symptomatic (with a peak
expiratory flow rate variability of >10 %) had an increased adhesion to the b 2 integrin
ligand ICAM-1 compared to non-symptomatic patients (with a PEF variability of <10 %). 
The same group showed that eosinophils from patients allergic to birch pollen were 
primed in the adhesion to VCAM-1 and ICAM-1 during birch pollen season but not 
before season (47). This suggests that only in an active season, when these patients 
have complaints, an increased adhesion is present. This is comparable with our study
because the allergic asthmatic patients all had complaints at the moment of drawing
blood. Thus, it seems that eosinophils of symptomatic allergic asthmatic patients have
increased adhesion to endothelial adhesion molecules.
The discrepancy in binding of platelets to eosinophils of allergic asthmatics but not of
healthy individuals is not known. Different hypotheses can be postulated: I) the platelets
of the allergic asthmatic patient are different or II) the eosinophils are different. 
AdI. Because the interaction between the platelet and eosinophil can be blocked by anti-
P-selectin, it might be that platelets of allergic asthmatic patients are activated in vivo
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therefore expressing P-selectin. Burgers et al. (48) suggested that activation of platelets
can occur in asthmatics and that PAF is a candidate activator in mediating this 
response. Also, they showed a slight decrease in platelet blood count after allergen 
challenge in allergic asthmatic patients, which was also shown by others (49). This 
suggests that activated platelets leave the bloodstream, possibly leading to the 
persistence in airway inflammation. 
AdII. It might be that the expression or functionality of PSGL-1 on the eosinophils of 
allergic asthmatic patients is higher than on cells of control subjects. For neutrophils,
eosinophils and other leukocytes it is known that PSGL-1 on resting cells is located 
randomly on the cell at the tips of the microvilli. Upon activation of neutrophils the 
PSGL-1 molecules are redistributed to the uropod of the cell (50). Clustering of 
adhesion molecules is known to induce changes in avidity, thereby increasing the 
binding to their ligands. However, clustering of PSGL-1 leads to weakened interactions
with P-selectin and a concomitant shift to integrin-mediated adhesions on activated 
neutrophils adhering to a surface. For eosinophils this has not been studied, but what 
is known is that PSGL-1 of eosinophils adhere better to P-selectin than PSGL-1 of 
neutrophils (33). Thus far, no differences have been described in PSGL-1 expression or
function between eosinophils of allergic asthmatic patients versus healthy controls.
Another mechanism for platelet binding to eosinophils of allergic asthmatics might be
due to the primed phenotype of these cells (22). Many effector functions of eosinophils,
like respiratory burst (51), production of lipid mediators (52), degranulation (53) and
migration (20) are sensitive for priming. The priming agents PAF (54) and IL-5 (55) can
increase the affinity of b 2 integrins on eosinophils. This might subsequently lead to 
the increased binding to platelets. In this study we found a minor role for activated 
b 2-integrins that could be due to priming of the eosinophils in vivo.
In summary, platelets are prone to bind eosinophils of allergic asthmatic patients; 
a phenomenon that might influence secondary tethering and thereby eosinophil 
adhesion and migration to inflammatory sites. These processes can contribute to the
increased eosinophils found in bronchial tissue in allergic asthmatic patients.
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Abstract
Eosinophils exhibit a rolling interaction with E-selectin-expressing endothelium
and need to be activated by inflammatory mediators to firmly adhere to this surface. 
This study shows that IL-8 induces a transient arrest of unprimed eosinophils that roll on
E-selectin present on tumor necrosis factor a -activated human umbilical vein 
endothelial cells in an in vitro flow chamber. This process was antagonised by 
neutralising antibodies directed against IL-8, showing the specificity of the IL-8 effect.
Furthermore, blocking antibodies against both a 4- and b 2-integrins inhibited the IL-8-
induced transient arrest while these antibodies had no effect when they were added
separately. The IL-8-induced arrest was Pertussis Toxin (PTX) sensitive. Studying the
effect of IL-8 in more detail we evaluated putative changes in [Ca2+]i in eosinophils 
induced by IL-8. We showed that IL-8 induces a transient increase in [Ca2+]i in ~40 % 
of the cells, provided that the eosinophils are interacting with endothelial cells or 
fibronectin-coated surfaces. Together these data show that resting eosinophils respond
to IL-8 provided that the cells adhere on physiological surfaces. The induction of a 
transient arrest provides a new level of chemokine-induced regulation of leukocyte
adhesion under flow conditions.
Introduction
Eosinophils play an important role in allergic inflammatory diseases like asthma.
Infiltrates of these cells are present in the structures of the airway wall and the lumen of
the bronchi of allergic asthmatic patients (1). To enter the site of inflammation, 
eosinophils must leave the bloodstream and pass the endothelium. A widely accepted
paradigm for leukocyte extravasation is referred to as the multistep model (2). In this
model selectins and their carbohydrate-bearing ligands mediate rolling interactions
between leukocytes and the endothelium. In this respect E-selectin, which is present 
on activated endothelium, has been shown to mediate rolling of neutrophils (3) 
and eosinophils (4). Subsequently, cells can be activated upon interaction with 
inflammatory mediators, resulting in the activation of integrins which bind to their
ligands expressed on the endothelium. In this way, firm adhesion of the cells to the 
endothelium is established (5;6). 
An important class of inflammatory mediators involved in the arrest of inflammatory
cells are chemokines which are released at the site of inflammation. Chemokines can
be divided in 4 different groups: CL, CCL, CXCL, and CX3CL in which X is the number of
amino acids in between cysteine residues at the NH2-terminal site of the molecule. 
Of the CL and CX3CL families, only one member of each group has been described, 
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namely lymphotactin (7) and fraktalkine (8), respectively. CCL chemokines, including
eotaxin, RANTES and MCP-3 have been reported to be mainly chemotactic for 
monocytes, lymphocytes and eosinophils. CXC chemokines, including IL-8 and GRO- a ,
have been shown so far as more specific for neutrophils (see 9;10 for reviews).
However, several clinical studies indicate that expression of the CXCL chemokine IL-8 is
enhanced both at the level of mRNA and protein in pulmonary “eosinophilic” diseases
such as asthma (11-13). IL-8 has been shown to be produced by bronchial epithelium
cells of asthmatic patients (11). Other sources for IL-8 include endothelial cells, 
fibroblasts, macrophages and mast cells (see 12 for review). These cells play a key role
in the pathogenesis of allergic asthma. Many studies have been designed to link 
the production of different chemokines to the occurrence of inflammatory cells in the 
tissues. As allergic asthma is characterized by a clear eosinophilic inflammation in 
the bronchial tissue, several studies evaluated the role for IL-8 in eosinophil activation
and migration processes in vitro and in vivo. No clear consensus exists concerning this
issue. Some in vitro studies on IL-8 induced eosinophil chemotaxis failed to show an 
IL-8 dependent effect on eosinophil migration (14), whereas other reports did: some 
studies were performed with cytokine-activated or “primed” eosinophils (15;16) and
other studies were performed with cells from allergic asthmatic (17) or eosinophilic (18) 
subjects. In most of these studies the effect of IL-8 on eosinophils have been determined
by the use of chemotaxis assays such as the Boyden chamber. Subtle differences in
experimental set up (e.g. choice of filters, medium etc.) might explain differences in 
outcome between the different studies. In addition to these in vitro studies the effect of
IL-8 on eosinophils has also been suggested by an in vivo study that showed that 
provocation with IL-8 induces eosinophilia in the nasal epithelium (19).
Chemokines are ligands for G-protein-coupled serpentine receptors. On neutrophils, two
high-affinity G-protein-coupled receptors for IL-8 have been described, CXCR1 and
CXCR2 (20;21). When chemokines bind to their receptor, an increase in intracellular free
Ca2+ ions [Ca2+]i is elicited. Increased [Ca2+]i leads to multiple downstream signaling
events, and these have been correlated with a number of cellular functions (22). 
It has been questioned whether eosinophils can increase [Ca2+]i upon IL-8 stimulation,
because these changes in [Ca2+]i were very small (15). Indeed, Petering et al.
contributed these small changes to contamination of neutrophils. Remarkably, all studies
that failed to show the effect of IL-8 on [Ca2+]i mobilization in eosinophils were 
performed on cells in suspension. Migration studies, on the other hand, showed that
eosinophils can respond to IL-8, and in these experiments cells adhered to substrates. 
We hypothesize that eosinophils that adhere to physiological substrates are more
susceptible for IL-8 stimulation compared to cells in suspension. Therefore, the effect of
IL-8 on eosinophils adherent to physiological relevant surfaces was evaluated. 
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Materials and Methods
Reagents 
Percoll was obtained from Pharmacia (Uppsala, Sweden). N-formyl-methionyl-
leucyl-phenylalanine (fMLP) was purchased from Sigma Chemicals (St. Louis, MO, USA).
Human serum albumin (HSA) was purchased from the Central Laboratory of 
The Netherlands Red Cross Blood Transfusion Service (Amsterdam, The Netherlands).
Recombinant human TNF a was purchased from Boehringer Mannheim (Germany). 
IL-8 was purchased from Peprotech (72aa, Rocky Hill, NJ, USA) and Eotaxin-1 was 
purchased from R&D Systems (Minneapolis, MN, USA). Pertussis Toxin (50 m g/ml, Sigma,
St. Louis, Missouri, USA). Incubation buffer contained 20 mM HEPES, 132 mM NaCl, 
6 mM KCl, 1 mM MgSO4, 1.2 mM KH2PO4, supplemented with 5 mM glucose, 
1.0 mM CaCl2, and 0.5 % (w/v) HSA (Human Serum Albumin). All other materials were
reagent grade. 
Antibodies 
The MoAb HP2/1 (anti VLA-4, CD49d) was purchased from Immunotech (Marseille,
France). MoAb IB4 was isolated from the supernatant of a hybridoma obtained from the
American Type Culture Collection (Rockville, MD, USA). The antibodies we used against
a 4 integrins (HP2/1) and b 2 integrins (IB4) have been described as functional blocking 
antibodies (23-25;26) Therefore, antibody-induced differences in function of 
the eosinophils caused e.g. by crosslinking of integrins, seem to be unlikely. Control 
antibody W6/32 (anti HLA-A,B,C) was isolated from the supernatant of a hybridoma
obtained from the American Type Culture Collection (Rockville, MD, USA). Activating
antibody 8A2 (26) was kindly provided by dr. J.M. Harlan (University of Washington,
Seattle, USA) and dr. T.W Kuijpers (Central Laboratory for Blood Transfusion (CLB),
Amsterdam, The Netherlands). Anti-CXCR1 and anti-CXCR2 antibodies, 5A12 and 6C6
(Pharmingen, San Diego, USA), respectively, have been described as blocking MoAbs of 
neutrophil migration (27). Anti-E-selectin MoAb BBIG-E4 (5D11) was purchased from
R&D systems (Abingdon, UK). MoAbs were incubated with eosinophils (4x106 cells/ml)
at 10 m g/ml during 15 minutes before the experiments. The cell suspensions were 
diluted once with incubation buffer (final concentration of 5 m g/ml MoAb at 2x106
cells/ml in incubation buffer), and the coverslips were placed directly in the system. 
Anti-IL-8 (clone B-K8, Biosource International, California, USA) was added to IL-8 10-8 M
in a final concentration of 20 m g/ml.
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Isolation of eosinophils
Blood was obtained from healthy volunteers from the Red Cross Blood Bank,
Utrecht, The Netherlands. Mixed granulocytes were isolated from the buffy-coat of 500
ml blood anti-coagulated with 0.4 % (w/v) trisodium citrate (pH 7.4), as previously 
described (28). Mononuclear cells were removed by centrifugation over isotonic Ficoll
(1.077 g/ml). After lysis of the erythrocytes with an isotonic ice-cold NH4Cl solution, the
granulocytes were washed and resuspended in RPMI 1640 (Gibco, Paisley, UK) with 
0.5 % (w/v) HSA. 
Granulocytes were incubated for 30 min at 37°C to restore the initial density of the cells.
Thereafter, the cells were washed and resuspended in phosphate-buffered saline (PBS)
supplemented with 0.5 % HSA and 13 mM trisodium citrate, and incubated with fMLP 
(10 nM) for 10 min at 37°C, to decrease the specific gravity of the neutrophils, but not that
of the eosinophils. Subsequently, eosinophils were obtained by centrifugation (20 min,
1000 g) over isotonic Percoll (density 1.082 g/ml, layered on Percoll with a density of 1.1
g/ml), washed and resuspended in incubation buffer. Purity of eosinophils was >95 %.
This procedure leads to the isolation of relatively unprimed eosinophils compared to
conventionally used isolation procedures with immunomagnetic beads (29).
Endothelial cells
Human umbilical vein endothelial cells were isolated from human umbilical cord
veins according to Jaffe et al. (30), with some minor modifications (31). The cells were
cultured in RPMI 1640 containing 20 % (vol./vol.) heat-inactivated human serum, 200
m g/ml penicilin/streptomycin (GIBCO, Life Technologies, Breda, The Netherlands) and
fungizone (GIBCO, Life Technologies, Breda, The Netherlands). Cell monolayers were
grown to confluence in 5-7 days. Endothelial cells of the second passage or third 
passage were used in perfusion assays. HUVEC was activated by TNF a (100 U/ml, 
7 hours, 37°C) prior to the perfusion experiments.
Perfusion chamber
Perfusions under steady flow were performed in a modified form of transparent
parallel plate perfusion chamber (32) as previously described by Van Zanten et al. (31).
This micro-chamber has a slit height of 0.2 mm and width of 2 mm. The chamber 
contains a circular plug on which a coverslip (18 mm x 18 mm) with confluent HUVEC
was mounted. Immediately after mounting the HUVEC, which were activated with 
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TNF a for 7 hours, the flow chamber was flushed with HEPES buffer during 2 minutes to
wash out residual TNF a .
Eosinophil perfusion and evaluation
Eosinophil perfusions were performed as described (4). In short, eosinophils in
suspension (2x106 cells/ml in incubation buffer) were aspirated from a reservoir through
plastic tubing and the perfusion chamber with a Harvard syringe pump (Harvard
Apparatus, South Natic, MA). The individual runs all occurred under specific shear 
conditions in a 37°C temperature box. Perfusion experiments were recorded on video
tape. The eosinophil suspension was perfused during 3 minutes at a shear stress of 
0.8 dyn/cm2 to obtain an endothelial surface with firmly adhering and rolling eosinophils
(4). After these 3 minutes buffer was added and the shear stress was increased to 
2 dyn/cm2. After 20 seconds at a shear stress of 2 dyn/cm2, recording of the images on
video was started. Subsequently, HEPES buffer containing IL-8 (10-8 M) or eotaxin 
(10-8 M) was added to the flow chamber. During the whole perfusion experiment 
antibodies (IB4; 10 m g/ml, HP2/1; 10 m g/ml, anti IL-8; 50 m g/ml or W6/32; 10 m g/ml) were
present. After ~30 seconds the cytokine buffer reached the cells and the cells arrested.
Subsequently it took 30 seconds to ~2 minutes for the cells to start rolling again.
Therefore the percentage rolling cells were determined at the following points: “before”
stimulation: this is at time point 30 sec before addition of the cytokine-containing buffer;
“during” stimulation: this is at the time point that cytokine-containing buffer has reached
the cells and the cells arrest; “after” stimulation: this is at time point 1 minute after 
the cytokine-containing buffer reached the cells. One randomly chosen image per 
experiment was recorded. Cells which started rolling again after the IL-8-induced arrest
rolled out of the recorded image, but also cells at the front of the image rolled into the
recorded image. Therefore we calculated the total amount of adherent cells present in
the field “before”, “during” and “after” stimulation which did not differ significantly in all
tested circumstances. More than 90 % of the firmly adherent cells under baseline condi-
tions were stable throughout the whole observation period when no cytokine was added
(results not shown). Also, of the stable stationary cells in the “before” period, less than 
5 % of the cells started rolling again after addition of IL-8.
To automatically determine the percentage of rolling cells custom-made software 
was developed in Optimas 6.1 (4). In short, a sequence of 50 frames, representing an
adjustable time interval, was digitally captured. The velocity of each cell was calculated.
The cut-off value to distinguish between rolling and static adherent cells was set at 
1 m m/sec. With this method, static adherent, rolling and freely flowing cells (which were
not in focus) could be clearly distinguished. 
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Flow cytometry
Flow cytometry analysis was carried out as described before (33). As primary
MoAbs were used antibodies against b 2 integrins (IB4), CXCR1 (5A12), CXCR2 (6C6) or a
control antibody (5D11 anti-E-selectin). Granulocytes were analyzed with a FACSvantage
flowcytometer (Becton Dickinson immunocytometry systems, Mountain View, CA).
Imaging of intracellular free Ca2+
Imaging of intracellular free Ca2+ was performed with a custom-built setup, 
consisting of a computerized excitation filterswitcher (Lambda-10, Sutter Instrument
Company, Novato, California, USA) with excitation filters (D340/10 and D380/13, Chroma
Technology Corporation, McHenry, Illinois, USA) coupled to a Leica (Wetzlar Germany)
Leitz DMIL inverted microscope, which was equipped with light filters appropriate for
Fura-2 (D510/40 and 400 DCLP, Chroma Technology Corporation, McHenry Illinois, USA),
high n.A Immersion objective (UV-F 40x nA 1.30 Glycerol Imm., Nikon Corporation,
Tokyo, Japan) and a Xenon arc lamp (XBO 75 W/2, Osram, Berlin, Germany). Series of
50 image pairs (512 x 512, ~1 second apart) were sequentially grabbed with a black and
white framegrabber (Pulsar, Matrox Electronic Systems Ltd., Dorval, Quebec, Canada)
from an intensified video camera (LI-m CAM, Lambert Instruments, Leutingewolde, The
Netherlands) directly into computer memory. Ratios and calcium values were computed
off line with Image Analysis software (Optimas 6.1, Media Cybernetics, Silver Spring
Maryland, USA) and custom-made macros (A.L.I.). Calcium levels were calculated 
with the standard calibration formula of Grynkiewics et al. (34): 
[Ca2+]i = Kd x b x ((R-Rmin)/(Rmax-R)) with parameters Kd=225 nM, b =2.4, and  were
displayed in false colors (blue-red ramp). Cell calcium was separated from background
by calculating the threshold mask from the mean of the two ratio images for each of the 
50 ratio images in the series. Threshold level was obtained by choosing the first and the
last level in the series, and then by linear interpolation for the rest of the series, thereby
counteracting the effect of bleaching over time. Intracellular [Ca2+] levels are 
determined by calculating the mean [Ca2+]i of all pixels in a cell in each of the 50 ratios
taken. The cut-off value to distinguish between a responding and a non responding cell
was set at a mean value of 200 nM. Figure 4 and 6 show the mean [Ca2+]i of all cells
exceeding this cut-off value. In the experiments investigating the IL-8-induced increase
in [Ca2+]i, eotaxin was given after the IL-8. The cells which did not respond to eotaxin
(likely to be neutrophils) were excluded from analyses. 
Freshly isolated eosinophils adhere strongly to some glass substrates. Under these 
circumstances attachment induces cells to flatten out with activation and generation of
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calcium signals (unpublished observations). To circumvent these problems we let 
eosinophils adhere to fibronectin-coated surfaces with the use of MoAb 8A2 or to 7h 
TNF-a -activated HUVEC. Addition of this MoAb leads to freezing of b 1 integrins in a 
high-affinity state. By this procedure, the cells strongly attach to fibronectin, but 
otherwise remain deactivated, keeping a round shape (35), thus allowing clear ratio 
imaging. Eosinophils attached in this way display low intracellular free Ca2+ levels under
control conditions for long periods of time, up to 30 minutes. Hereby large numbers of
cells could be imaged while being treated with IL-8 and eotaxin. 
All washing and incubation steps were performed in incubation buffer. Eosinophils
(5x106/ml) were loaded with 2.5 m M Fura-2 AM (Molecular Probes, Eugene, Oregon, USA)
for 15 minutes. Hereafter, the cells were incubated in the absence or presence of the 
antibody 8A2 (10 m g/ml) for 15 minutes at 37°C in an agitated water bath. After washing,
8A2 treated cells (1 x106 to 2 x106) were plated onto fibronectin (0.1 mg/ml in Hepes, 
15 min, 37°C) coated 24 mm cover slips. 7h TNF- a -activated HUVEC cultured on 24 mm
cover slips were extensively washed with PBS and non-treated, Fura-2 AM loaded 
eosinophils were plated on the endothelium. The eosinophils were allowed to settle for
15 minutes on the substrate, and non-adherent cells were removed by washing the cover
slips. Cover slips were mounted in an open chamber and placed in a warmed (37°C)
metal ring for Calcium Imaging. Stimulants were added from the top after two 
pre-stimulus image ratios had been obtained. Stimulants (37°C, at two times the 
concentration) were added to an equal volume (250 m l) of incubation buffer already 
present in the chamber to obtain a homogenous mixture at the start of the ratio imaging.
Measurement of oxygen consumption
Oxygen consumption was measured at 37°C with an oxygen electrode as 
described previously (36). In short, eosinophils were resuspended in incubation buffer
(2x106 cells/ml). PMA (100 ng/ml) was added and oxygen consumption was measured
for 5 minutes. 
Statistical Analysis. Results are expressed as mean ± standard error of the mean (SEM).
Statistical analysis of the data was performed using a Student T test for paired data; 
p values < 0.05 were considered to be significant.
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Results 
Eosinophils exhibit a transient arrest upon IL-8 addition during rolling 
adhesion along TNF aa -activated endothelium.
To investigate the effect of IL-8 on rolling eosinophils, freshly isolated eosinophils
were perfused over 7h TNF a -activated confluent HUVEC at a shear stress of 2 dyn/cm2.
When eosinophils were treated with a control anti-HLA-class-I antibody (W6/32, figure
1a, 2a) the percentage of rolling cells compared to the total number of adherent cells
(rolling and firmly adherent cells) was 48 ± 3 %. Upon stimulation with IL-8 (10-8 M), the
percentage of rolling cells decreased to 12 ± 3 %. After 1 minute, the percentage of 
rolling cells increased to 28 ± 5 % (movie of IL-8-induced transient arrest is available on
CD-ROM). Addition of anti-IL-8 antibody (10 m g/ml) to the IL-8 suspension prevented this
transition from rolling to a stationary arrest of W6/32 treated (control) eosinophils 
(figure 1a). When eotaxin (10-8 M), a potent chemokine for eosinophils, was added to
the rolling, W6/32-treated eosinophils, the percentage rolling cells decreased from 
56 ± 3 to 7 ± 3 %. The cells now bound stably and longterm because after 1 minute the
percentage of rolling cells was still very low (8 ± 3 %, figure 1a, 2b) (movie of eotaxin
induced firm arrest is available on CD-ROM). In addition, the eosinophils flattened upon
eotaxin treatment, while this was not observed upon addition of IL-8. We also tested
whether eotaxin could induce a stable and longterm arrest when applied to cells which
started rolling again after the IL-8-induced arrest. Indeed, more than 97 % of the cells
were longterm arrested after addition of eotaxin to W6/32-treated eosinophils which
were rolling after the IL-8-induced transient arrest.
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Figure 1. Effect of perfusion of cytokines 
on percentage of rolling eosinophils on 7h 
TNF a -stimulated HUVEC. The percentage of 
rolling cells per field for W6/32-, HP2/1- and
HP2/1-, IB4-treated eosinophils are depicted.
The percentage of rolling cells was determined
before (white bars ), during (black bars) and 
1 minute after (grey bars) stimulation. The effect
of A) IL-8 (10-8 M), IL-8 (10-8 M)/ anti-IL-8 and
eotaxin (10-8 M) on control MoAb W6/32- 
treated rolling eosinophils, B) IL-8 (10-8 M), IL-8
(10-8 M)/ anti-IL-8 and eotaxin (10-8 M) on
MoAb HP2/1-treated rolling, C) IL-8 (10-8 M)
and eotaxin (10-8 M) on anti- b 2 integrin 
integrin-treated and both anti a 4- and 
b 2-integrin-treated eosinophils. Percentage rolling cells are plotted for 3 to 6 experiments 
± SEM, except for W6/32 / IL-8 (n=10) and HP2/1 / IL-8 (n=16). The statistically significant
effects of the different treatments against the situation before treatment were determined by 
paired Student T test (*: p<0.05).
To investigate whether a 4 integrins played a role in this IL-8-induced arrest, eosinophils
were treated with anti-a 4 integrin antibody (HP2/1, figure 1b, 2c). The percentage of 
rolling cells of HP2/1-treated eosinophils on TNFa -activated HUVEC was 52 ± 5 % which
was significantly higher than W6/32-treated eosinophils, as shown in a previous study
(4). The rolling percentages of all groups are higher in this study compared to an earlier
study (4). This is caused by the increase in the shear stress used in this study 
(2 dyn/cm2 ) whereas the shear stress in the former study was 0.8 dyn/cm2. Upon sti-
mulation with IL-8 (10-8 M) the percentage of rolling cells decreased to 14 ± 3 %. After 1
minute, the percentage of rolling cells increased from 14 ± 3 % to 33 ± 5 %. Within 2
minutes almost all arrested cells (both W6/32- and HP2/1-treated) started rolling again.
Addition of anti-IL-8 antibody (10 m g/ml) prevented the IL-8-induced transition from 
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Figure 2. Computerized analyses of the effect of perfusion with cytokines on the percentage of
rolling eosinophils on 7h TNFa -stimulated HUVEC. Eosinophils (2x106/ml) were incubated with 
10 m g/ml of the indicated MoAbs before the assay. Lines indicate the rolling tracks of the cells in
one field during 2 seconds. Cells are positioned at the beginning of the track. Images depict 
rolling tracks before, during and 1 minute after indicated cytokine stimulation. Data are 
depicted as representative experiments (see also figure 1).
rolling to stationary arrest of HP2/1-treated eosinophils (figure 1b). When eotaxin 
(10-8 M) was added to the rolling HP2/1-treated eosinophils, all cells bound stably and 
longterm (figure 1b). The experiment with the W6/32- and HP2/1-treated cells show that
the IL-8 effect on eosinophils can occur independently of the interaction between 
a 4 b 1 integrin with its ligand VCAM-1 on activated endothelium. 
To investigate whether b 2 integrins are implicated in the IL-8-induced arrest, eosinophils
were incubated with an anti- b 2 integrin MoAb IB4. When b 2 integrins were blocked, 
the percentage of rolling cells per field was 66 ± 6%. Upon IL-8 stimulation, the 
percentage of rolling cells decreased to 28 ± 6 % and after 1 minute increased to 
40 ± 6 % rolling cells again (figure 1c). When eotaxin was added to rolling IB4-treated
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eosinophils, the percentage of rolling cells decreased from 64 ± 8 % to 9 ± 3 %. 
After 1 minute the cells were still firmly adhered to the endothelial cells. 
Finally, we investigated the effect of blocking of b 2 integrins and a 4 integrins 
simultaneously. When both b 2 integrin and a 4 integrins were blocked, the percentage 
of rolling cells was 84 ± 4 %. Upon additon of IL-8 all cells kept rolling (80 ± 5 %). After 
1 minute upon addition of IL-8 the percentage of rolling cells was still 85 ± 5 %. When
eotaxin was added to IB4 and HP2/1 treated eosinophils, no significant changes in 
the percentage of rolling cells were observed (figure 1c). These data show that the IL-8-
induced transient arrest and the eotaxin induced stable arrest can be mediated by either
b 2 integrins or a 4 integrins.
To investigate whether the known IL-8 receptors CXCR1 and CXCR2 mediated the IL-8-
induced response, eosinophils were incubated with antibodies against CXCR1 and
CXCR2 (6C6 and 5A12, respectively). IL-8-induced transient arrest was not inhibited 
and the percentage of rolling cells decreased from 46 ± 10 % to 16 ± 5 % upon IL-8 
stimulation (figure 3a). The IL-8 induced arrest was transient and the percentage rolling
cells increased from 16 ± 5 to 27 ± 11 %. The functionality of these antibodies on IL-8
(10-8 M)-induced neutrophil chemotaxis in a Boyden chamber assay was confirmed by
their ability to block the IL-8 induced migration by 74 %, as was also shown by others
(27). In figure 3b and 3c it is shown that CXCR1 and CXCR2 are not present on isolated 
eosinophils whereas they are present on neutrophils (40). To address whether the IL-8-
induced arrest was mediated by G-protein-coupled receptors, eosinophils were 
incubated with solvent (0,5 % glycerol), or PTX (100 or 500 ng/ml) for 2 hours. Control,
glycerol-treated eosinophils arrested transiently upon IL-8 perfusion, comparable to
W6/32- and HP2/1-treated eosinophils. In contrast, eosinophils treated with PTX showed
a dose-dependent inhibition of IL-8-induced arrest (figure 3a). To control for possible
negative effects of PTX on the normal physiology of the eosinophils, we performed 
respiratory burst experiments. Eosinophils incubated with glycerol (0.5 %) or PTX 
(500 ng/ml) for 2h at 37°C were tested for the induction of the respiratory burst upon 
activation with PMA. No differences were found in the PMA-induced oxidative burst of
glycerol- vs. PTX-treated eosinophils (not shown).
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Figure 3. A) The effect of inhibition of serpentine receptors on the percentage of rolling 
eosinophils on 7h TNF a -stimulated HUVEC. The effect of IL-8 on anti-CXCR1 and anti-CXCR2
antibodies (5A12 and 6C6, 15 min, 37°C), control solvent (glycerol 0.5 %, 2h, 37°C), and
Pertussis Toxin (100 and 500 ng/ml, 2h, 37°C)-treated eosinophils was determined before (white
bars), during (black bars) and 1 minute after (grey bars) stimulation. Percentages of rolling cells
are plotted for 3 to 6 experiments ± SEM. The statistically significant effects of the different 
treatments compared to the situation before treatment were determined by paired Student T test
(*: p<0.05). In B) and C) granulocytes were stained for b 2 integrins (IB4, blue line), CXCR1
(5A12, green line), CXCR2 (6C6, red line) or an irrelevant antibody (black line) by FACS. B) and
C) show the fluorescence for eosinophils and neutrophils, respectively. The experiment shown is
representative for 3 independent experiments.
Eosinophils bound to fibronectin and endothelium show significant calcium 
responses upon IL-8 addition
To investigate the changes in intracellular free Ca2+ of adherent eosinophils upon
IL-8 and eotaxin stimulation, cells were incubated with 8A2 and loaded on fibronectin-
coated cover slips or non-treated cells were loaded on 7h TNFa -stimulated HUVEC 
(see Materials and Methods 35). After stimulation with IL-8 (10-8 M) a clear increase in
[Ca2+]i (>200 nM) was observed in 42 ± 7 % and 30 ± 7 % of the cells adherent 
to fibronectin and activated HUVEC, respectively (figure 4a and 4b showing a 
representative experiment). The increase in [Ca2+]i of cells adherent to fibronectin is
depicted in figure 5a. When neutralizing antibodies for IL-8 (clone B-K8) were added 
to the IL-8 solution before addition to the cells, the change in [Ca2+]i response was 
blocked (figure 4a and 5b). A second IL-8 stimulation given did not elicit a [Ca2+]i
response, indicating homologous desensitization of the receptor (data not shown). 
Upon eotaxin (10-8 M) stimulation 97 ± 0.5 % and 98 ± 1.7 % of the cells adherent 
to fibronectin and activated HUVEC, respectively, increased their intracellular free 
Ca2+ concentration (figure 4 and 5c). 
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Figure 4. Effect of adding cytokines to adhering eosinophils on fibronectin. Eosinophils were
loaded with 2.5 m M Fura-2 AM, incubated with MoAb 8A2 (35) and put on A) fibronectin-coated
glasses for 15 minutes or put on B) 7h TNFa -activated HUVEC for 15 minutes. Non-adherent
cells were washed away. IL-8 (open squares), eotaxin (solid diamonds) or IL-8/anti-IL-8 
(open triangles) was added after 2 blanco images (arrow) and 48 images were taken at 340 and
380 nm after addition of cytokines. [Ca2+]i was measured by calculating 340/380 ratios 
(see Materials and Methods). The figure is representative for 3 independent experiments.
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To investigate whether the IL-8-induced [Ca2+]i responses were sensitive to PTX, eosi-
nophils were incubated with control solution (glycerol 0,5 %) or 500 ng/ml PTX for 2
hours at 37°C. Figure 6 shows that the [Ca2+]i responses were blocked in PTX-treated
cells adherent to fibronectin (figure 6a) or 7h TNF-a -activated HUVEC (figure 6b). Also,
the positive control C5a induced a [Ca2+]i response which was completely blocked by
PTX (500 ng/ml).
Figure 5. Computerised analyses of the effect of adding cytokines to fibronectin-adhering 
eosinophils. Eosinophils were loaded with 2.5 m M Fura-2 AM, incubated with 8A2 and put 
on fibronectin-coated glasses for 15 minutes. A) shows effect of IL-8 before, during and after
addition. B) shows the effect of IL-8/anti-IL-8 before, during and after addition. C) shows the
effect of eotaxin before, during and after addition. Data are depicted as a representative of 
3 experiments (see also figure 4A).
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Figure 6. Effect of Pertussis Toxin on IL-8 (10-8 M) and C5a (10-8 M) induced [Ca2+]i
responses in eosinophils. Eosinophils were incubated with glycerol (0.5 %) or Pertussis Toxin (500
ng/ml, 2h, 37°C) and loaded with 2.5 m M Fura-2 AM. A) 8A2-treated cells were put on 
fibronectin-coated glasses or B) 8A2-untreated cells were put on 7h TNF a -activated HUVEC for
15 minutes. IL-8 (open squares) and C5a (solid diamonds) were added (arrow) to glycerol 
treated cells and IL-8 (open circles) and C5a (solid line) were added to Pertussis-Toxin-treated
cells. Images were taken at 340 and 380 nm. [Ca2+]i was measured by calculating 340/380
ratios (see Materials and Methods). The figure is representative for 3 independent experiments.
Discussion
In this article, the hypothesis was tested whether IL-8 can activate eosinophils
when interacting with a physiological relevant substrate such as endothelial cells and/or
fibronectin. Therefore, we first performed in vitro flow chamber experiments and 
evaluated the effect of IL-8 on rolling, non-stimulated eosinophils. We showed that IL-8
induced a transient arrest of eosinophils which were rolling on 7h TNF a -stimulated
HUVEC even when a 4- or b 2-integrins were blocked. Only in the presence of blocking
antibodies against both a 4- and b 2-integrins the IL-8-induced arrest was prevented. 
This shows that IL-8 can transduce signals leading to activation of a 4- as well as 
b 2-integrins. Furthermore we conclude that the chemokines eotaxin and IL-8 both act on
a 4- and b 2-integrins. In contrast to IL-8 activation, eotaxin-induced activation of the 
integrins leads to firm adhesion and spreading. Also, Weber et al. concluded from static
adhesion assays that chemoattractants, like RANTES, regulate the avidity of both b 1- and
b 2-integrins expressed on the same eosinophil (37). 
This is the first report showing I) that IL-8 affects resting, unprimed eosinophils in the
transition from rolling to firm adhesion (figure 1 and 2) and II) that a chemokine can
induce a transient arrest for a period of 0.5 to 2 minutes in the presence of the stimulus.
Recently, Gerzten et al. (38) showed that monocytes, which are typical C-C chemokine
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responders, firmly adhere to endothelium upon stimulation with the CXC chemokine 
IL-8. In contrast to eosinophils, monocytes adhered longterm to the endothelium upon
IL-8 stimulation. These results suggest that the reaction to IL-8 is not restricted to the
neutrophil lineage and can have different effects on different leukocyte subsets. 
We cannot exclude that activation of the endothelium by TNFa induces IL-8 secretion or
presentation which could influence the eosinophil function. However, this seems 
unlikely because I) treatment of the endothelium by anti-IL-8 did not influence rolling
velocity (data not shown) and II) the HUVEC was washed extensively before every 
experiment. 
Our results also suggest that at least for unprimed eosinophils an additional stimulus 
besides IL-8 is needed to induce long term adhesion. This could be cytokines/
chemokines which are associated with allergic inflammation, like IL-5, IL-4 or eotaxin.
Indeed, it is known from in vitro (15;16) studies that cytokine-activated eosinophils
migrate in response to IL-8 in contrast to unactivated eosinophils. When eosinophils,
which started rolling after the IL-8-induced transient arrest, were subsequently activated
by eotaxin, the cells adhered firmly and longterm to the endothelium and spreading was
visible. This indicates that IL-8 does not cross desensitise or modulate the eotaxin 
induced response. Longterm adhesion and spreading was also visible when eotaxin was
administered directly to rolling cells (figure 1b, 1d, 2b). This transition between transient
and longterm adhesion allows the control of leukocyte extravasation by 
integration of different signals induced by multiple cytokines. The effect of IL-8 on the
arrest of cytokine-primed eosinophils cannot be addressed because cytokine-primed
eosinophils showed static adhesion on activated endothelium, i.e. they did not roll 
because b 2 integrins were activated (39).
Activation of leukocytes by chemoattractants is often associated with an increase in the
intracellular free Ca2+ concentration. However, many reports have only shown a small
(if any) increase in [Ca2+]i upon IL-8 stimulation of eosinophils (15;40;41). These studies
measured the mean increase in [Ca2+]i of a large population of cells in suspension.
Indeed, Petering et al. showed increasing [Ca2+]i responses in eosinophil suspensions
to which increasing concentrations of neutrophils were added, suggesting that 
eosinophils in suspension do not raise [Ca2+]i upon IL-8 stimulation (41). From a 
point of view it is more relevant to study changes in [Ca2+]i in eosinophils adherent 
to natural relevant surfaces for several reasons: I) adhesion changes signaling in 
granulocytes (42), and II) chemokines are often presented by large carbohydrate 
structures on the surface of endothelial cells (43). Therefore, we investigated if IL-8
would elicit a change in [Ca2+]i in eosinophils when attached to fibronectin or 
activated endothelium. We showed that ~40 % of the eosinophils adherent to fibronec-
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tin (induced by b 1 integrin freezing antibody 8A2) and ~30 % of the eosinophils adherent
to activated HUVEC exhibited an increase in [Ca2+]i in response to IL-8. Petering et al.
(41) concluded that contaminating neutrophils in the eosinophil suspensions caused the
IL-8-induced increase in total [Ca2+]i. However, contaminating neutrophils cannot
explain our results for varying reasons (I) our eosinophil populations contained less than
5 % neutrophils while 30 to 40 % of the adherent cells showed a [Ca2+]i response upon
IL-8 stimulation, (II) the contaminating effects of neutrophils were excluded by using
single-cell measurement on adherent cells. Moreover, the eosinophil-specific eotaxin
was added at the end of every experiment to show that the IL-8-responsive cells were
indeed eosinophils. 
In the static Ca2+ experiments only 30 and 40 % of the eosinophils adherent to activated
HUVEC and fibronectin, respectively, were activated by IL-8. In contrast, almost all of 
the rolling eosinophils responded upon IL-8 in the flow chamber experiments. This 
discrepancy is consistent with the hypothesis that the subpopulation of IL-8-responsive
cells are prone for an interaction with cytokine-activated endothelial cells under flow
conditions.
We were not able to block the IL-8 induced transient arrest of eosinophils by antibodies
against CXCR1 and CXCR2 (5A12 and 6C6, respectively) although the functionality 
of these antibodies was confirmed in migration assays. Using 5A12 and 6C6, the IL-8
receptors CXCR1 and 2 were not detected by FACS on eosinophils (figure 3b, c). This is
analogous to the data of Petering et al. (41). Therefore, it is tempting to hypothesize the
existence of an unknown IL-8 receptor on eosinophils. To show that a G-protein-coupled
receptor is involved, PTX was added to the eosinophils, and this inhibited the 
IL-8-induced transient arrest and also the IL-8- and C5a-induced increase in [Ca2+]i. 
This indicates that a PTX sensitive G-protein-coupled receptor is mediating the effects of
IL-8 on eosinophils. 
Our experiments were performed on physiological surfaces expressing several 
integrin ligands, which might lead to cross-linking of integrins on the cell surface and
concomitant cross-talk between these proteins (44). This putative cross-talk between
integrins is not necessary per se for this transient arrest, because blockade of either 
Mac-1 or VLA-4 did not affect the IL-8 induced arrest in our flow chamber experiments.
However, this does not mean that cross-talk did not occur. Interestingly, our 
experiments shown in figures 4 and 6 seem to indicate that possibly cross-linking of
integrins by their ligands expressed by different surfaces influenced the kinetics of the 
IL-8- and/or C5a-induced changes in [Ca2+]i. The IL-8-induced changes in [Ca2+]i are
remarkably slow compared to eotaxin and C5a. These latter agonists were in contrast to
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IL-8, very active in increasing [Ca2+]i in eosinophils in suspension (41;15). Therefore,
adhesion mediated by cross-linking of integrins might initiate a permissive signal for the
IL-8-induced increase in [Ca2+]i in adherent eosinophils. In addition, the C5a response
had an unexpected sustained behaviour in eosinophils adherent on a surface, e.g. 
TNF a -activated endothelium, which is rich in different integrin ligands. Again, the 
kinetics of this response in adherent cells is different compared to the situation in 
suspension.
Summarizing, this study shows that resting, rolling eosinophils on 7h TNFa -stimulated
HUVEC arrest transiently upon IL-8 stimulation at a shear rate of 2 dyn/cm2. This a 4- and
b 2-integrin-dependent process was probably not mediated by the known IL-8 
receptors CXCR1 or CXCR2. In addition, ~40 and ~30 % of the adherent eosinophils 
(to fibronectin and activated endothelium respectively) increased their [Ca2+]i in
response to IL-8 stimulation. Our findings are consistent with a model that IL-8 can only
transiently activate eosinophils, provided that they adhere to physiologically relevant 
surfaces. Transient arrest can easily be shifted to firm long-term arrest by additional 
chemokines. The transient arrest of eosinophils upon IL-8 exposure increases the time
of contact between the cell and the endothelial lining, which potentiates the 
immunological surveillance. 
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Abstract
The role of chemoattractants IL-8, eotaxin and C5a on integrin-dependent arrest of
rolling leukocytes on activated endothelium was studied. Since changes in intracellular
free Ca2+ levels ([Ca2+]i ) have been implicated in the adhesive behaviour of cells, we
focussed on the phospholipase C (PLC) family of enzymes that regulate [Ca2+]i and
which have been proposed to play a role in modulating integrin function. The effect of
PLC inhibitor U73122 on chemoattractant-induced eosinophil adhesion under flow 
conditions was tested. IL-8-induced a b 2- and a 4-integrin-dependent transient arrest of
unprimed eosinophils on TNF a -activated HUVEC under flow conditions. Interestingly,
U73122 prevented the IL-8-induced arrest only when a 4- but not b 2-integrins were 
blocked. This suggests that the IL-8-induced activation of b 2 integrins but not of 
a 4 integrins is mediated via PLC. Eotaxin-1 induced an a 4- and b 2-integrin-dependent
firm adhesion of eosinophils to activated endothelium under flow conditions. U73122
inhibited this arrest in the presence of blocking antibodies against b 2 integrins or against
a 4 integrins. This suggests that the eotaxin-induced activation of both a 4 integrins as well
as b 2 integrins are mediated via PLC. C5a, similar to eotaxin, induced a permanent firm
arrest leading to spreading of the cells. U73122 prevented this arrest by 50 % in the 
presence of blocking antibodies against a 4 integrins or against b 2 integrins. When both
a 4- and b 2- integrins were blocked, still 70 % of the cells arrested by C5a, in marked 
contrast to IL-8 and eotaxin, which have shown to be totally dependent on a 4- and 
b 2- integrins. Thus, it seems that C5a, unlike eotaxin, induced both PLC-dependent and
independent adhesion of eosinophils under flow conditions. These data suggest that
integrin receptors are differentially regulated through specific chemoattractant-receptor 
inside-out signal transduction pathways.
Introduction
The migration of leukocytes to inflammatory sites occurs in multiple steps. 
Cells roll along the endothelium, and when a chemoattractant is present, firm adhesion
is induced and the migration through the endothelium starts (1). Firm adhesion is 
a result of activation of integrins that under resting conditions are not able to bind to their
ligands, except for a 4 b 1 integrin, that binds its ligand VCAM-1 without activation. This 
chemoattractant-induced activation of integrins is called “inside-out” signaling and
results in 1) a conformational change of the integrin which enhances affinity and/or 
2) clustering of integrins, which enhances avidity of the integrin.
Chemoattractants can be divided in several classes. The classical peptide chemo-
attractants, like C5a (2), act on many leukocyte subtypes and are known to be very
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potent. More specific chemoattractants are the chemokines that can be divided in CXCL,
CCL, CL and CX3CL families, based on the position of the cysteine motif (reviewed in
(3)). CXCL chemokines are most active on polymorphonuclear cells, T and B cells, 
whereas CCL chemokines exert their action more on eosinophils, monocytes, basophils,
T cells and NK cells. IL-8, a CXCL chemokine, is a very good chemoattractant for 
neutrophils and far less for eosinophils and monocytes (4). In contrast, eotaxin (5), a CCL
chemokine, acts predominantly on eosinophils and basophils but not on neutrophils
(6;7). Although there is specificity, no inflammatory chemokine is uniquely active on one
population of leukocytes.
Chemoattractant-induced “inside-out” signaling results in affinity and/or avidity changes
of integrins. Especially the activation of b 2 and b 1 integrins are important for adhesion 
to ICAM-1 and VCAM-1, respectively, expressed on activated endothelium. Of the 
b 2 integrins, LFA-1 (CD11a/CD18) which is highly expressed on lymphocytes, and Mac-1
(CD11b/CD18), which is highly expressed on granulocytes, can bind ICAM-1. Most of the
b 1 integrins are ligands for extracellular matrix components, whereas only a 4 b 1 (VLA-4)
has the capacity to bind VCAM-1. Under resting conditions, a 4 b 1 is present on 
eosinophils, monocytes and lymphocytes but not on neutrophils. 
Binding of chemoattractants to their G-protein-coupled receptors results in the activation
of phospholipase C, that cleaves phosphoinositol (4,5) bisphosphate (PIP2) into inositol
1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 induces an increase in 
intracellular Ca2+ from internal stores, whereas DAG activates protein kinase C (PKC).
[Ca2+]i might play a crucial role in regulating avidity and affinity changes of integrins 
in leukocytes since it has been reported that an increase in [Ca2+]i can activate 
integrins via inside-out signaling (8). Also, many cytoskeletal and signaling molecules are
involved in regulating avidity changes of integrins and are themselves dependent 
on [Ca2+]i increases in the cell (9;10). 
In this study we compared the effects of different chemoattractants on changes 
in [Ca2+]i and integrin activation. Since it was known from a previous study (11) that
chemoattractant-induced arrest of rolling eosinophils on activated HUVEC was largely
dependent on a 4- and b 2-integrins, we used this as a model sytem. Moreover, IL-8,
eotaxin and C5a were compared in the context of their signaling routes to activate a 4 and
b 2 integrins in an in vitro flow chamber model. 
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Materials and Methods
Reagents
CD16, CD14 and CD3 beads and isolation tools were purchased from Miltenyi, 
Biotec (Germany). Human serum albumin (HSA) was purchased from the Central
Laboratory of The Netherlands Red Cross Blood Transfusion Service (Amsterdam, 
The Netherlands). Recombinant human TNF a was purchased from Boehringer
Mannheim (Germany). Isolation buffer contained PBS supplemented with pasteurized
plasma solution (10 %) and sodium citrate (10 %). IL-8 (72aa, Peprotech INC., 
Rocky Hill, NJ, USA), Eotaxin-1 was purchased from R&D Systems (Minneapolis, MN, 
USA) and C5a was purchased from Sigma (St. Louis, USA). The Phospholipase C (PLC)
inhibitor U73122 (1-{{6-{[(17 b -3-methoxestra-1,3,5(10)trien-17- g l]amino}hexyl}}-1H-
pyrrole-2,5-dione) and its inactive congener U73343 (1-{{6-{[(17 b -3-methoxestra-
1,3,5(10)trien-17- g l]amino}hexyl}}-2,5-pyrrolidine-dione) were from Calbiochem 
(La Jolla, CA, USA). Incubation buffer contained 20 mM HEPES, 132 mM NaCl, 6 mM KCl,
1 mM MgSO4, 1.2 mM KH2PO4, supplemented with 5 mM glucose, 1.0 mM CaCl2, and 0.5
% (w/v) HSA. All other materials were reagent grade. 
Antibodies 
The MoAb HP2/1 (anti VLA-4, CD49d) was purchased from Immunotech (Marseille,
France). MoAb IB4 was isolated from the supernatant of a hybridoma obtained from the
American Type Culture Collection (Rockville, MD, USA). MoAbs mentioned above are
functionally blocking antibodies. Control antibody W6/32 (anti HLA-A,B,C) was isolated
from the supernatant of a hybridoma obtained from the American Type Culture
Collection (Rockville, MD, USA). MoAbs were incubated with eosinophils (4x106cells/ml)
at 10 m g/ml during 15 minutes before the experiments. The cell suspensions were 
diluted once with incubation buffer (final concentration of 5 m g/ml MoAb at 2x106
cells/ml in incubation buffer), and the coverslips were placed directly in the system. 
Isolation of eosinophils
Blood was obtained from healthy volunteers from the Red Cross Blood Bank
(Utrecht, The Netherlands) anti-coagulated with 0.4 % (w/v) trisodium citrate (pH 7.4).
Mixed granulocytes were isolated as described previously (12). Mononuclear cells were
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removed by centrifugation over isotonic Ficoll (1.077 g/ml). After lysis of the erythrocytes
with an isotonic ice-cold NH4Cl solution, the granulocytes were washed and 
resuspended in isolation buffer. Eosinophils were purified from granulocytes by negative
immunomagnetic selection with anti-CD16-conjugated microbeads (MACS; 
Miltenyi Biotec, 13). To avoid mononuclear cell contamination also anti-CD3- and 
anti- CD14-conjugated microbeads were added to the granulocyte suspension. Purity of
eosinophils was >97 %. 
Endothelial cells
Human umbilical vein endothelial cells (HUVEC) were isolated from human 
umbilical cord veins according to Jaffe et al. (14), with some minor modifications (15).
The cells were cultured in Endothelial cell Growth Medium-2 (EGM-2) (Biowhittaker,
Walkersville, MD, USA). Cell monolayers were grown to confluence in 5-7 days.
Endothelial cells of the second passage or third passage were used in perfusion assays.
HUVEC was activated by TNFa (100 U/ml, 5-7 hours, 37°C) prior to the perfusion 
experiments.
Perfusion chamber
Perfusions under steady flow were performed in a modified form of transparent
parallel-plate perfusion chamber (16) as previously described by Van Zanten et al. (15).
This micro-chamber has a slit height of 0.2 mm and a width of 2 mm. The chamber 
contains a circular plug on which a coverslip (18 mm x 18 mm) with confluent HUVEC
was mounted. 
Eosinophil perfusion and evaluation
In vitro flow chamber experiments were performed as described (11;17). In short,
eosinophils in suspension (2x106 cells/ml in incubation buffer) were aspirated from a
reservoir through the perfusion chamber. Eosinophil perfusions were performed as 
individual runs under specific shear conditions by 37°C. During the perfusion, the flow
chamber was mounted on a microscope stage (DM RXE, Leica, Weitzlar, Germany)
which was equiped with a B/W CCD-video-camera (Sanyo, Osaka, Japan), coupled to a
VHS video recorder. Perfusion experiments were recorded on video tape. Video 
images were evaluated for the percentage of rolling cells by dedicated routines made in
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the image-analysis software Optimas 6.1 (Media Cybernetics systems, Silverspring, MD,
USA). The eosinophils which were in contact with the surface appeared as bright 
white-centered cells after proper adjustment of the microscope during recording. 
The adherent (rolling or firmly attached) cells on the HUVEC were detected by the image
analyzer. The eosinophil suspension was perfused during 3 minutes at a shear stress of
0.8 dyn/cm2 to obtain an endothelial surface with firmly adherent and rolling 
eosinophils (17). Shear stress was increased to 2 dyn/cm2, and recording of the images
on video was started. Subsequently, the cytokines IL-8 (10-8 M), eotaxin (10-8 M) or C5a
(10-8 M) were added in the presence or absence of antibodies (IB4, HP2/1 or W6/32; 10
m g/ml) or in the presence of the PLC inhibitor U73122 or the control analogue U73343. 
To automatically determine the velocity of rolling cells, custom-made software was 
developed in Optimas 6.1. For determining the percentage of rolling cells and the rolling
velocity sequence of 50 frames representing an adjustable time interval ( d t, with a 
minimal interval of 80 milliseconds, ~30 sec before, during and 1 minute after stimulus
addition) was digitally captured. Within each frame, the position of every cell was 
detected and for all subsequent frames the distance moved by each cell and the 
number of images in which a cell appeared in focus was measured. The velocity of a cell
(v) in micrometers per sec was calculated from the equation: v = L/d t(x-1) in which L is
the covered distance ( m m), d t is the time interval between images (seconds), and x is the
number of images in which a cell appears. The cut-off value to distinguish between 
rolling and static adherent cells was set at 1 m m/sec. With this method, static adherent,
rolling and freely flowing cells (which were not in focus) could be distinguished clearly. 
Imaging of intracellular free Ca2+ on adherent cells
Imaging of intracellular free Ca2+ was performed with a custom-built set-up as
described before (11). Series of 50 image pairs (512 x 512, 0.6 second apart) were
sequentially grabbed with a black and white framegrabber (Pulsar, Matrox Electronic
Systems Ltd., Dorval, Quebec, Canada) from an intensified video camera (LI-m CAM,
Lambert Instruments, Leutingewolde, The Netherlands) directly into computer memory.
Ratios and calcium values were computed off-line with Image Analysis software
(Optimas 6.1, Media Cybernetics, Silver Spring, MD, USA) using custom-made macros
(A.L.I.). Calcium levels were calculated with the standard calibration formula of
Grynkiewics et al. (18): 
[Ca2+]i = Kd x b x ((R-Rmin)/(Rmax-R)) with parameters Kd=225 nM, b =2.4 and 
displayed in false colors (blue-red ramp). Cell calcium was separated from background
by calculating the threshold mask from the mean of the two ratio images for each of the 
50 ratio images in the series. The threshold level was obtained by choosing the first and
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the last level in the series, and then by linear interpolation for the rest of the series, 
thereby counteracting the effect of bleaching over time. Intracellular [Ca2+] levels were
determined by calculating the mean [Ca2+]i of all pixels in a cell in each of the 50 ratios
taken. The cut-off value to distinguish between a responding and a non-responding cell
was set at a mean value of 200 nM. The insert in figure 1 shows the mean [Ca2+]i of all
cells exceeding this cut-off value. All washing and incubation steps were performed in
incubation buffer. Eosinophils (4x106/ml) were loaded with 1.25 m M Fura-2 AM
(Molecular Probes, Eugene, OR, USA) for 15 minutes, then washed and kept at room
temperature. 7h TNF- a -activated HUVEC cultured on 24 mm cover slips were 
extensively washed with PBS and non-treated, Fura-2 AM- loaded eosinophils were 
plated on the endothelium. The eosinophils were allowed to settle for 15 minutes on the
substrate, and no adherent cells were removed by washing the cover slips. Cover slips
were mounted in an open chamber and placed in a warmed (37°C) metal ring for
Calcium Imaging. Stimulants were added from the top after two pre-stimulus image
ratios had been obtained. Stimulants (37°C, at 2 times the concentration) were added to
an equal volume (250 m l) of incubation buffer already present in the chamber to obtain
a homogenous mixture at the start of the ratio imaging.
Imaging of intracellular free Ca2+ on non-adherent cells
Cells were loaded with Fura-2AM as described above and were kept at room 
temperature until use. Cells were put in a quartz cuvette (400 m l, 2x106/ml) and 
stimulated with indicated chemoattractants. The fluoresence was measured under 
stirring conditions at 37°C in a Hitachi F-4500 fluorescent spectrophotometer (Hitachi Ltd,
Tokyo, Japan), using a multi-wavelength timescan program. Fura-2 fluorescence was
measured at 340 nm (F1) and 380 nm (F2) at 510nm emission. [Ca2+]i was calculated as
described above.
Statistical Analysis. Statistical analysis of the data was performed using the Student T test,
p values < 0.05 were considered to be significant.
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Results
Different effects of IL-8, eotaxin and C5a on [Ca2+]i in both adherent and 
non-adherent eosinophils
An important difference between IL-8, eotaxin and C5a is that the IL-8 induced
increase in [Ca2+]i occurs only when eosinophils adhere to a substrate but not when
cells are in suspension, whereas eotaxin and C5a induce an increase in [Ca2+]i
in both adherent and non-adherent cells (figure 1, 2 and also a previous study (11)). 
The previous study also showed that IL-8-induced an activation of b 2- and a 4-integrins,
resulting in an arrest of eosinophils on activated endothelial cells. Therefore, we 
hypothesize that upon IL-8 activation the integrins are cross-linked to their ligands on the
endothelium. And subsequently, the integrin cross-linking might result in the observed
release of [Ca2+]i. It is known that cross-linking of b 2 integrins phosphorylates PLC- g
which results in an increase in [Ca2+]i (19). Since this isoform of the PLC family is
dependent on tyrosine phosphorylation, we investigated whether a tyrosine kinase 
inhibitor could block the IL-8-induced Ca2+ signal. Figure 1b shows that genistein, an
inhibitor of tyrosine kinases, blocks the IL-8 induced increase in [Ca2+]i but had no
effect on eotaxin- and C5a-induced increase in [Ca2+]i. This suggests that the IL-8, but
not the eotaxin- or C5a-induced increase in [Ca2+]i is dependent on a tyrosine kinase. 
Next, the PLC inhibitor U73122 was used to show that IL-8, eotaxin and C5a absolutely
depend on functional PLC activity. Figure 2 shows that on adherent cells (2a, 2b) and
cells in suspension (2c) U73122 (2a, 2c), but not the control compound U73343 (2b, 2c),
abrogates the increase in [Ca2+]i. Remarkably, the Ca2+ experiments on adherent cells
showed that U73122 not only abrogated the chemoattractant-induced increases in
[Ca2+]i but also interfered with adhesion. Cells were attached very loosely to the 
endothelial surface. Thus, PLC appears to be critical for changes in [Ca2+]i but also for
adhesion events. 
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Figure 1. IL-8-, eotaxin- and C5a-induced Ca2+ response in the presence of control solvent 
treatment (A) or genistein (B). Fura-2AM-loaded eosinophils were incubated with DMSO (0.1 %)
or genistein (50 m M) for 15 minutes and loaded on activated endothelial cells. IL-8 (10-8 M, solid
squares), eotaxin (10-8 M, solid triangles, point up) and C5a (10-8 M, solid triangles, point down)
were applied with 3-4 minutes recovering time in between. Mean Ca2+ tracks are shown of cells
in one image. The insert depicts the mean track of the cells that responded to 
IL-8 (15 % of the cells responded, cut-off value [Ca2+] >200 nM) in the presence of control 
solvent (solid squares). Genistein treated cells (insert, flat line) showed no increase in 
[Ca2+] > 200 nM upon IL-8. This is a representative experiment out of 3.
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Figure 2. IL-8-, eotaxin- and C5a-induced Ca2+ response on adherent eosinophils in the 
presence of A) control compound (U73343, 10 m M) or B) PLC inhibitor (U73122, 10 m M). 
Fura-2AM loaded eosinophils were incubated with U73343 or U73122 for 15 minutes and
loaded on activated endothelial cells. IL-8 (10-8 M, solid circles), eotaxin (10-8 M, solid squares)
and C5a (10-8 M, solid triangles) were applied with 3-4 minutes recovering time in between.
Mean Ca2+ tracks are shown of cells in one image. This is a representative experiment out of 3.
IL-8-, eotaxin- and C5a-induced Ca2+ responses in the presence of U73343 (C) or U73122 
(D) are shown for eosinophils in suspension. Peak Ca2+ responses are depicted. This is a 
representative experiment out of 2.
Effect of U73122 on adhesive behaviour of eosinophils under flow
Since the Ca2+ experiments revealed that U73122 interfered with adhesion, we first
examined the effect of U73122 on the rolling behaviour of eosinophils on activated
endothelial cells. Eosinophils were incubated with the indicated inhibitors and 
monoclonal antibodies (MoAbs) and perfused for 3 minutes, and the percentage of 
rolling cells was determined at a shear rate of 2 dyn/cm2. Figure 3 shows that 35 ± 6 %
of the eosinophils treated with the control compound U73343 and W6/32 (control/non-
blocking MoAb) rolled on the activated endothelium. Addition of the active compound
U73122 and W6/32 showed an increase in rolling eosinophils to 81 ± 3 %. Treating the
eosinophils with HP2/1 (a blocking MoAb against a 4 integrins) together with the control
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compound U73343 resulted in a percentage of rolling cells of 74 ± 4 %. Addition of
U73122 and HP2/1 to eosinophils even further increased the percentage of rolling cells to
88 ± 3 %. IB4 (a blocking b 2 integrin MoAb) together with the control compound U73343
resulted in a percentage rolling of 44 ± 5 %, whereas the combination of IB4 with U73122
further increased rolling to 81 ± 4 %. We conclude that U73122 as well as inhibiting 
intracellular Ca2+, also decreased the basal activity of a 4 integrins. Furthermore, 
comparing W6/32-treated cells and IB4-treated cells both in the presence of U73433, 
the percentage of rolling cells is 35 ± 6 and 44 ± 5 %, respectively. Although these 
values do not differ significantly, it seems that b 2 integrins on resting eosinophils are
slightly activated. This slight activation is further addressed by the observation that in the
presence of blocking antibodies against a 4 integrins, and thus focussing on b 2 integrin
mediated processes, U73122 leads to a higher percentage of rolling cells than U73343 (88
± 3 % compared to 74 ± 4 %, respectively, p<0.01). 
Figure 3. Effect of inhibition of PLC on 
the percentage of rolling eosinophils on 
activated HUVEC in the presence of 
different MoAbs. Eosinophils were 
incubated with indicated MoAbs against
HLA(A,B,C), (W6/32, control), b 2 integrins
(IB4) or a 4 integrins (HP2/1) and in the
presence of the control compound
U73343 (10 m M, white bars) or the PLC
inhibitor U73122 (10 m M, black bars) for
15 minutes. Cells were perfused over 5-7
hours TNF a -activated HUVEC and the
percentage of rolling cells was determined
at a shear rate of 2 dyn/cm2. *: p<0.01,
#: p<0.001, p values were determined by
an unpaired Student T-Test.
IL-8, eotaxin and C5a induced arrest of rolling eosinophils
Previous results have shown that IL-8 induced a transient arrest of eosinophils on
TNF a -activated HUVEC that is a 4- and b 2- integrin dependent (11). Remarkably, cells
remained round upon IL-8-induced arrest (figure 4a and 4b) suggesting that IL-8 can 
activate integrins that does not result in firm adhesion and spreading. In contrast to IL-8,
eotaxin (figure 4c and 4d) and C5a (figure 4e and 4f) induced a firm arrest of eosinophil
to activated HUVEC followed by spreading of the cells. To address the differences 
in integrin modulation by these chemoattractants we focussed on chemoattractant-
induced intracellular signals in eosinophils upstream of [Ca2+]i. 
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Figure 4. Effect of IL-8, eotaxin and C5a on the transition from rolling to arrest of eosinophils
on TNFa -activated HUVEC under flow conditions (2 dyn/cm2). Panel A, C, and E show the effects
of IL-8 (A), eotaxin (C) and C5a (E) the moment the cells arrest. Cells were round. Panel B, D 
and F show the effects of IL-8 (B), eotaxin (D) and C5a (F) one minute after the chemoattractants
induced the arrest. In panel B (IL-8) the cells remained round and some started rolling again, as
shown by the different positions the cells had compared to panel A (arrows indicate rolling cells).
In panel D (eotaxin) and F (C5a) the cells spreaded and were at the exactly same place as in
panel C and E, respectively.
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Effect of inhibition of PLC on the IL-8-, eotaxin- and C5a-induced arrest 
of rolling eosinophils
U73122 and U73343 were used as a tool to study chemoattractant-induced 
inside-out signaling in eosinophils. Cells were incubated with the indicated inhibitors
and MoAbs and perfused for 3 minutes. The percentage of rolling cells was determined
at a shear rate of 2 dyn/cm2. Subsequently chemoattractants were perfused over the
cells and the percentage rolling was determined ~0.5 minute and ~1 minute after
adding the chemoattractant. Figures 5a, 5b and 5c depict the effects of IL-8 (10-8 M),
eotaxin (10-8 M) and C5a (10-8 M), respectively. Figure 5a shows that eosinophils treated
with the control compound U73343 in combination with W6/32, HP2/1 or IB4 showed a
transient arrest upon IL-8 addition. A transient arrest upon IL-8 stimulation was also
observed when eosinophils were incubated with W6/32 and U73122. However, HP2/1-
and U73122-treated cells showed no arrest upon IL-8 stimulation, the cells kept rolling.
IB4- and U73122-treated cells did arrest transiently upon IL-8, comparable to the control
(W6/32) treated cells. This suggests that the IL-8-induced activation of b 2 integrins, but
not of the a 4 integrins, is dependent on PLC. Figure 5b shows that the control compound
U73343 has no effect on the eotaxin-induced firm arrest in the presence of W6/32, HP2/1
or IB4. However, when cells were incubated with U73122 in the combination with either
W6/32, HP2/1 or IB4, the cells did not arrest but kept rolling. This suggests that the
eotaxin induced a 4- and b 2-integrin activation are both dependent on PLC.
The conclusions for IL-8- and eotaxin-induced effects can be drawn because we 
recently showed that IL-8- and eotaxin-induced arrest was totally dependent on a 4- and
b 2-integrins (11). For C5a this is not yet known. In figure 5 (last set of data) it is shown
that C5a induced arrest of eosinophils is for 30 % dependent on the combined action 
of b 2 and a 4 integrins. The control compound U73343 in combination with either W6/32,
HP2/1 or IB4 induced firm adhesion of eosinophils on activated HUVEC. In all three
cases, U73122 in combination with either W6/32, HP2/1 or IB4 induced a 50 % decrease
in rolling cells.
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Figure 5. Effect of inhibition of PLC on chemoattractant-induced arrest of rolling eosinophils on
activated HUVEC in the presence of different MoAbs. Eosinophils were incubated with the 
indicated MoAbs against HLA(A,B,C) (W6/32, control), b 2 integrins (IB4) or a 4 integrins (HP2/1)
and in the presence of the control compound U73343 (10 m M) or the PLC inhibitor U73122 (10
m M) for 15 minutes. Cells were perfused over 5-7 hours TNF a -activated HUVEC, and the per-
centage of rolling cells was determined before (white bars), during (black bars) of one minute
after addition of chemoattractant (hatched bars). The chemoattractants IL-8 (10-8 M, A), eotaxin
(10-8 M, B) and C5a (10-8 M, C) were tested. In panel 5C the last set of bars represents the effect
of C5a on HP2/1- and IB4-treated eosinophils. Values are displayed as mean ± SEM of at least 
3 experiments.
C
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Discussion
Most of the chemoattractant receptors on granulocytes belong to the serpentine
family. Signaling via these receptors induced by the corresponding chemoattractants,
such as bacterial products, bioactive lipids and chemokines, follows a general theme.
Upon receptor engagement high-molecular trimeric G-proteins are activated, which in
turn activate phospholipase-C b, leading to liberation of inositol-1,4,5-trisphosphate and
1,2-diacylglycerol. These second messengers induce an increase in intracellular free
Ca2+ ([Ca2+]i) and activation of protein kinase C (PKC), respectively (20). These 
signaling molecules are thought to play an important role in the movement of the cells
(10;21) by activating adhesion molecules, integrins, on the surface of the leukocytes
(8;9;22;23). Several lines of evidence, obtained from experiments employing cells 
adherent to several surfaces, are in support of this hypothesis (24-26).
General validity of this mechanism is hampered by an important conceptual 
problem, namely how specificity is achieved. If all chemoattractant receptors utilize
similar signaling routes in controlling the affinity/avidity state of the integrins, the cell 
cannot discriminate between the presence of one chemoattractant from the other. 
We set up experiments to test an alternative hypothesis, postulating that different 
chemoattractants modulate the functionality of integrins on eosinophils in different
ways. We tested this hypothesis with eosinophils adherent to endothelial cells under
flow conditions. This adhesion system resembles the in vivo situation more than models
under static conditions. We chose three eosinophil chemoattractants that have unique
characteristics: IL-8 only activating adherent and/or primed eosinophils (11;27;28),
eotaxin, a more specific chemokine for eosinophils (29) and C5a, a very potent 
chemoattractant (30). Eosinophils were activated with these three chemoattractants 
and evaluated in the context of activation of PLC and increased [Ca2+]i and 
adhesion under flow conditions to TNFa -activated endothelial cells.
An important difference between the three chemoattractants was found in their 
ability to increase the [Ca2+]i in eosinophils. In marked contrast to eotaxin and C5a, 
IL-8 induced an increase in [Ca2+]i only after adhesion of the cells to a physiological 
surface (figure 2 and (11)). These increases in [Ca2+]i must have been mediated by 
activation of PLC, because the PLC inhibitor U73122 completely blocked these 
responses, whereas the inactive analogue U73122 did not have an effect. These findings
are consistent with the hypothesis that both CCR3 and C5aR signal via a G-protein- 
dependent activation of PLC-b , as has been shown by others (20;31). The situation with
IL-8 is more complex. The IL-8-induced increase in [Ca2+]i in eosinophils is mediated 
by a mechanism involving a tyrosine-kinase-mediated activation of PLC (figure 1).
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Together with the finding that the increase is late (optimal only after several seconds, see
figure 1 and reference 11) it is tempting to speculate that PLC-g is activated under these
conditions. It is not likely that this isoform is directly activated by a chemokine receptor.
A more attractive hypothesis is that PLC-g is activated as a result of cross-linking of 
integrins on the cell surface. Indeed, cross-linking of b 2 integrins in several cell systems
induces a clear increase in [Ca2+]i that is mediated by PLC- g (19). This also explains why
IL-8 can only induce changes in [Ca2+]i in adherent cells.
Activation of PLC is the common denominator in activation of eosinophils by the three
different chemoattractants. Therefore, we evaluated whether inhibition of PLC has a 
consequence on the adhesion behaviour of human eosinophils to activated endothelial
cells under flow conditions. It has been reported that PLC plays a role in granulocytes
and platelets as determined by static adhesion assays (32;33). We found that IL-8,
eotaxin- and C5a-induced adhesion events were differentially regulated by PLC. 
IL-8 induced a transient arrest of eosinophils that had been incubated with blocking 
antibodies against b 2 integrins and with the PLC inhibitor. When a 4 integrins and PLC
were inhibited in eosinophils, IL-8 did not induce an arrest. In an earlier study 
we showed that the IL-8- as well as the eotaxin-induced arrest of eosinophils to 
activated endothelium were both totally dependent on a 4- and b 2- integrins (11). Thus,
IL-8 induced a PLC-dependent b 2 integrin but a PLC-independent a 4 integrin-mediated
arrest. For eotaxin a different phenotype was observed. Eotaxin did not induce an arrest
of eosinophils that were incubated with the PLC inhibitor and a control antibody
(W6/32). Concomitant with this observation we showed that the PLC inhibitor in 
combination with blocking antibodies against a 4- or b 2-integrins also prevented an
eotaxin induced arrest. This indicates that eotaxin activates b 2 integrins and a 4 integrins
in a PLC dependent manner. 
The situation for C5a is more complex. In contrast to IL-8 and eotaxin, the C5a-mediated
arrest of eosinophils was only inhibited by 30 % when both a 4- and b 2-integrins were 
inhibited. This suggests that additional adhesion molecules may exist. Furthermore, 
inhibition of PLC resulted in a C5a-induced arrest of 50 % of the cells, irrespective of
whether a 4 integrins or b 2 integrins were blocked simultaneously. From this observation
we can conclude that PLC-dependent processes are involved in C5a-induced arrest. 
We showed that different chemoattractants may use PLC in different ways and we 
postulate that this leads to specificity in chemoattractant-induced integrin modulation.
We hypothesize that the order of potency of the three chemoattractants in inducing 
eosinophil adhesion is C5a > eotaxin > IL-8. Possible mechanisms explaining this 
phenomenon are: 1) additional, but undefined, adhesion mechanisms that can be 
initiated by C5a but not by eotaxin and IL-8 and 2) C5a and eotaxin activate 
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intracellular pathways that lead to spreading of the cells, whereas IL-8 does not. 
The observed differences between the studied chemoattractants in inducing the 
transition from the rolling to the firm adhesion state may predict differences in the 
migratory capacity of these chemoattractants. Indeed, IL-8 was only able to induce a
transient arrest of rolling eosinophils and IL-8 appeared to be a weak inducer of 
eosinophil migration. Only when eosinophils are primed, IL-8 was only able to induce
small migratory responses (27). Eotaxin appeared to be a strong inducer of the 
migratory reponse of eosinophils over endothelial cells (34;35;29) that equals the C5a-
induced transmigration (J. Alblas, unpublished observations). However, eotaxin-induced
eosinophil migration over bare filters only succeeded using thin (10 m m) filters (36). 
In thick (150 m m) bare filters, eotaxin only induced migration in the presence of 10 %
human pooled serum (J. Alblas, personal observations). Furthermore, eosinophils 
isolated from IL-5 transgenic mice migrated equally well in response to eotaxin in the
presence or absence of endothelial cells (34). This indicates that eosinophils need an
additional stimulus (provided by endothelial cells, serum or cytokines) besides eotaxin
to induce migration over long distances. On the contrary, C5a induced eosinophil 
migration on bare, thick filters (30) without additional signals needed. Thus, the potency
of IL-8, eotaxin and C5a to induce an arrest of eosinophils may equal their potency 
in inducing chemotaxis. This might be a result of the differences between the 
chemoattractants in activating adhesion molecules on the cells. 
In summary, this study showed that phospholipase C plays an important role in integrin-
mediated arrest of leukocytes. The a 4 integrin-mediated arrest is dependent on 
functional PLC only for the chemoattractants eotaxin and C5a, but not IL-8. This IL-8 
induced PLC-independent pathway for activating a 4 integrins is intriguing but the 
mechanism is not known for the moment. The b 2 integrin-mediated arrest is dependent
on PLC for the chemoattractants IL-8 and eotaxin, and possibly also for C5a. Therefore,
different chemoattractant receptors can induce different inside-out signaling pathways
for regulating the same integrin. Also, one chemoattractant can use different inside-out
signaling pathways for activating different integrins on the same cell. In conclusion, each
chemoattractant may lead to activation of specific intracellular pathways leading to 
specific control of adhesion processes.
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Abstract
Detachment of the rear of the cell from its substratum is an important aspect of
locomotion. The signaling routes involved in this adhesive release are largely unknown.
One of the few candidate proteins to play a role is RhoA, since activation of RhoA in
many cell types leads to contraction, a mechanism probably involved in detachment. 
To study the role of RhoA in detachment regulation, we analyzed several subsets of  
migratory leukocytes by video microscopy. In contrast to fast migrating neutrophils, 
eosinophils did not detach the rear of the cell unless stimulated with serum. When
measuring the amount of active RhoA, using a GST-Rhotekin pull-down assay, we found
that serum is an excellent activator of RhoA in granulocytes. Inhibition of RhoA or one of
Rho’s target proteins, the kinase ROCK, in neutrophils resulted to the phenotype 
observed in eosinophils: the rear of the cell was firmly attached to the substratum, 
whereas the cell body was highly motile. ROCK inhibition resulted to impaired migration
of granulocytes in filters, on glass and through endothelial monolayers. Also, the ROCK
signaling pathway is involved in changes in integrin-mediated adhesion. Eosinophil
transduction by a tat-fusion construct containing active RhoA resulted in detachment 
stimulation in the presence of chemoattractant. From these results we conclude
that activation of the RhoA-ROCK pathway is essential for detachment of migratory 
leukocytes. 
Introduction
When an eukaryotic cell migrates, the leading lamella protrudes, then the cell
body moves forward and finally the rear of the cell (or uropod) releases the binding from
the extracellular environment. When the process of rear release is slow compared 
to the protrusion of the leading lamella, it will determine the migration rate (1). 
The mechanisms by which adhesions release are largely unknown. First, cytoskeletal
contraction may overcome the negative force that is excerted by the adhesion 
molecules bound to the extracellular matrix. Contraction of actin filaments can pull on
filaments connected to integrins that link the cell to the extracellular matrix (2).
Alternatively, ligand-induced signaling has been proposed to play a role in adhesive 
release. Calcineurin, a calcium-regulated serine-threonine phosphatase, plays a role
in recycling of integrins in neutrophils (3). Also implicated in adhesive release is RhoA:
inhibitors of RhoA induce cytoskeletal breakdown and cell rounding (4) and inhibit
migration in several cell types (5). 
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RhoA is a member of the Ras superfamily of small GTP-binding proteins that regulate 
formation of actin stress fibers and focal adhesions. RhoA activation can be blocked by
the ADP-ribosyltransferase from Clostridium botulinum, C3 exoenzyme. In this way the
importance of RhoA in several cellular processes, such as cell morphology, migration,
cytokinesis, DNA synthesis and cell growth, has been established (reviewed in 6). Like
Ras, RhoA cycles between a GDP-bound inactive state and a GTP-bound active state. 
RhoA-bound nucleotides are regulated by several groups of proteins: guanine 
nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), and guanine
nucleotide dissociation inhibitors (GDIs). When GTP-bound, RhoA binds to and activates
a number of downstream effectors such as Rho kinase, lipid kinases and Rhophilin (7).
Rho kinase, also known as ROCKII or ROKa is closely related to p160ROCK (ROCKI) or
ROKb (8). ROCKII is implicated in mediating actomyosin-based contractility stimulated
by RhoA. It phosphorylates myosin phosphatase, resulting in elevated myosin light chain
(MLC) phosphorylation (9). MLC phosphorylation is correlated with myosin II filament
assembly and actin-activated myosin ATPase activity (10). Apart from this, Rho kinase
may also phosphorylate MLC directly (11). Using the specific inhibitor Y27632, ROCKs
were shown to be important for many of the Rho-mediated cellular processes, including
smooth muscle contraction (12), myosin light chain phosphorylation (13), tumor cell
invasion (14) and motility (15).
Until recently, RhoA activity was established by the appearance of stress fibers or focal
adhesions. In leukocytes, however, stress fibers and focal adhesions are not formed.
Several groups have now published an activation assay for RhoA, using the RhoA-binding
domain of Rhotekin (16), and were able to show RhoA activation upon stimulation of 
3T3 cells with the integrin ligand fibronectin or with LPA (17;18).
We have studied the role of RhoA and its downstream kinase ROCK in the process 
of detachment of highly motile leukocyte subsets. Serum stimulation of detachment-
defective eosinophils leads to RhoA-activation and enhanced migration. Inhibition 
of RhoA or ROCK in motile neutrophils results in a phenotype similar to eosinophils: 
the leading lamella is protruding, whereas the rear of the cell remains firmly attached to
the substratum. Furthermore, we investigated the effects of ROCK activity on adhesion.
The results are discussed with respect to the theoretical background of rear release and
its role during cell migration.
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Materials and Methods
Reagents and antibodies
Eotaxin was obtained from R&D Systems; PAF (1-O-hexadecyl-2-acetyl-sn-glycero-
3-phosphoryl-choline) and fMLP were from Sigma; recombinant human IL-5 was a gift
from M. McKinnon (Glaxo-Wellcome, Stevenage, UK); Ficoll-paque and Percoll were
from Pharmacia (Uppsala, Sweden); human serum albumin (HSA) and pasteurized
plasma solution were from CLB (Amsterdam, The Netherlands); Calcein-AM and 
Alexa-phalloidin were from Molecular Probes; VCAM-1 and ICAM-1 were from R&D
Systems (Abingdon,UK); neutralizing antibodies against a 4-integrin (HP2/1) were from
Immunotech (Marseille, France); antibodies against b 2-integrins (IB4) were isolated
from culture medium of hybridoma obtained from the ATCC (Rockville, USA); anti-RhoA
was from Santa Cruz, anti-phospho-Erk1/2, anti-phospho-p38 and anti-phospho-PKB
were from BioLabs. The ROCK-inhibitor Y27632 was kindly provided by Welfide
Corporation (Osaka, Japan).
Cell isolation
Blood was obtained from healthy volunteers via the Red Cross Blood Bank
(Utrecht, The Netherlands). Eosinophils were isolated as previously described (19). 
In short, buffy coats of citrate-anticoagulated (0.4 % w/v) blood were subjected to Ficoll
centrifugation. Erythrocytes were removed by isotonic shock (NH4Cl), and the mixed
granulocyte fraction, after 10 min treatment with fMLP (10-8 M), was subjected to 
discontinuous Percoll gradient (1.082/1.1 g/ml) centrifugation. Dense eosinophils were
washed once with PBS containing 0.3 % citrate and 10 % pasteurized plasma, then taken
up in RPMI-Hepes supplemented with 0.5 % HSA. The eosinophils were more than 95 %
pure and more than 98 % viable. Cell viability was not affected by treatment with Y27632
(100 m M) for up to 2.5 hours.
Video microscopy and tracking of granulocytes
Glass coverslips (0.3 mm) were coated with a solution of 1 % human serum 
albumin (HSA). Purified neutrophils or eosinophils, suspended in RPMI-Hepes with 
0.5 % HSA, were attached to the coverslip for 10-15 min at room temperature. 
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The coverslip was then inverted in a droplet of medium containing the desired ligands
or antibodies and sealed with a mixture of beeswax, paraffin and Vaseline (1:1:1,
w/w/w). Cell migration at 37°C was monitored by time-lapse microscopy and analyzed
by custom-made macro (A.L.I.) in image analysis software (Optimas 6.1, Media
Cybernetics, Silverspring, USA). Cells were followed for 8 minutes (figure 1 and 3) or 20
minutes (figure 7). As expected with the use of primary cells, a heterogeneous 
population of different age and priming, there is a variation in the rate and the amount of
movement observed in the figures. However, the results shown are representative for a
larger field of cells (usually 50-100 cells) and, the experiments were repeated at least
three times for every assay condition. For figures 1, 3 and 7 video material is available on 
CD-ROM.
RhoA activation assay
RhoA activity assay was performed as described (18). Neutrophils or eosinophils
were stimulated in suspension, then lysed in (50 mM Tris pH 7.5, 150 mM NaCl, 10 % 
glycerol, 1 % NP-40, 0.1 % Triton X-100, 5 mM MgCl2, 0.1 mM PMSF, 10 m g/ml leupeptine,
10 m g/ml aprotinin). Cleared lysates were incubated with bacterially produced 
GST-RBD[Rhotekin] (16) bound to glutathion-agarose beads for 45 min at 4°C. 
The beads were washed 3 times with lysis buffer, then bound proteins were eluted 
in SDS-sample buffer and analyzed by Western blotting using anti-RhoA MoAb from 
Santa Cruz.
Migration assay in the Boyden chamber
Eosinophil migration was measured in the modified Boyden chamber assay 
as described (20). Cellulose nitrate filters (pore width 8 m m, thickness 150 m m; Sartorius)
were soaked in 0.5 % HSA. The assays were performed in Hepes-buffered RPMI 
supplemented with 0.5 % HSA for 2.5 hours at 37°C in a CO2 incubator. Filters were fixed,
stained with haematoxilin (Weigert’s method) and embedded in malinol. Analysis of the
filters was done by an image analysis system (Quantimet 570 C) and an automated
microscope to score the number of cells at 15 intervals of 10 m m in the 
Z-direction of the filters. The results are expressed as the chemotactic index, indicating
the mean migrated distance, excluding cells with migration 0. 
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Transendothelial migration
Human umbilical vein endothelial cells (HUVEC) were plated in Transwell 
chambers (Costar; pore width 8 m m; diameter 6 mm), coated with fibronectin. When
confluence was reached, purified eosinophils (105/well) were calcein-AM (Molecular
Probes) loaded according to the manufacturer, washed, resuspended in RPMI-Hepes
and placed in the upper wells. The lower wells were filled with RPMI-Hepes containing
the chemoattractant. The chambers were placed for 1 hour at 37°C in a CO2 incubator. 
At the end of the experiment, the migrated cells in the lower wells, the inserts as well as
the cells from the upper wells were lysed in 1 % Triton-X100-containing buffer.
Fluorescence intensities were measured with a FluorImager. Standard curves with fixed
amounts of calcein-AM-loaded cells were prepared each time. Values are given as 
percentage migrated cells of total cells loaded.
Adhesion assay
Static adhesion of eosinophils was performed in 96-well Elisa plates (Nunc),
coated for 1 hour at room temperature with 0.1 % HSA or VCAM-1 (5 m g/ml) in PBS. 
Cells were calcein-AM loaded, incubated with antibody or inhibitors and added to the
wells already containing medium with or without serum. After 5 min, the plates were
placed at 37°C for 5 min, then they were washed once with PBS containing 0.1 % BSA
and lysed in TX-100 containing buffer. Remaining cells were quantified using a
FluorImager.
Tat-fusion constructs
PCR products comprising the coding region of constitutively active V14RhoA, 
dominant negative N19RhoA or dominant negative N17Rac-1 (6) were cloned into the
pTAT-HA vector (31), sequenced and transformed into the BL21(DE3) strain. Bacteria
were obtained from an overnight culture, resuspended and sonicated in Z-buffer 
(8 M Urea, 100 mM NaCl and 20 mM Hepes, pH 8.0), and supernatants containing 10 mM
imidazole were loaded onto a Ni-NTA column (Qiagen). Tat-fusion proteins were eluted
with 1 M imidazole in Z buffer, diluted 5 times with 20 mM Hepes buffer pH8.0 and
applied to a Source 30Q column (Amersham). After washing, bound proteins were 
eluted with 1 M NaCl, desalted on a PD-10 column into PBS/1 mM CaCl2, flash frozen in
10 % glycerol and stored at -80°C.
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When using tat-V14RhoA constructs in eosinophil migration assays, such as shown in
figure 7, we found no effect of the tat-constructs in a minority of the experiments, which
we cannot explain. The effects of tat-V14 Rho decreased after incubations of more than
45 minutes.
Results 
Imaging of cellular detachment
To study the migration of migratory leukocytes, we performed video 
microscopy on human eosinophils. Tracking of cells attached to albumin-coated 
glass-slides allows the study of speed, direction and morphology of each cell. Figure 1
(video available on CD-ROM) shows the tracks of eosinophils and neutrophils migrating
in the absence or the presence of stimulus. Eosinophils in the control situation or when
stimulated with the chemoattractant platelet activating factor (PAF), were highly motile. 
Under these circumstances eosinophils moved the cell body, but were not able to detach 
the uropod and therefore hardly migrated (figure 1G). While the addition of 
chemoattractants had no effect on eosinophil detachment, serum-stimulation of the
cells resulted to rear release. More cells were able to detach their uropod, resulting in a 
higher mean migration speed, as can be concluded from the longer tracks. Neutrophils 
however, were optimally stimulated with the chemoattractant fMLP and serum did not
further enhance neutrophil migration (figure 1D-F).
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Figure 1. Cell tracks of randomly moving eosinophils (A,B,C,G,H) and neutrophils (D,E,F). 
The cells were attached to albumin-coated glass coverslips in RPMI-Hepes containing 0.5 % HSA.
Then they were transferred to the same buffer complemented as indicated without stimulus (A,D)
with PAF (10-7 M; B,G), fMLP (10-8 M; E) or 10 % human pooled serum (C,F,H). The cells were 
warmed to 37°C and then monitored for 20 min (A-C), 8 min (D-F) or 30 min (G-H). 
Bar: 30 m m (A-F) or 10 m m (G-H). Arrows indicate a non-detached uropod (G) and a detached
uropod (H). Video material is available on CD-ROM.
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Involvement of RhoA in detachment of the uropods
Because serum is able to stimulate detachment, we hypothesize that serum may
activate the RhoA-ROCK pathway. We used a recently developed RhoA activation assay
(18) to test this hypothesis. In this assay a GST-Rhotekin pull-down assay is performed on 
lysates of activated leukocytes, then the amount of active RhoA present in the cells is
determined by Western blotting. Figure 2 shows that serum is an excellent activator of
RhoA, both in neutrophils and eosinophils. Compared to serum, the activity of RhoA after
stimulation by the chemoattractant fMLP (formyl-Met-Leu-Phe) and PAF was rather
weak. However, these latter experiments show that a relatively small and transient 
activation of RhoA per se is not sufficient for rear release (see below). These results
indicate that increased detachment observed after serum stimulation correlates with
strong RhoA activation. This RhoA activation was not dependent on a cycle of attachment
and detachment because the experiments were performed with cells in suspension.
Figure 2. RhoA activation assay in
neutrophils and eosinophils. The cells
were stimulated with fMLP (10-7 M),
PAF (10-7 M) or serum (S) for the 
time-periods indicated, lysed and 
subjected to GST-Rhotekin pulldown
as described in Materials and
Methods. Western blots of active RhoA
(arrow) are shown.
To determine whether RhoA is involved in stimulation of detachment, we used a 
specific inhibitor of RhoA; C3-exoenzyme. We studied the migration of neutrophils,
because these cells have no rear release problems when monitored on a glass coverslip
in the presence of chemoattractant. Figure 3 (video available on CD-ROM) shows tracks
of neutrophils that were control-treated (3A) or preincubated with C3-exoenzyme (3B).
Those cells showed a morphology similar to eosinophils: the uropod was attached, but
the cell body was still highly motile, as can be seen in the videos. These results indicate
that RhoA is involved in cellular detachment of the uropod.
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Figure 3. Migration of
neutrophils on albumin-
coated glass coverslips.
The cells were untreated
(A,C) or pre-treated with
C3-exoenzyme (10 m g/ml;
4 h, B) or Y27632 (10-5 M;
30 min, D) then attached
to the coverslips. 
The coverslips were 
inverted in assay medium
containing fMLP (10-8 M)
and embedded. Random
movement of the cells 
was recorded at 20 sec 
intervals. Tracks recorded
during an 8-min period
are shown. Bar: 30 m m. 
(E) fMLP-induced activity of
Erk1/2, p38 and PKB 
in neutrophils in the 
absence or presence of
Y27632 (10-5 M; 30 min)
using phosphospecific
antibodies. Video material
for 3 A -D is available on
CD-ROM.
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ROCKs are involved in rear release regulation
ROCKI and ROCKII are downstream targets of RhoA, involved in MLC 
phosphorylation and thereby in force generation and contraction of cells. To investigate
whether or not ROCKs are involved in detachment, we used the ROCK-inhibitor Y27632
(12) in several migration assays. Figure 3 (video available on CD-ROM) shows tracks of
neutrophils that were stimulated with fMLP either in the absence (3B) or in the 
presence (3C) of Y27632. After ROCK-inhibition by Y27632, the cells showed a decreased
net cell translocation and thus a decreased mean migration speed, which can be 
concluded from the track length. However, these cells were still highly motile, as can 
be seen in the videos provided with figure 3B. The uropod of the cells was again attached
to the substratum, while the cell body moved around it. It is obvious that the cells treated
with Y27632 were not able to detach. The specificity of the ROCK inhibitor Y27632 has
been tested in vitro by Uehata et al. (12). Several important kinases were tested: 
PKC, PKA, MLCK, PAK. Furthermore, Y27632 did not have any effect on RhoA-dependent
transcription and Rac-dependent membrane ruffling. In neutrophils, we tested 
fMLP-stimulated activation of PKB, Erk1/2 and p38 (figure 3E). We found no inhibitory
effect of Y27632 on these key signaling routes.
The importance of ROCKs during transendothelial migration
Migration of eosinophils across a monolayer of endothelial cells is complicated by
the fact that the endothelial cells not only form the substrate over which the eosinophils
must move and the barrier they must cross, but the endothelial cells also provide signals
to the eosinophils, for instance by secreted chemokines. In the past, attention has
focussed on the role of RhoA and Rho kinase in the contraction and permeability of
endothelial cell layers (21). We investigated the involvement of ROCK in eosinophils
when transmigrating an endothelial cell layer in the absence of serum. 
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Figure 4. Transendothelial
migration of eosinophils in the
presence of Y27632. Eosinophils
migrating over confluent 
monolayers of HUVEC (see
Materials and Methods for details)
were stimulated with PAF (10-7 M)
or eotaxin (10-7 M). Pre-treatment
of the eosinophils with Y27632 (in
m M) was for 30 min as indicated.
After 1 hour of migration, the cells
were taken out of the lower wells,
filters and upper wells and 
quantified separately with the use
of calcein. The results are 
expressed as % of total cells
(mean ± SEM) of a representative
experiment performed in 
duplicate.
Figure 4 shows a transwell assay performed on eosinophils pretreated with Y27632. 
The transmigration (top) induced by PAF or eotaxin was completely blocked by Y27632
at 100 m M, whereas the control values were hardly affected. Analysis of the filters 
(middle) shows that after inhibition of ROCK by Y27632, a considerable number of cells
remained present in the filter, independent of the stimulus. This could indicate an incre-
ase in adhesion of eosinophils to the endothelial cells or a decreased detachment. To
rule out the first possibility, we performed adhesion assays of eosinophils to endothelial
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monolayers. We never observed an increased adhesion after Y27632 treatment (results
not shown). Therefore, we conclude that the high number of Y27632-treated cells pre-
sent in the filter is likely the result of a defect in detachment. 
ROCK involvement in chemotaxis and chemokinesis
In the Boyden chamber assay, neutrophils or eosinophils migrate through a 
3-dimensional filter of nitrocellulose. Migration of cells in filters occurs under less 
stringent circumstances. The main difference between these experimental set-ups is the
presence of a 2- versus a 3-dimensional substrate. Eosinophils migrating through filters
showed efficient migration after stimulation with PAF or IL-5, which was not the case
when migrating over albumin-coated glass coverslips. Preincubation of eosinophils with
the ROCK-inhibitor Y27632 resulted in a dose-dependent inhibition of chemotaxis
towards PAF (figure 5A). When serum was present in both the upper and the lower wells
of the chemotaxis chamber, chemokinesis was observed. The ROCK-inhibitor was 
effective in inhibition of chemokinesis stimulated by IL-5 or serum as well as chemotaxis
stimulated by PAF. The observed IC50 for the different stimuli was 3-10 m M, which is in
range with the published value in smooth muscle cells (12). Similarly, chemotaxis of
neutrophils induced by fMLP is inhibited by Y27632 (figure 5B). Thus, activation of ROCK
is necessary for the migration of granulocytes.
Figure 5. Granulocyte chemotaxis in the presence of ROCK-inhibitor Y27632. A) Eosinophils
migrating in the Boyden chamber were stimulated with PAF (10-7 M) present in the lower wells,
IL-5 (10-10 M) in the upper well or with serum (10 %) in both wells. B) Boyden chamber 
chemotaxis assay of neutrophils stimulated with fMLP (10-8 M). Y27632 pre-treatment was in 
all cases for 30 min. The results are expressed as chemotactic index (mean ± SEM of 
2-6 experiments performed in duplicate). 
146
ACTIVATION OF RhoA AND ROCK ARE ESSENTIAL FOR
DETACHMENT OF MIGRATING LEUKOCYTES
ROCKs influence attachment
Activation of ROCK leads to phosphorylation of myosin light chain (MLC), an event
that is correlated with force generation and contraction of cells. It can be envisioned how
a higher contractility of a cell leads to better detachment from its substrate. Alternatively,
RhoA activation is implicated in adhesion of neutrophils (22). Therefore, RhoA’s 
downstream kinase ROCK could elicit a signal towards adhesion molecules, thereby
regulating the affinity for ligands present on the substrate. To address this hypothesis, 
we measured the effect of ROCK-inhibitor on the activity of two important adhesion
Figure 6. Adhesion of eosinophils to ICAM-1 or VCAM. Eosinophils were calcein-loaded, 
incubated for 30 min with Y27632 at the indicated concentrations (between brackets, in m M), or
with neutralizing antibodies against a 4- (HP2/1) or b 2- (IB4) integrins. Then the cells were placed
in 96-well plates coated with ICAM-1 (5-10 m g/ml) or VCAM (0.1-5 m g/ml) containing control
buffer or serum-containing buffer and incubated for 5 min at 37°C. The cells were washed 
and lysed and fluorescence intensity was measured. The results are expressed as % of maximal
binding (mean ± SEM of 2-5 experiments performed in duplicate).
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molecules present on eosinophils (23): a 4 b 1-integrin (binding to VCAM-1) and 
b 2-integrins (binding to ICAM-1). Figure 6 shows that Y27632 had an inhibitory effect on
the activity of a 4- as well as b 2-containing integrins. The effects of Y27632 are rather
small, as observed by the partial inhibition of cells binding to ICAM and the fact that 
inhibition of binding to VCAM-1 is only observed at limiting ligand concentration. 
This means that ROCK activation does influence attachment as well as detachment.
Is RhoA-activity sufficient to stimulate detachment?
To investigate whether RhoA activation is the primary mechanism of detachment,
we transduced eosinophils with activated RhoA (V14RhoA). As classic transfection 
procedures are unsuccessful on these primary cells, we made use of the cell 
permeability of tat-fusion proteins (31). When tat-V14RhoA was applied to the cells in
the presence of the chemoattractant PAF, tat-V14RhoA was able to replace serum and
stimulate detachment (figure 7B, video is available on CD-ROM). The experiments were
performed in the continuous presence of tat-fusion protein to avoid diffusion out 
of the cell. The stimulation of detachment increased in time, probably due to a higher
concentration of tat-V14RhoA in the cell, but decreased again after about 45 minutes
(figure 7E). As a control, a fusion-protein containing syntenin was used, which had 
no effect on detachment (figure 7C, D). To substantiate the hypothesis we did the 
reverse experiment. Tat-N19RhoA was applied to the cells in the presence of serum. 
This resulted in an inhibition of detachment (figure 7F). In the control situation, 
eosinophils incubated with tat-syntenin in the presence of serum showed normal 
detachment. From these results we conclude that activation of the Rho-ROCK pathway
alone is necessary but not sufficient to stimulate detachment. Other, as yet unidentified
signals, elicited by the stimulus PAF may contribute to the stimulation of detachment.
Figure 7. Video microscopy of migrating eosinophils in the presence of tat-fusion proteins. 
Cells were attached to albumin-coated glass coverslips, transferred to medium containing 1 m M
of the indicated tat-fusion proteins and/or PAF (10-7 M) or human pooled serum (10 %) and
embedded at t=0. Images were recorded with 20 sec intervals during 20 min at 37°C. Cell tracks
of a representative experiment are shown. Bar: 30 m m. Video material is available on CD-ROM.
Discussion
We have shown that the Rho-ROCK pathway is essential in the regulation of the 
process of uropod detachment or rear release, a field in migration research that has not
received much attention until now. One of the possible explanations is the difficulty in
monitoring rear release. The only method to appreciate cellular rear release is through
time-lapse (video) microscopy of cells migrating on a two-dimensional substratum.
Highly motile cells that are detachment-defective can easily be recognized by direct 
viewing of the cells. Such a cell has a uropod that is firmly attached to the substratum.
Under high magnification viewing it becomes clear that the cell body is moving actively
around the cell. 
We found that high motility and stimulation of rear release can be separated. 
In eosinophils, a situation of high motility and no detachment was found in the absence 
of serum. This situation can be mimicked in neutrophils by inhibition of RhoA or ROCK.
This leads us to the conclusion that motility and rear release have a different 
molecular basis.
The mechanisms underlying rear release are largely unknown. Based on our findings,
ROCK-mediated cytoskeletal contraction turns out to be very important. The measure-
ment of force generation in cells is expected to correlate with rear release stimulation. 
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A second mechanism that may explain rear release involves integrin modulation. In this
model, ligand-stimulated signaling is responsible for changes in affinity or avidity of 
integrins (1;24). It is clear that the strength of adhesions determines the migration speed
of cells (25): at decreased adhesive strength migration speed is enhanced. This occurs
in a situation without addition of external stimuli, which implies no changes in 
cytoskeletal contraction. Whether or not RhoA signaling plays a role in integrin 
modulation is still in debate. RhoA was found to be important for b 2 integrin-dependent
lymphocyte aggregation (26) and b 1- and b 2-integrin dependent leukocyte adhesion (22)
but not for inside-out signaling towards platelet a IIb b 3 (27). 
From previous work we know that interference with the ligand binding capacity 
of a 4-containing integrins can improve rolling of eosinophils (28) and rear release 
and migration of the cells (unpublished results). We found a contribution of Rho’s
immediate downstream target ROCK in signaling towards a 4 b 1- or b 2-integrin-
dependent attachment. This means that at the same time ROCK stimulated detachment
and attachment. Detachment of the rear of the cell resulted in to migration, not 
necessarily in detachment of the entire cell. This can be observed in figure 6: serum 
stimulation, which very efficiently stimulated detachment of the uropod, resulted in  
increased adhesion, i.e. attachment. Adhesion per se does not correlate with migration
properties of cells. Whether or not integrins are turned off during rear release has to be
further explored.
In migrating cells, Rac and Cdc42 are responsible for lamellipodial protrusions, 
whereas RhoA regulates uropod detachment by stimulation of actomyosin filament 
contraction. Coordination of the activity of these three GTPases is necessary for optimal
migration. In adherent cells that contain focal adhesions, Rac was able to counteract 
Rho-stimulated formation of stress fibers and focal adhesions directly or through 
activation of PAK (18;29). In leukocytes however, focal adhesions are not present. 
Here, the formation of contractile forces appeared to be enough to ensure adhesive 
release, and Rac or Cdc42 may have been activated in concert with RhoA (30). Clearly,
the adhesive state of cells influences RhoA activation by soluble factors (17). 
In conclusion, our results point to an essential role for the Rho-ROCK pathway in 
migration of leukocytes, namely in the relatively unknown process of rear release. 
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Two ways for leukocyte recruitment 
to lung tissue
Biopsies of patients suffering from asthma or deceased from a status asthmaticus
have shown that infiltration of eosinophils occurs in the bronchial compartment (1). 
This part of the lung is supplied by blood from the bronchial circulation, as part of the
systemic circulation. Only 1 % (~0.05 liters/min) of the cardiac outflow is supplying this
site. In the pulmonary circulation, on the other hand, approximately 5 liters of blood are
passing per minute. In the dense alveolar capillary network of the pulmonary circulation
oxygen uptake takes place. Moreover, emigration of leukocytes occurs mainly in 
the capillaries of the pulmonary circulation. In contrast, in the systemic circulation 
leukocyte emigration is thought to occur mainly in the postcapillary venules and not in
the capillaries (2). 
The mechanisms of influx of inflammatory cells to the alveolar compartement are 
different from those to the bronchial compartement. It is known that induction of an 
asthma phenotype is characterized by influx of inflammatory cells (especially T cells and
eosinophils) to the bronchial tissue (reviewed in (3)). The mechanism is largely 
dependent on adhesion molecules, since animal models have shown that inhibition of
multiple integrins (for example CD11/CD18) and Ig-superfamily members (for example
ICAM-1) abrogates the influx of cells (4-7). This is in contrast to what is found in animal
models in which the mechanisms of leukocyte influx upon infection of the lower 
airways have been investigated. Emigration of neutrophils into the alveolar space in
response to certain bacterial stimuli (e.g. S. pneumoniae) is independent of adhesion
molecules such as CD11/CD18 (8-10). It is thought that emigration of neutrophils from
the cappillaries into the lumen of the alveoli is facilitated by mechanical changes in 
leukocyte shape. Typically capillaries are very small in diameter (4-9 m m). Neutrophils
(6-8 m m diameter) likely pass these capillaries at very low velocity and are already in
close contact with the endothelial layer, without any need for selectin function.
Doerschuk et al. have suggested that a stimulus-induced decrease in leukocyte 
deformability can increase the time a leukocyte remains in close contact with the 
endothelium in the capillaries (reviewed in (2)). This might be an alternative for rolling
events. However, the exact mechanism of emigration of neutrophils to the alveolar
space remains to be determined. The possibility that unidentified adhesion molecules
at capillary endothelial cells mediate the migration is not excluded yet, and might still be
an alternative mechanism for this phenomenon. 
Allergic asthma is a disease of the tracheobronchial tree, and the blood flow to this site
is part of the systemic circulation in which leukocyte emigration mainly occurs in 
postcapillary venules. Therefore, we used a model system under flow conditions in
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which HUVEC cells were activated with TNF a -stimulating inflamed postcapillary venu-
les. TNF a was chosen because it can be produced by many cells that play an important
role in allergic diseases (11-15). Recently, Broide et al. (16) showed that rolling and firm
adhesion of leukocytes to the endothelium was inhibited in TNFa -receptor p55/75 
knock-out mice compared to wild-type mice after allergen challenge. It was suggested
that this effect was due to the inhibiton of adhesion molecules on the endothelium.
Besides its effect on endothelial cells, TNF a can also activate eosinophils from 
allergic asthmatic patients but not those from healthy controls (17). This further 
indicates that TNFa may be an important cytokine in allergic diseases.
We focused on the multistep paradigm of leukocyte extravasation, because it is thought
to be valid for eosinophil extravastion to the bronchial compartement of patients with
allergic asthma. The in vitro flow chamber model was used to investigate eosinophil
tethering, rolling and adhesion processes.
Eosinophil tethering and rolling by selectins 
and aa 4 integrins
The mechanism of recruitment of leukocytes to inflammatory sites is tightly 
regulated and ensures the temporal and spatial distribution of cells through the body. 
A first prerequisite for extravasation is the presence of selectins and their counter 
structures that mediate rolling (18). In chapter 2 it was shown that eosinophils can use
E-selectin on the endothelium for rolling interactions. Although many studies suggest
that P-selectin is the preferred selectin used by eosinophils (reviewed in 19), we clearly
show that eosinophil roll stably on E-selectin expressed by activated endothelial cells.
Furthermore, the a 4 integrins on freshly isolated eosinophils mediate initial attachment
(chapter 2) to the endothelium, without the need for activation of the eosinophils.
Indeed, in vitro (20;21 and in vivo 22;23) studies have shown that a 4 integrins on 
several leukocyte subsets can bind to their ligand VCAM-1 without prior activation of the
cells. While all these studies (including ours) used isolated cells, it can not be excluded
that leukocyte isolation might lead to activation of these cells and thereby induce the 
activation of a 4 integrins. A reasonable assumption is that leukocytes in whole blood are
less manipulated than isolated leukocyte subsets from whole blood. Therefore, studies 
with whole blood might shed light on the activation status of a 4 b 1 integrins. 
Such studies demonstrated that lymphocytes express a pool of a 4 integrins that exist in
an intermediate affinity state, and this pool has been shown to bind to 
high concentrations of VCAM-1 (24). Also, Patel (25) showed by in vitro flow chamber
experiments with whole blood that eosinophils preferentially accumulated in an 
a 4 integrin dependent fashion on IL-4-activated HUVEC. Furthermore, a study on E-, 
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P- and L-selectin triple knock-out mice revealed that the residual rolling interactions 
in the venules of the cremaster muscle were dependent on a 4 integrins. In this 
experimental set-up, autologous peripheral leukocytes in mice were observed without
manipulation of the cells (26). Thus, it is tempting to speculate that a 4 integrins display
an intermediate activation state and thus are functionally active in vivo. At least two 
factors might be needed in vivo to establish that the basal a 4 b 1 integrin activity leads to
leukocyte migration, 1) the presence and the density of the ligand and 2) the presence
of chemoattractants for further activation of integrin-mediated migration. 
Ad1, VCAM-1 expression on endothelial cells needs cyokine-induced upregulation so in
a normal non-inflammatory situation, VCAM-1 is not present on endothelial cells. 
An exception is the bone marrow, because venules at this site constitutively express
VCAM-1 (22). In this respect, tethering and rolling interactions are probably not sufficient
to ensure migration of a 4 b 1 integrin-bearing cells. Ad 2) Mazo and von Andrian (27) 
suggested that the chemokine SDF1a might play an important role in further activation
of the integrins and induction of migration. This illustrates that chemokines are needed
to increase the activity of a 4 b 1 integrins for their ligands and also to activate other 
integrins, for example the b 2 integrins. Indeed, activation of eosinophils can further 
increase the affinity of a 4 b 1 for its ligands and can also activate b 2 integrins (chapter 4
and 5). Recently, it was shown that chemokines activate a 4 integrins on lymphocytes in 
sub-seconds, leading to small clusters of a 4 integrins and thereby increasing the 
tethering efficiency to the surface (28). This illustrates that chemokines can already
interfere with the first step of extravasation; tethering and rolling processes, in addition
to their already established role in the second, third and fourth step; i.e. activation, 
firm adhesion and migration, respectively. Moreover, a 4 integrins that exist in an inter-
mediate activation state on leukocytes in vivo might increase immuno-surveillance,
because when ligand is present a 4 integrins increase tethering and rolling interactions.
This is in contrast to other integrins like b 2 integrins, which have not been described to
mediate initial tethering or rolling processes.
Eosinophil arrest: an interplay between 
serpentine receptors and adhesion molecules
A prerequisite for succesful migration is chemokine-induced arrest of eosinophils.
The types of the chemoattractants that are present on the apical surface of the 
endothelial cells and the ones that create a soluble gradient from the site of 
inflammation towards the lumen of the blood vessel determine the type of adhesion 
of leukocytes to the endothelium. For eosinophils this is illustrated in chapters 4 and 5. 
IL-8 induces a transient arrest of eosinophils, in contrast to eotaxin and C5a that induce
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a firm and longterm arrest. Although IL-8 is not potent enough to induce longterm arrest,
it does increase the time of interaction of the eosinophil with the endothelium. In this
way, the chance to respond to additional stimuli increases. When eotaxin or C5a was
applied after the IL-8-induced transient arrest, the rolling cells arrested and longterm
arrest was induced (chapter 4 and data not shown). For monocytes a similar observation
has been described (29). In this study it was shown that immobilized Gro- a on 
endothelial cells via heparan-sulfate proteoglycans induced the transition from rolling to
firm adhesion of monocytes but did not induce transmigration. Secreted MCP-1, in 
contrast, did not induce a transition from rolling to firm adhesion but did induce 
migration. This suggests that chemokines can act in different ways and on different levels
in the multistep model. The combination of chemoattractants present at the site of 
inflammation and the set of adhesion molecules expressed might determine the 
specificity in the extravasation of the different leukocyte subpopulations.
Control of integrin function
Chemoattractants induce signals into the cell that lead to activation of integrins
(inside-out signaling). Two modes of integrin activation have been described, 1) a 
change in conformation of the heterodimer, leading to a high-affinity state of the 
integrin and 2) induction of integrin clustering in the plasma membrane, leading to 
increased avidity. Integrins in high-affinity and/or avidity state bind to their substrates,
and this leads to the transmission of signals back into the cell (outside-in signaling). 
The mechanisms how activators induce integrin affinity and/or avidity changes of 
integrins, and the consequences this has for the binding of the cell, are getting more
clear. Recently, it was shown that chemokines such as SDF-1 a induce rapid integrin
affinity changes and lateral mobility changes of integrins on lymphocytes (30). The 
affinity change was transient and was thought to be important for fast binding to ligand.
The avidity change was more sustained, and it was shown that at low ligand 
concentration an increase in avidity is needed to maintain stable adhesion. The authors
further postulated that the binding of clustered integrins to their ligands is needed to
maintain a high-affinity state of the integrins. For eosinophils it has been shown that 
chemoattractants such as RANTES and C5a can induce a prolonged integrin-affinity state
(31), as determined by an antibody recognizing the high affinity epitope on Mac-1. 
This might lead to the maintenance of a stable integrin cluster and, as a consequence,
firm adhesion of the leukocyte to the substrate. For a cell to migrate on a surface it 
subsequently has to protrude at the front but also detach at the back of the cell. Integrin
binding to ligand can induce outside-in signals that may contribute to this adhesion and
de-adhesion process.
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In chapter 4 we show that when rolling eosinophils encounter IL-8 the a 4- and 
b 2-integrins become activated and bind to endothelial cells. This binding is a 
prerequisite for an IL-8-induced increase in [Ca2+]i, because in suspension IL-8 does not
induce an increase in [Ca2+]i. Thus, IL-8 induces an activation of integrins (inside-out
signaling). Subsequently, ligand engagement of integrins activates a tyrosine-kinase-
dependent signal that induces an increase in [Ca2+]i (outside-in signaling) (chapter 5).
Besides the observed increase in [Ca2+]i, integrin-induced outside-in signaling might
also lead to other effector functions. Many studies suggest that outside-in signals can lead 
to a shift in the type of integrin used by the cell for movement processes. It has been
documented that activation of a 4 b 1 integrins by ligand binding (32) or by the use of an 
activating antibody (33) induces signals leading to activation of b 2 integrins. Also, it has
been shown that activation of b 2 integrins leads to a decrease in a 4 b 1 integrin activation
(34). The same mechanism has been shown for mouse T cells and monocytes: 
ligand binding of a vb 3 leads to reduced a 4b 1 integrin functions and LFA-1 integrin 
function, respectively (35;36). For eosinophils differences in kinetics of integrin binding
to ligands have been shown for different chemoattractants (31). Also, evidence exists
that b 2 integrin activation leads to modulation of a 4 integrins. Blom et al. (37) showed
that IL-5 activates b 2 integrins and that this resultes in a decrease in the binding of 8A2- 
treated eosinophils to fibronectin. This IL-5-induced effect required an intact 
cytoskeleton, since cytochalasin B in combination with IL-5 and 8A2 increased the 
binding to fibronectin, which was totally a 4 integrin-dependent. From this study it is
tempting to speculate that stimulus-induced activation of b 2 integrins may lead to 
de-activation of a 4 b 1 integrins via a cytoskeleton-dependent mechanism. Furthermore, it
has been shown that eotaxin-2 and other chemokines that bind CCR3 lead to 
detachment of eosinophils from endothelial cells (38). Whether or not this is via 
activation and ligand binding of one type of integrin that shuts down a 4 b 1 integrins is not
known. It would be interesting to investigate whether chemoattractant-induced 
activation of integrins on eosinophils leads to outside-in signaling and subsequent effects
on integrin-mediated function. Chapter 4 and 5 show that chemoattractants induce the
arrest of eosinophils on activated endothelium via a 4 and b 2 integrins. Eotaxin and C5a
induce spreading of eosinophils on the endothelial cells, and when cells were recorded
for a longer time, we observed migrating cells on the surface of endothelial cells (data
not shown). For this process, eosinophils need to control the ligand binding of their
integrins. Outside-in signaling of integrins leading to a decrease in activity of another type
of integrin is an attractive model to regulate adhesion and migration processes, and we
do not exclude cross-talk to have occurred in our experiments. 
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Integrin regulation by Phospholipase C 
In chapter 5 we describe that inhibition of PLC in resting cells leads to a decrease
in integrin activity. This was similar to the results of Smith et al. (39), who showed that
adhesion of resting, non-activated neutrophils to TNFa -activated endothelial cells was
inhibited by U73122 because of the inhibition of Mac-1 ( a M b 2 integrins) avidity.
Furthermore, we describe in chapter 5 that chemoattractants activate integrins via PLC-
dependent and -independent intracellular pathways. Figure 1 shows a working model 
how the different chemoattractants might affect integrin activation in eosinophils. 
IL-8 can activate a 4 as well as b 2 integrins, as was shown in the flow chamber 
experiments with blocking antibodies (chapter 4). The IL-8-induced transient arrest via
b 2 integrins did not occur when PLC was inhibited, whereas the a 4 integrin mediated
arrest did occur when PLC was inhibited. Thus, the IL-8 induced b 2 integrin activation,
but not the a 4 integrin activation, was dependent on PLC function. Furthermore, 
we showed that IL-8 cannot induce an increase in [Ca2+]i in cells in suspension.
However, IL-8 does induce an increase in [Ca2+]i on adherent cells that was late in onset
and tyrosine-kinase dependent. Thus, we speculate that upon IL-8-induced activation of
a 4 integrins and subsequent binding to ligand, outside-in signals lead to PLC-g activation.
Indeed, it has been shown that crosslinking integrins can induce tyrosine 
phosphorylation and activation of PLC-g (40). Activated PLC-g might subsequently 
activate b 2 integrins. However, we cannot exclude that IL-8 directly activates 
b 2 integrins via a PLC-dependent mechanism since we showed that 1) eosinophils in the
presence of blocking antibodies against a 4 integrins arrest upon IL-8 addition in a b 2
integrin-dependent way and 2) the IL-8-induced b 2 integrin-mediated arrest was 
dependent on PLC function.
Eotaxin and C5a can both induce increases in [Ca2+]i in cells in suspension.
Furthermore, the increase in [Ca2+]i on adherent cells by these stimuli was not 
sensitive to tyrosine-kinase inhibitors and was rapidly induced. Thus, it is very likely that
PLC- b is activated by these two chemoattractants. However, it does not exclude that
PLC- g is activated as well. It might be that the effect of eotaxin and C5a on PLC-b is 
dominant over PLC-g in the induction of [Ca2+]i, whereas it is the PLC-g isotype that is
more important in integrin activation. Indeed, PLC- g has been shown to be present in
focal adhesions and it contains many domains by which it can interact with signaling
molecules (see below). For eotaxin we found that the a 4- and b 2-integrin dependent
arrest both were dependent on PLC function. For C5a this is different. The C5a-induced
arrest was only for 30 % dependent on the combined function of a 4- and b 2-integrins, 
suggesting that other factors might also play a role (see below). Furthermore, inhibition
of PLC resulted in a prevention of C5a-induced arrest of 50 % of the cells. Surprisingly,
preliminary experiments suggest that inhibition of a 4 integrins, b 2 integrins and PLC 
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prevents C5a-induced arrest. This might lead to the hypotheses that 1) PLC-independent
a 4- and b 2-integrin activation leads to the activation of an unknown factor that mediates
the eosinophil arrest to the endothelium. 2) C5a activation in the presence of blocking
antibodies against a 4 and b 2 integrins leads to PLC activation and subsequent activation
of the unknown factor. This unknown factor might be a highly organized adhesisome
with a 4 integrins and b 2 integrins clustered in such a way that the blocking antibodies
cannot recognize it anymore. Whether PLC functions upstream or downstream of the
eotaxin- and C5a-induced integrin activation or both remains to be established.
Figure 1. Working model for integrin 
activation by chemoattractants A) IL-8, 
B) eotaxin and C) C5a. A) IL-8-induced 
activation of a 4 integrins leads to 
ligand binding and subsequent PLC- g
activation. PLC- g is needed for activation 
of b 2 integrins. b 2 integrins that bind
ligands might induce outside-in signaling. 
B) Eotaxin-induced activation of a 4- and
b 2-integrins is dependent on PLC function.
Ligand binding of the integrins might lead
to outside-in signaling and subsequently
lead to spreading of the cells. C) C5a-
induced activation of a 4- and b 2-integrins
might proceed via PLC-independent and
dependent routes. PLC activation and
ligand binding by a 4 and b 2 integrins might
lead to activation of an unkown factor.
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Two major questions arise from chapter 5 which remain to be resolved. 1) How can 
inhibition of PLC function lead to a decreased integrin activity in resting eosinophils? 
2) How does PLC regulate chemoattractant-induced integrin activity? Different 
hypotheses can be put forward that address these questions.
How can inhibition of PLC function lead to a decreased integrin activity 
in resting eosinophils?
Chapter 6 shows that inhibition of PLC leads to a decreased affinity of a 4 integrins
on resting eosinophils. We hypothesize that PLC itself is needed to keep the integrin 
linked to the cytoskeleton, to preserve the configuration state of the integrin. It is known
that the PLC-g isoforms, but not the PLC- b and d isoforms, contain PH, SH2 and SH3
domains (41). Thereby, PLC- g might function as an adaptor molecule and link 
the enzyme to the plasma membrane and/or to proteins with phosphotyrosine motifs or
proline-rich domains, respectively. Of the many proteins present in focal sites, paxillin
has been shown to bind to PLC- g 1 directly (42). Paxillin was immunoprecipitated in a
complex with PLC-g 1 in fibroblasts adhering to fibronectin. In non-adherent cells the
interaction between paxillin and PLC-g 1 could not be detected. Furthermore, it has been
shown that the intracellular tail of the a 4 integrin binds to the signaling adaptor protein
paxillin (43;44). This interaction ensures that spreading of fibroblasts is limited because
cells remained in a round shape. In contrast, cell spreading of a 4 containing fibroblasts
on VCAM-1 is induced in the absence of paxillin (43). It might be that inhibition of 
PLC interferes with paxillin binding to the a 4 integrin, thereby mediating a decrease in
adhesion of eosinophils to the activated endothelium. 
How does PLC regulate chemoattractant-induced integrin activity?
Different hypotheses can be put forward for a working mechanism for PLC in the
regulation of chemoattractant-induced integrin activation. Affinity/avidity changes of
integrins can be induced by 1) PLC itself 2) the PLC product IP3 and subsequent Ca2+
release from intracellular stores, 3) the PLC product DAG and subsequent PKC activation.
A fourth hypothesis for the working mechanism of PLC is that U73122 inhibits the 
expression of new integrins on the cell surface, thereby inhibiting adhesion.
Ad1) It is known that a functionally active cytoskeleton is needed for integrin avidity
changes in leukocytes. Disruption of the cytoskeleton by agents such as cytochalasin D
are known to prevent integrins from clustering in the cell membrane. However, at low
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concentrations cytochalasin D can stimulate integrin clustering (45-47). It has been
reported that PLC-g is present in focal adhesions (48) and that it can regulate the actin
cytoskeleton by degradation of PIP2, that is a binding partner of profilin and gelsolin
(reviewed in 48). In fibroblasts it has been shown that activation by EGF induces 
PLC- g activation, leading to dissociation of PIP2 from profilin and possibly from gelsolin
(49). The product IP3 that is generated by PIP2 hydrolysis leads to an increase in [Ca2+]i.
Ca2+ activates profilin and gelsolin and these proteins start severing and capping actin
filaments, which is required for spreading of cells. It might be that, when PLC is blocked,
PIP2 remains associated with gelsolin and profilin, thereby inhibiting actin filament 
turnover and in this way inhibiting integrin avidity changes in the cell membrane and 
spreading of the cells. It could be that comparable mechanisms for PLC function in focal
adhesions apply to focal sites or adhesisomes in leukocytes. These structures are formed
upon cellular activation and contain many signaling and structural proteins. 
Ad2) Changes in [Ca2+]i might influence integrin affinity/avidity changes. Although no
increase in [Ca2+]i is observed when U73122 is present, IL-8 still induces activation of 
a 4 integrins (chapter 5 figure 5). This at least suggests that [Ca2+]i is not necessary to
activate a 4 integrins upon IL-8 stimulation. A role for Ca2+ in b 2 integrin activation 
cannot be excluded from this observation, and experiments in which intracellular Ca2+
mobilization is inhibited could shed light on this question. How [Ca2+]i may act on
integrin affinity/avidity changes in eosinophils is not known. It is known that [Ca2+]i and
the Ca2+-dependent phosphatase calcineurin are important in the recycling of integrins
from the rear to the front of a migrating neutrophil. Buffering [Ca2+]i led to an 
accumulation of a v b 3 integrins in the uropod of neutrophils, thereby inhibiting 
detachment (50). It has been postulated that Ca2+ acts on other Ca2+-dependent 
proteins that are involved in regulation of integrin-avidity changes such as calpain (51).
In T cells it is known that upon T-cell receptor engangement the activated tyrosine 
kinase ZAP70 induces PLC- g activation, leading to increased b 2 integrin mediated 
adhesion. This event was abrogated by treating the cells with the PLC inhibitor U73122
and also with the calpain inhibitor calpeptin (52). Preliminary results, however, showed
that eosinophils incubated with calpeptin and anti- a 4 integrin antibodies did not inhibit
the eotaxin-induced arrest, suggesting that calpain is not neccesary for b 2 integrin-
mediated eotaxin-induced arrest. Another Ca2+-dependent protein, L-plastin, is 
important in diffusion of integrins in the plasma membrane (53). It might be that 
changes in Ca2+ in cells lead to dissociation of L-plastin from actin bundles, preventing
integrins from free diffusion. 
Ad 3) The third hypothesis is that PLC-induced DAG generation and subsequent PKC 
activation influences integrin activation. Indeed, it is known that PKC can activate 
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b 2 integrins (54). PMA is a potent stimulus for PKC, that phosphorylates and binds RACK,
and subsequently RACK binds to the intracellular domain of the b 2 integrin LFA-1 (55).
Furthermore, PKC can activate MacMarcks, which subsequently induces an increase 
in b 2 integrin avidity via phosphoylation of paxillin, leading to spreading of macrophages
(56). However, preliminary results show that incubation of eosinophils with 
staurosporine, which is a very potent but not specific inhibitor of PKC, does not inhibit
the eotaxin-induced arrest of eosinophils (data not shown). This suggests that inhibition
of this pathway is not the working mechanism of U73122. This is comparable to the study
of Soede et al. (52) who showed that the activated PLC- g -induced increase in b 2
integrin-mediated adhesion in T cells was abrogated by U73122 but was not inhibited 
by a PKC inhibitor. 
Ad 4) The fourth hypothesis that U73122 inhibits the expression of new integrins on 
the cell surface is not very likely, for the following reasons. 1) Stimulus induced 
expression of new integrins on the cell surface is thought not to contribute 
to adhesion events (57) and 2) U73122 can also inhibit stimulus-induced b 2 integrin 
avidity changes on cytoplasts, which lack integrin-containing vesicles and only contain
integrins on the cell membrane (39). 
Further studies will focus on these working hypotheses. Special attention will be given to
the possibility that PLC itself directly acts on integrin affinity and/or avidity changes.
Techniques like Western blotting and immunohistochemistry on adherent eosinophils
will shed light on the isotype of PLC that is implicated in integrin regulation and the type
of adhesion (affinity and/or avidity changes) that is induced by the different 
chemoattractants. Next, protein transduction technology renders it possible to fuse the
tat-protein of the HIV virus to recombinant PLC, thereby creating a fusion protein that can
enter primary leukocytes. Also, enzyme-dead mutants or in the case of PLC- g , protein
with mutations in the SH2, SH3 or PH domains, can be used for further studying the role
of PLC in integrin regulation. 
Control of eosinophil migration by 
regulating detachment
Especially in fibroblasts the function of the different GTP-ases in the migration 
process has been well studied (58;59). Cdc42 and Rac1 mediate filopodia and 
lamellipodia formation, respectively, and RhoA induces stress fiber and focal adhesion
formation. For leukocytes, the Cdc42- and Rac1-mediated processes seem to be 
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similar (60-62). On the other hand, the RhoA-dependent processes seem to differ from
fibroblasts. Leukocytes move much faster that fibroblasts ( ~1-10 m m/min, vs. ~0.1-1
m m/min respectively 63) and have no large focal adhesions but instead have smaller
adhesion sites. Also, no stress fibers can be detected in leukocytes. Therefore, the role
of RhoA in leukocytes is thought to be different from that in fibroblasts. In chapter 6 we
found a role for RhoA in the detachment of the uropod of leukocytes (figure 2). Recently,
a similar role for RhoA has been found in monocytes (64) and tumor cells (65). 
We showed that neutrophils migrate very well on albumin-coated glass in response to
fMLP. However, when RhoA or its downstream effector Rho-kinase was inhibited, 
migration was inhibited. Eosinophils did not migrate well on albumin when stimulated
with PAF. On the other hand, serum stimulation induced migration and this correlated
with RhoA activation. Also, introducing dominant active RhoA (tat-V14RhoA protein) in
the eosinophils induced migration on an albumin surface in the presence of PAF. 
We showed that PAF only transiently activates RhoA, whereas serum leads to a 
sustained stimulation of RhoA. Probably, activation by PAF (chapter 6) or eotaxin 
(data not shown) alone is not sufficient to give a sustained activation of RhoA in 
eosinophils needed for detachment from albumin. Preliminary experiments showed that
eotaxin can induce migration when eosinophils were put on fibronectin coated glass (1
and 0.1 mg/ml). Therefore, it is tempting to speculate that binding of a 4 b 1 integrins to
fibronectin leads to a sustained activation of RhoA. Indeed, Cox et al. (66) have shown
that binding of cells to high concentrations of fibronectin (0.1 mg/ml) induced RhoA 
activation. Different hypotheses can be put forward to explain how RhoA induces
detachment. 1) RhoA is known to act on the actinomyosin protein motor in non-muscle
cells, therefore, activation of RhoA could lead to retraction forces that stimulate 
detachment. 2) RhoA could act on integrin activation and/or recycling 
processes of integrins in the rear of the cell, leading to detachment. Worthylake et al. (64)
showed for monocytes that RhoA and p160/ROCK activation is needed for tail (uropod)
retraction. Inhibition of RhoA (by C3) or p160/ROCK (by Y-27632) induced the formation
of long tails that inhibited the monocytes from migration. While contractility inhibitors
that act on myosin light chain kinase (which is a target of RhoA) could not induce tail 
formation, RhoA and Rho-kinase inhibitors were able to do this. Furthermore, the tails of
the C3 and Y-27632 treated monocytes contained high concentrations of b 2 integrins, in
contrast to tails of control-treated cells. Another study (67) showed that inhibiton of RhoA
and Rho kinase in T cells resulted in an increased avidity of b 2 integrins. From these 
studies it was concluded that RhoA acts on integrin dependent processes. However a
role for retraction forces or alternative mechanisms cannot be excluded. 
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Figure 2. Model of the proposed mechanism of eosinophil migration on albumin-coated glass.
A) The PAF and eotaxin-induced activation of RhoA is not strong enough to let the cells detach
from the surface. B) The serum-induced potent activation of RhoA induces detachment. 
This might lead to a) integrin recycling processes that subsequently lead to less adhesion at the
uropod and detachment and/or b) actinomyosin-based contraction of the uropod.
Interference with adhesion: 
a tool to combat asthma?
A characteristic of the chronic inflammation that is present in the airways of 
allergic asthmatics is the infiltration of the bronchial tissue by leukocyte subsets, 
especially eosinophils. It is thought that the presence of eosinophils contributes to the
severity of the disease. Therefore, eosinophil extravasation to the bronchial tissue might
be an interesting target to interfere with. A clear characterization of the molecular 
interactions controlling eosinophil extravasation will shed light on possible target 
molecules. The results described in this thesis address the importance of some of these
molecules. Chapters 2 and 3 show that eosinophils of healthy individuals and allergic 
asthmatic patients use an E-selectin ligand and a 4 integrins for initial attachment and 
rolling interactions with activated endothelium. Chapter 3 further shows that eosinophils
of allergic asthmatics but not of healthy individuals are prone to bind platelets.
Consequently, a P-selectin-dependent secondary tethering mechanism results in 
increased adhesion to and cluster index on activated endothelium (figure 3). So far, this
is the first report describing platelet-mediated adhesion events for eosinophils. 
Binding of platelets to patient eosinophils might have contributed to the observed 
b 2 integrin activity (chapter 3), though we did not address this possibility directly. 
166
GENERAL DISCUSSION
Figure 3. Platelet-mediated secondary clustering of eosinophils of allergic asthmatic patients. 
A) Eosinophils of healthy controls do not bind platelets. Adhesion to the endothelium is 
mediated via primary tethering processes. B) Eosinophils of allergic asthmatic patients bind 
platelets. Platelet-derived P-selectin-dependent secondary tethering processes increase the 
number of cells that are recruited to the surface. 
167
GENERAL DISCUSSION
We tried to address the question whether eosinophils from allergic asthmatic patients
were primed. It is known from previous studies that eosinophils from allergic asthmatic
patients migrate well towards low concentrations of PAF due to their primed phenotype
(68). We tested whether an activated phenotype could be deduced in the transition from
rolling to firm adhesion. PAF was perfused over rolling eosinophils in the presence 
of blocking antibodies against a 4-integrins in an attempt to study b 2 integrin-mediated
arrest. More eosinophils from allergic asthmatic patients than from healthy controls
arrested at a concentration of PAF of 10-10 M but the difference was only small (figure 4a).
The PAF-induced arrest was dependent on b 2 integrins (figure 4b), suggesting that 
indeed the eosinophils of allergic asthmatic patients were primed. A drawback of these
experiments is that they were performed with eosinophils isolated and perfused in the
presence of anti-P-selectin since eosinophils from healthy controls that do not bind 
platelets are not a good control for eosinophils of allergic asthmatic with platelets. It is
very likely that the eosinophils that bind platelets are the eosinophils that are primed
most. Since these eosinophils were blocked in our set-up, a possible strong effect of PAF
could have been missed. 
Figure 4. PAF-induced arrest of eosinophils of healthy controls vs. allergic asthmatic patients on
TNF a -activated HUVEC. Eosinophils were isolated in the presence of anti-P-selectin antibodies
and perfused in the presence of both anti-P-selectin and anti-a 4-integrin functional blocking
MoAbs. In A) rolling cells after PAF treatment as a percentage of the amount of rolling cells 
before treatment is depicted. At PAF 10-10 M and 10-9 M more eosinophils of patients arrest
compared to cells of controls. In B) rolling cells in the absence (white bar) or presence (black bar)
of blocking anti b 2 integrin MoAbs after PAF treatment (10-10 M) as a percentage of the amount
of rolling cells before treatment is depicted for eosinophils of allergic asthmatic patients. 
Data are presented as mean ± SEM of at least 4 experiments.
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The molecules that mediate adhesion of eosinophils to activated endothelium are E- and
P-selectin ligands, a 4 integrins and b 2 integrins. Because many adhesion molecules are
involved in eosinophil recruitment to activated endothelium and often show overlapping
function, the question arises to which target molecule therapy should be directed.
Inhibition of the selectins might be a tool to decrease tethering and rolling interactions
and prevents thereby subsequent adhesion and migration processes. Indeed, E- as well
as P-selectin-dependent adhesion processes play a role in eosinophil adhesion (chapter
2 and 3). However, these selectins have also been shown to be important for homing of
leukocytes to e.g. skin tissue. E- and P-selectin double knock-out mice show recurrent
bacterial skin infections, implying that these selectins are very important for normal
homeostasis and immuno-surveillance (69). b 2 integrins seem an attractive target for
inhibition since many studies have shown the need for this type of integrin in migration 
processes of eosinophils. However, not only eosinophils but all other leukocyte subsets
use b 2 integrins for migration. Inhibition or dysfunction of b 2 integrins leads to severe
bacterial infections, as illustrated by the disease LADI, in which b 2 integrins are absent
(70). Thus, the concept that b 2 integrins are a possible target for therapy can be ruled out.
The a 4 integrin might be an attractive candidate, since this molecule is involved in both
tethering and firm adhesion processes of eosinophils. Furthermore, lymphocytes also
bear a 4 integrins and play a dominant role in allergic asthma, too. Indeed, a 4 integrin
antagonists are being developed by pharmaceutical companies (71). A drawback of the
use of a 4 integrin antagonists might be that this is an important molecule for the homing
of leukocytes to the bone marrow, although selectin mediated rolling interactions can
also occur at this site (22). The results of adhesion molecule antagonist therapies for 
diseases like asthma, but also for other chronic inflammatory diseases such as 
rheumatoid arthritis, are to be awaited. The eventual conclusions of these 
integrin-antagonist therapies might be that the working mechanism is too broad. It may
be worthwhile to develop a 4 integrin antagonists that block either VCAM-1 or fibronectin
binding to circumvent the problem of possible side effects. For this possibility a more
detailed knowledge will be needed concerning the binding sites of integrins, which can
be obtained by crystal structure analysis. Recently, the crystal structure of the 
extracellular domain of the a vb 3 integrin has been determined (72). This is the 
first integrin that has been characterized at this level, and the knowledge of 
the quaternary arrangements will contribute to new insights in integrin function and 
regulation. Furthermore, it may contribute to the development of drugs that are directed
against integrins.
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Concluding remarks
Eosinophil rolling, adhesion and migration processes are under control of 
numerous adhesion molecules and chemoattractants, as outlined in this thesis. A clear
picture is present of the type of adhesion molecules and chemoattractants that can
mediate the different steps of eosinophil extravasation. Although the exact mechanisms
how different chemoattractants communicate with adhesion molecules at the 
molecular intracellular level in primary cells are not known, a start has been made in
this field. We showed that under flow conditions different chemoattractants can 
regulate integrins on eosinophils in different ways, and that PLC is involved in this 
process. It is important for further research that the inside-out signaling pathways 
leading to integrin activation and subsequent adhesion and migration processes of 
leukocytes are performed under flow conditions. Only at these more physiological 
situations the subtle differences between integrin functions will be found. When 
specificity in the mechanisms of the different chemoattractants on adhesion events is
found, the way opens that leads to more specific therapeutic strategies.
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Een stappenmodel voor de uittreding 
van witte bloedcellen
Witte bloedcellen kunnen reizen door het lichaam. Dit is van belang voor de 
continue bewaking die het immuunsysteem uitvoert om eventuele gevaren in het
lichaam direct te kunnen waarnemen. Wanneer er gevaar is, hetgeen bijvoorbeeld een
binnengedrongen worm of bacterie (ook wel pathogeen genoemd) kan zijn, dan moet
dit opgeruimd worden. Een vereiste is dat de witte bloedcellen vanuit het bloed naar 
de plek waar de pathogeen zich bevindt moeten reizen. De cellen doen dat door met
hechtingsmoleculen (adhesiemoleculen) die op de celmembraan (= het “jasje van de
cel”) zitten te hechten aan hechtingsmoleculen die op de binnenbekleding van de
bloedbaan (de endotheelcellaag) zitten. Als de cellen vastzitten aan de endotheelcellen
dan beginnen ze vervolgens tussen de endotheelcellen door te kruipen en zo komen ze
uiteindelijk in de weefsels terecht. Daar zoeken ze de pathogeen op die ze vervolgens
vernietigen.
De uittreding vindt plaats in verschillende stappen. Stap 1. Omdat het bloed continu
stroomt moet de cel eerst afgeremd worden voordat ze kan hechten. Het afremmen
gebeurt doordat de cel met specifieke adhesiemoleculen (selectines) bindt aan 
suikerstructuren op de endotheelcellen. Dit resulteert in het rollen van de witte bloedcel
over de endotheelcellen. Stap 2. Als er signaalmoleculen (chemoattractanten) 
aanwezig zijn dan passen deze als een sleutel in een slot. Het slot (op de witte 
bloedcel) is een specifiek eiwit ook wel receptor genoemd. De receptor kan vervolgens
signalen via de celmembraan naar binnen toe doorgeven, waardoor de cel wordt 
geaktiveerd. Stap 3. Aktivatie van de cel resulteert in het aktiveren van een andere 
klasse adhesiemoleculen, de integrines. Deze zitten altijd op de witte bloedcel maar
kunnen alleen door aktivatie binden aan hun tegenstructuren op de endotheelcellen, de
vasculaire adhesiemoleculen. Dit resulteert in de overgang van een rollende cel naar
een stilzittende cel en vervolgens in een spreidende cel. Stap 4. De witte bloedcel
gebruikt nu de geaktiveerde integrines en haar cytoskelet (de “botten” van de cel) om
over het endotheel te kruipen en een plek te zoeken waar ze tussendoor kan glippen
richting de weefsels. Dit wordt migratie genoemd. Chemoattractanten helpen ook bij
deze stap omdat de cel richting de hoogste concentratie chemoattractant kruipt welke
aanwezig is rondom de pathogeen die zich in het weefsel bevindt. (Deze stappen zijn
geïllustreerd in figuur 1 van hoofdstuk 1; stap 1 is rolling, stap 2 is activation, stap 3 is firm
adhesion en stap 4 is migration).
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Dit algemene mechanisme van uittreding van witte bloedcellen van de bloedbaan naar
het weefsel treedt op bij verschillende ziektes. Sommige uitgetrede cellen doen goede
zaken door b.v. het opruimen van pathogenen, maar andere uitgetrede cellen doen
slechte zaken omdat ze niets te zoeken hebben op de plek waar ze naar toe gaan. 
Dit laatste kan negatieve gevolgen hebben voor het weefsel en zodoende kan een goed
bedoelde immuunreaktie leiden tot een bepaald ziektebeeld. 
Allergisch astma
De ziekte allergisch astma onstaat doordat het immuunsysteem een fout maakt. 
Bij mensen met allergisch astma kunnen onschadelijke stoffen in het milieu 
(b.v. huisstofmijt, kattestof, pollen) door het immuunsysteem als schadelijk worden
gezien. Dit kan leiden tot een reaktie in het bronchiale weefsel van de long. Een scala
aan immunologische reakties vindt plaats welke tot uiting komen in de klinische 
symptomen benauwdheid en piepen. Een van de meest opmerkelijke immunologische
reakties die plaatsvindt is dat een bepaalde witte bloedcel, de eosinofiele granulocyte, 
in een groot aantal naar het bronchiale weefsel van de long reist. Er is aangetoond dat
deze cellen mede verantwoordelijk zijn voor het verslechteren van de longfunctie 
doordat ze het epitheel (de cellen die de barrière vormen tussen buitenlucht en 
bronchiaal weefsel) kunnen beschadigen.
De eosinofiele granulocyte
De eosinofiele granulocyte (afgekort eo) is een witte bloedcel die haar naam heeft
gekregen toen onderzoeker Paul Ehrlich eind 19de eeuw met de kleurstof eosin dit 
celtype aan kon kleuren. Eosin kan basische stoffen aankleuren die in de blaasjes 
(granula) van de eo’s te vinden zijn. Deze basische stoffen gebruikt de cel om 
pathogenen op te ruimen. Er wordt gedacht dat vooral wormen kunnen worden gedood
en opgeruimd door eo’s. Aangezien er amper nog schadelijke wormen voorkomen in
het milieu van de westerse wereld heeft dit geleid tot werkeloosheid onder de eo’s.
Werkeloosheid leidt tot verveling en dat leidt tot ongewenste aktiviteiten die 
eo’s uitoefenen in personen met de ziekte allergisch astma. Zoals gezegd verplaatsen de
eo’s zich vanuit het bloed naar het longweefsel waar ze vervolgens schade berokkenen.
In dit proefschrift worden experimenten beschreven waarin is onderzocht hoe de 
eo’s vanuit het bloed naar het longweefsel kunnen komen. Als je weet welke 
hechtingsmoleculen de eo gebruikt om aan het endotheel te hechten en vervolgens naar
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het longweefsel te reizen, zou daar een stof voor kunnen worden ontwikkeld om dat
tegen te gaan. Want zolang de eo’s in het bloed blijven zijn ze niet schadelijk.
Het onderzoeksmodel
De experimenten beschreven in dit proefschrift zijn niet in een heel organisme 
uitgevoerd (in vivo) maar in een testsysteem buiten het lichaam (in vitro). Het rollen, de
aktivatie en de hechting van eo’s in vivo vindt plaats in het bloed dat continu stroomt.
Omdat de stroming een essentiële factor is voor het optreden van de verschillende 
stappen, werd de stroming in het in vitro testsysteem nagebootst. Een andere factor is 
de endotheelcellaag. De endotheelcellen werden geïsoleerd uit navelstrengen 
(die bevatten een prachtig dik bloedvat) en werden in de proefopzet geaktiveerd zodat
ze rolmoleculen (E-selectine) en hechtingsmoleculen (VCAM-1, ICAM-1) op hun 
oppervlak kregen. Uit bloed werden eo’s geïsoleerd en deze werden over de 
endotheelcellaag gestroomd. Door gebruik te maken van stoffen die specifiek 
adhesiemoleculen kunnen remmen (monoclonale antistoffen) werd de functie van elk
adhesiemolecuul bestudeerd. 
De resultaten
In hoofdstuk 2 wordt beschreven dat eo’s (van gezonde donoren) rollen over 
E-selectine. Daarnaast speelt de integrine a 4 b 1 die op eo’s zit ook een voorname rol in
de eerste hechting van de eo aan het endotheel. Als de E-selectine moleculen en de 
a 4 integrines tegelijkertijd werden geblokkeerd dan konden de eo’s niet meer rollen en
hechten. Ze stroomden langs het endotheel zonder een interactie aan te gaan. De rol
voor a 4 integrine in de eerste hechting was onverwacht omdat de integrines over het
algemeen alleen hechting mediëren na aktivatie van witte bloedcellen. Maar in de 
experimenten werden de eo’s niet geaktiveerd. De hypothese die hieruit volgt is dat 
de a 4 b 1 integrine zich in een intermediaire aktivatie staat bevindt op een rustende 
(=niet geaktiveerde) eo en daardoor aan een hechtingsmolecuul op het endotheel 
kan binden. 
In hoofdstuk 3 worden de hechtingsmechanismen van eo’s van astma patiënten aan
endotheelcellen onder stromingscondities beschreven. De hechting verliep bij deze eo’s
net als bij eo’s van gezonde donoren via E-selectine en a 4 b 1 integrine. Maar in 
tegenstelling tot de situatie bij eo’s van gezonde donoren (gebruikt in de studies 
beschreven in hoofdstuk 2) kon de rolling en hechting van eo’s van astma patiënten niet
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totaal worden verhinderd door het blokkeren van E-selectine en a 4 b 1 integrine. 
Het resterende hechtende deel deed dat volgens een bepaald patroon namelijk in 
groepjes; de eo’s klusterden op het endotheel. Dit is een mechanisme wat cellen vaker
gebruiken. Het werkt doordat een eo (eo 1) die aan komt stromen hecht aan een eo 
(eo 2) die al vast aan het endotheel zit. Eo 1 komt vervolgens vlak achter eo 2 terecht.
Als dit proces vaker optreedt komen de cellen heel dicht bij elkaar in groepjes te liggen.
Het opmerkelijke aan de eo’s van allergische patiënten was dat er bloedplaatjes aan de
eo’s bonden. Deze bloedplaatjes zorgden voor de klustervorming van eo’s omdat de
klustervorming voorkomen kon worden door een rollingsmolecuul (P-selectine), dat in
het testsysteem alleen op plaatjes voorkomt, te blokkeren. Het idee is dat bloedplaatjes
een brug tussen eo’s kunnen slaan en daardoor klustering kunnen bevorderen. Tevens
werden er aanwijzingen gevonden dat b 2 integrines op eo’s van astmatische patiënten
een beetje meer geaktiveerd zijn dan b 2 integrines op eo’s van gezonde donoren. 
In hoofstuk 4 wordt de rol van de aktivator IL-8 op de hechtingsmechanismen van de 
eo beschreven. IL-8 is oorspronkelijk gekarakteriseerd als een zeer goede aktivator van
neutrofiele granulocyten (het broertje van de eo) maar werd lang als een slechte 
aktivator van eo’s beschouwd. Experimenten in hoofdstuk 4 tonen aan dat IL-8 rollende
eo’s stil liet zitten. Maar de eo’s bleven niet lang stilzitten en begonnen weer te rollen na
ongeveer een minuut. Deze observatie wordt “transiënte hechting” genoemd. 
Als eotaxine, een specifieke eo aktivator, werd toegevoegd aan rollende eo’s gingen de
eo’s stilzitten en platten ze tevens af. Eotaxine is dus een sterkere aktivator voor eo’s dan
IL-8. Maar IL-8 kan wel degelijk eo’s aktiveren. Dit wordt mede onderbouwd door het
feit dat IL-8 naast het hechtingssignaal ook een ander signaal gaf namelijk het verhogen
van de concentratie calcium ionen in de cel. IL-8 kon dit alleen als eo’s gehecht waren
op een oppervlak en niet wanneer de cellen in een vloeistof dreven. Daarom is de 
hypothese dat 1) IL-8 eerst leidt tot aktivatie van de integrines, 2) dat de integrines door
de stevige hechting verder worden geaktiveerd, 3) dat de integrines vervolgens signalen
naar de binnenkant van de eo geven wat leidt tot verhoging van de calcium ionen in 
de cel. Kortom, IL-8 leidt niet direct tot een verhoging van calcium ionen maar doet dit
via de integrines.
In hoofdstuk 5 zijn de aktivatoren IL-8, eotaxine en C5a vergeleken. Het bleek dat de 
verschillende aktivatoren verschillende routes binnen de cel gebruikten om de 
integrines aan te schakelen. Het enzym (een eiwit dat kan knippen) phopholipase C
leek een grote rol te spelen in deze regulatie want het blokkeren van dit enzym 
bewerkstelligde dat de aktivatoren de integrines niet of nauwelijks nog konden 
aktiveren. En dus konden de eo’s niet meer hechten aan de endotheelcellen.
In hoofdstuk 6 worden proeven beschreven waarin de stap werd onderzocht die volgt
na het rollen en het stilzitten namelijk het kruipen van de eo. Het is bekend dat als 
cellen kruipen over een oppervlak ze een typerende vorm aannemen. Het voorste deel
179
NEDERLANDSE SAMENVATTING
(lamellipodium) is heel breed en het achterste deel (uropod) van de cel is smal 
(zie figuur 4 van hoofdstuk 1). Het voorste deel schuift over het oppervlak en het 
achterste deel wordt bijgetrokken. De proeven in hoofstuk 6 laten zien dat de eo 
problemen heeft met het bijtrekken van haar achterste. Alleen als de eo de goede 
stimulator “ruikt” dan kan hij haar achterste bijtrekken en verder vooruit komen. 
Serum (=bloed met alle cellen en stollingsprodukten daaruit verwijderd) bleek een
goede stimulator te zijn. Serum kon zowel de voorkant naar voren laten gaan en de 
achterkant bij laten trekken. Eotaxine daartegenover kon wel de voorkant van de eo in
beweging zetten maar kon niet de achterkant laten bijtrekken wat resulteerde in een
langgerekte cel die niet vooruit kwam. Vervolgens is laten zien dat een molecuul in de
cel, RhoA genoemd, belangrijk is voor het bijtrekken van de achterkant. Inderdaad,
serum kon RhoA langdurig aktiveren maar eotaxine kon het slechts kort aktiveren wat
overeenkomt met de discrepantie tussen serum en eotaxine in het kruipgedrag.
Additioneel bewijs dat RhoA belangrijk is voor het bijtrekken van de achterkant komt uit
de proeven waarin een aktief RhoA eiwit in de eo werd gebracht. Nu konden eo’s
opeens wel hun achterste bijtrekken in de aanwezigheid van eotaxine. 
Conclusies:
Eo’s rollen over E-selectine en kunnen ook hun a 4 integrine gebruiken voor de 
eerste hechting aan endotheelcellen.
Eo’s van astma patiënten hebben een additief mechanisme voor het hechten namelijk
het gebruik van bloedplaatjes. 
Eo’s kunnen worden gestimuleerd door IL-8 wat resulteert in hechting van de eo’s en in
het verhogen van de calcium ion concentratie in de cellen.
Verschillende aktivatoren kunnen de integrines op een eo via verschillende wegen 
aktiveren.
RhoA is belangrijk voor het bijtrekken van het achterste deel van de cel.
Interfereren met hechting: een middel om 
astma te verhelpen?
De blokkade van hechtingsmoleculen op eo’s door antilichamen wordt als een
mogelijke nieuwe therapie beschouwd. De grootste vraag is: Welk hechtingsmolecuul
kun je het beste blokkeren? Studies (onder andere dit proefschrift) tonen aan dat 
meerdere hechtingsmoleculen een rol spelen. Kandidaten zijn selectines, b 2 integrines
en a 4 integrines. Het blokkeren van selectines lijkt een optie maar er bestaat een ziekte
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(Leukocyte Adhesion Deficiency type II, LAD II) waarbij de cellen van de patiënt geen
goede receptoren voor de selectines hebben. Deze patiënten zijn erg ziek omdat witte
bloedcellen (vooral neutrofiele granulocyten) niet meer naar de plaats kunnen komen
waar b.v. een bacterie is binnen gedrongen. Het ontbreken van de selectines zelf zou tot
dezelfde verschijnselen kunnen leiden. Dit kan een reden zijn om de selectines niet 
tot doel van antilichaam-therapie te maken. Het blokkeren van b 2 integrines lijkt ook 
een mogelijkheid. Maar ook hiervan zijn natuurlijke voorbeelden bekend dat dit niet
ongestraft gaat. Kinderen die geboren worden met Leukocyte Adhesion Deficiency type
I hebben op geen enkele cel b 2 integrines zitten. Dit leidt eveneens tot infecties van 
allerlei organen net als bij LAD II. Blokkeren van b 2 integrines in astma patiënten zou dus
kunnen leiden tot grotere neveneffecten dan het eigenlijke verhelpen van de ziekte.
Waarschijnlijk zal de beste kandidaat de a 4 integrine zijn. Dan blijven er voldoende 
adhesiemoleculen over om het dagelijkse werk te doen: het bewaken van het lichaam
en het opruimen van bacteriën. Daarnaast wordt niet alleen de eo verhinderd in de
hechting aan endotheel maar ook de lymfocyte (weer een ander type witte bloedcel).
De lymfocyte speelt namelijk ook een belangrijke rol in het ontstekingsproces van astma.
Of het blokkeren van a 4 genoeg is om de eo’s buiten het longweefsel te houden, is een
interessant vraagstuk dat in de toekomst opgelost zal worden.
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